EX-13 8 y72746exv13.htm EX-13: FINANCIALS OF THE ANNUAL REPORT EX-13
Exhibit 13
Financials
 
 
         
 
       
Management’s Discussion and Analysis
    10  
 
       
Management’s Report on Internal Control over Financial Reporting      
    32  
 
       
Report of Independent Registered Public Accounting Firm
on Internal Control over Financial Reporting
    33  
 
       
Report of Independent Registered Public Accounting Firm
    34  
 
       
The Consolidated Financial Statements
    35  
 
       
Notes to the Consolidated Financial Statements
    39  
 
       
Five-Year Summary of Selected Financial Data
    71  
 9 

 


 

Management’s Discussion and Analysis
(Millions of dollars, except for share data)

         
Business Overview
    10  
2008 in Summary
    11  
2009 Outlook
    12  
Results of Operations
    12  
Pension Benefits
    20  
Environmental Matters
    22  
Liquidity and Capital Resources
    23  
Contractual Obligations
    25  
Off-Balance Sheet Arrangements
    27  
Related Party Transactions
    27  
Market Risks and Sensitivity Analysis
    27  
Inflation
    28  
Critical Accounting Policies and Estimates
    28  
New Accounting Standards
    31  
Forward-Looking Statements
    31  
All comparisons in the discussion are to the corresponding prior year unless otherwise stated. All amounts presented are in accordance with U.S. generally accepted accounting principles, except as noted. All amounts are presented in millions of dollars, except for share data, unless otherwise indicated.
BUSINESS OVERVIEW
Air Products and Chemicals, Inc. and its subsidiaries (the Company) serve customers in industrial, energy, technology, and healthcare markets. The Company offers a broad portfolio of atmospheric gases, process and specialty gases, performance materials, and equipment and services. Geographically diverse, with operations in over 40 countries, the Company has sales of $10.4 billion, assets of $12.6 billion, and a worldwide workforce of more than 21,000 employees.
The Company organizes its operations into four reportable business segments: Merchant Gases, Tonnage Gases, Electronics and Performance Materials, and Equipment and Energy. A general description of each segment and the key variables impacting the segment follow.
Previously, the Company reported results for a Chemicals segment, which consisted of the Polymer Emulsions business and the Polyurethane Intermediates (PUI) business, and a Healthcare segment. Beginning with the first quarter of 2008, the Polymer Emulsions business was accounted for as discontinued operations and the PUI business was reported as part of the Tonnage Gases segment. The PUI business model is similar to Tonnage Gases in that it has long-term contracts and raw material cost pass-through provisions. Beginning with the fourth quarter of
2008, the U.S. Healthcare business was accounted for as discontinued operations and the Europe Healthcare business was reported as part of the Merchant Gases segment. The Europe Healthcare business model is similar to Merchant Gases in that it has shorter-term requirement contracts and delivers oxygen in cylinders to end customers. Prior period information has been restated. For additional information on discontinued operations, refer to Note 5 to the Consolidated Financial Statements.
Merchant Gases
The Merchant Gases segment sells industrial gases such as oxygen, nitrogen and argon (primarily recovered by the cryogenic distillation of air), hydrogen and helium (purchased or refined from crude helium), and medical and specialty gases, along with certain services and equipment, throughout the world to customers in many industries, including those in metals, glass, chemical processing, food processing, healthcare, medical gases, steel, general manufacturing, and petroleum and natural gas industries. There are four principal types of products: liquid bulk, packaged gases, small on-sites, and healthcare products. Most merchant product is delivered via bulk supply, in liquid or gaseous form, by tanker or tube trailer. Smaller quantities of industrial, specialty, and medical gases are delivered in cylinders and dewars as “packaged gases,” or through small on-site gas generation plants (cryogenic or noncryogenic generators). Through its healthcare business, the Company offers respiratory therapies, home medical equipment, and infusion services. Electricity is the largest cost component in the production of atmospheric gases. The Company mitigates energy prices through pricing formulas and surcharges. Merchant Gases competes worldwide against global and regional industrial gas companies. Competition in industrial gases is based primarily on price, reliability of supply, and the development of industrial gas applications. Competition in the healthcare business involves regulatory compliance, price, quality, service, and reliability of supply.
Tonnage Gases
The Tonnage Gases segment supplies industrial gases, including hydrogen, carbon monoxide, syngas, nitrogen, and oxygen, via large on-site facilities or pipeline systems, principally to customers in the petroleum refining, chemical, and metallurgical industries. The Tonnage Gases segment also includes the Company’s PUI business. The PUI business markets toluene diamine to customers under long-term contracts. For large-volume, or “tonnage” industrial gas users, the Company either constructs a gas plant adjacent to or near the customer’s


10   AIR PRODUCTS 2008 ANNUAL REPORT | Management’s Discussion and Analysis

 


 

facility—hence the term “on-site”—or delivers product through a pipeline from a nearby location. The Company is the world’s largest provider of hydrogen, which is used by refiners to lower the sulfur content of gasoline and diesel fuels to reduce smog and ozone depletion. Electricity is the largest cost component in the production of atmospheric gases, and natural gas is the principal raw material for hydrogen, carbon monoxide, and syngas production. The Company mitigates energy and natural gas price changes through its long-term cost pass-through type contracts. Tonnage Gases competes against global industrial gas companies as well as regional sellers. Competition is based primarily on price, reliability of supply, the development of applications that use industrial gases and, in some cases, provision of other services or products such as power and steam generation.
Electronics and Performance Materials
The Electronics and Performance Materials segment employs applications technology to provide solutions to a broad range of global industries through expertise in chemical synthesis, analytical technology, process engineering, and surface science. This segment provides specialty and tonnage gases, specialty chemicals, services, and equipment to the electronics industry for the manufacture of silicon and compound semiconductors, LCD and other displays, and photovoltaic devices. The segment also provides performance chemical solutions for the coatings, inks, adhesives, civil engineering, personal care, institutional and industrial cleaning, mining, oil field, polyurethane, and other industries. The Electronics and Performance Materials segment faces competition on a product-by-product basis against competitors ranging from niche suppliers with a single product to larger and more vertically integrated companies. Competition is principally conducted on the basis of product performance, reliability of product supply, global infrastructure, technical innovation, service, quality, and price.
Equipment and Energy
The Equipment and Energy segment designs and manufactures cryogenic and gas processing equipment for air separation, hydrocarbon recovery and purification, natural gas liquefaction (LNG), and helium distribution, and serves energy markets in a variety of ways. Equipment is sold worldwide to customers in a variety of industries, including chemical and petrochemical manufacturing, oil and gas recovery and processing, and steel and primary metals processing. Energy markets are served through the Company’s operation and partial ownership of cogeneration and flue gas treatment facilities. The Company is developing technologies to continue to serve energy markets in the future, including gasification and alternative energy technologies. Equipment and Energy competes with a great number
of firms for all of its offerings except LNG heat exchangers, for which there are fewer competitors due to the limited market size and proprietary technologies. Competition is based primarily on technological performance, service, technical know-how, price, and performance guarantees.
2008 IN SUMMARY
Overall, 2008 represented another year of solid performance by the Company, with 14% sales growth and 9% earnings per share growth from continuing operations. These results were attributable to underlying base business volume increases, higher prices in Merchant Gases, favorable currency impacts, and higher natural gas contractual cost pass-through. The strong financial performance enabled the Company to invest in new plant and equipment, repurchase its stock, and raise dividends for the 26th consecutive year.
The Company continued to improve its business portfolio by selling its Polymer Emulsions business and completing the sale of its High Purity Process Chemicals (HPPC) business. In July 2008, the Board of Directors authorized management to pursue the sale of the U.S. Healthcare business. These businesses have been accounted for as discontinued operations.
Highlights for 2008
  Sales increased 14% to $10,415 due to volume growth in the Merchant Gases, Tonnage Gases, and Electronics and Performance Materials segments; improved pricing in Merchant Gases; favorable currency effects; and higher natural gas contractual cost pass-through.
 
  Operating income increased 9%, reflecting volume growth, improved pricing, and favorable currency effects. These gains were somewhat offset by higher pension settlement charges, the unfavorable impacts of a fire at an Electronics production facility in Korea, and recent Gulf Coast hurricanes. The prior year included a gain of $37 from a customer contract settlement.
 
  Equity affiliates’ income increased 27% due to underlying growth and favorable adjustments to certain affiliates.
 
  The effective tax rate was 25.1%, compared to 22.0%, as 2007 was favorably impacted by settlements of tax audits and the donation of a cost-based investment.
 
  Income and diluted earnings per share from continuing operations increased 7% and 9%, respectively.
 
  The Company sold its Polymer Emulsions business, recognizing a gain of $120 ($76 after-tax, or $.35 per share), and completed the sale of its HPPC business.


 11 

 


 

  In July, the Board of Directors authorized the Company to pursue the sale of its U.S. Healthcare business. The Company recognized a total charge of $329 ($246 after-tax, or $1.12 per share) related to the impairment/write-down of the U.S. Healthcare assets to net realizable value.
 
  The Company purchased 8.7 million of its outstanding shares at a cost of $787.
 
  The quarterly cash dividend was raised by 16%, from 38 cents to 44 cents.
Changes in Diluted Earnings per Share
                         
                  Increase  
  2008     2007   (Decrease)  
     
Diluted Earnings per Share
                       
Net Income
  $ 4.15     $ 4.64     $ (.49 )
Discontinued Operations
    (.82 )     .07       (.89 )
 
Continuing Operations
  $ 4.97     $ 4.57     $ .40  
 
Operating Income (after-tax)
                       
Underlying business
                       
Volume
                    .27  
Price/raw materials
                    .07  
Costs
                    (.01 )
Acquisitions/divestitures
                    .05  
Currency
                    .27  
Plant fire and hurricanes
                    (.10 )
2007 Customer contract settlement
                    (.11 )
2007 Global cost reduction plan
                    .04  
Pension settlement
                    (.05 )
2007 Sale/donation of cost investment
                    (.02 )
 
Operating Income
                    .41  
 
                       
Other (after-tax)
                       
Equity affiliates’ income
                    .10  
Minority interest
                    (.01 )
Average shares outstanding
                    .09  
Income tax rate
                    .05  
2007 Tax audit settlements/adjustments
                    (.17 )
2007 Tax benefit from donation of cost investment
                    (.07 )
 
Other
                    (.01 )
 
Total Change in Diluted Earnings per Share from Continuing Operations
                  $ .40  
 
2009 OUTLOOK
Looking forward, the Company will continue to focus on improving its operating margin and increasing return on capital through volume growth, effective cost management, and implementation of price increases.
The present economic downturn and the uncertainty of future economic conditions will be a challenge facing the Company in 2009. In response, the Company plans to implement several initiatives, including lowering discretionary spending, reducing selling and administrative expenses through effective utilization of existing information technology systems, increasing the energy efficiency of its plants, and investing in fuel-efficient equipment to reduce distribution expenses.
RESULTS OF OPERATIONS
Discussion of Consolidated Results
                         
    2008     2007     2006  
     
Sales
  $ 10,414.5     $ 9,148.2     $ 7,885.0  
Operating income
    1,495.8       1,375.6       1,041.9  
Equity affiliates’ income
    145.0       114.4       91.5  
 
Sales
                 
    % Change from Prior Year
    2008     2007  
   
Underlying business
               
Volume
    4 %     12 %
Equipment and Energy
    (2 )%     1 %
Price
    2 %      
Acquisitions/divestitures
    1 %     1 %
Currency
    4 %     3 %
Natural gas/raw material cost pass-through
    5 %     (1 )%
 
Total Consolidated Sales Change
    14 %     16 %
 
2008 vs. 2007
Sales of $10,414.5 increased 14%, or $1,266.3. Underlying base business growth accounted for 4% of the increase. Sales increased 4% from higher volumes as further discussed in the Segment Analysis which follows. Lower Equipment and Energy activity decreased sales by 2%. Improved pricing, principally in Merchant Gases, increased sales by 2%. Sales improved 4% from favorable currency effects, primarily the weakening of the U.S. dollar against the Euro. Higher natural gas/raw material contractual cost pass-through to customers increased sales by more than $450, or 5%.


12   AIR PRODUCTS 2008 ANNUAL REPORT | Management’s Discussion and Analysis

 


 

2007 vs. 2006
Sales of $9,148.2 increased 16%, or $1,263.2. Underlying base business growth of 13% resulted primarily from improved volumes across all business segments, as further discussed in the Segment Analysis which follows. Pricing impacts were flat, with improved pricing in Merchant Gases offset primarily by lower pricing in Electronics and Performance Materials. Sales improved 3% from favorable currency effects, driven primarily by the weakening of the U.S. dollar against the Euro and Pound Sterling. Lower natural gas/raw material contractual cost pass-through to customers decreased sales by 1%, mainly due to lower natural gas prices.
Operating Income
                 
    Change from Prior Year  
    2008     2007  
   
Prior Year Operating Income
  $ 1,376     $ 1,042  
Underlying business
               
Volume
    82       293  
Price/raw materials
    21       44  
Costs
    (3 )     (129 )
Acquisitions/divestitures
    16       11  
Currency
    80       41  
Global cost reduction plan
               
2007
    14       (14 )
2006
          71  
Pension settlement
    (20 )     (10 )
2008 Plant fire and hurricanes
    (28 )      
2007 Sale/donation of cost investment
    (5 )     5  
2007 Customer contract settlement
    (37 )     37  
2006 Hurricanes
          (18 )
Stock option expense
          7  
2006 Impairment of loans receivable
          66  
2006 Gain on a sale of a chemical facility
          (70 )
 
Operating Income
  $ 1,496     $ 1,376  
 
2008 vs. 2007
Operating income of $1,495.8 increased 9%, or $120.2.
 
  Higher volumes in the Merchant Gases, Tonnage Gases, and Electronics and Performance Materials segments, offset by a decrease in Equipment and Energy activity, increased operating income by $82, as discussed in the Segment Analysis that follows.
 
  Improved pricing, net of variable costs, increased operating income by $21, as pricing increases in Merchant Gases were partially offset by lower pricing in electronics specialty materials.
 
  Favorable currency effects, primarily the weakening of the U.S. dollar against the Euro, increased operating income by $80.
 
  Higher pension settlement charges negatively impacted operating income by $20.
 
  Unfavorable impacts caused by Hurricanes Gustav and Ike, and the fire at an Electronics production facility in Korea, decreased operating income by $28.
 
  2007 included a gain of $37 from a settlement of a supply contract termination.
2007 vs. 2006
Operating income of $1,375.6 increased 32%, or $333.7.
  Higher volumes across all segments increased operating income by $293, as discussed in the Segment Analysis that follows.
 
  Improved pricing, net of variable costs, increased operating income by $44, as pricing increases in Merchant Gases were partially offset by lower pricing in electronics specialty materials.
 
  Higher costs, principally to support growth and due to inflation, decreased operating income by $129.
 
  Favorable currency effects increased operating income by $41, as the U.S. dollar weakened against the Euro and the Pound Sterling.
 
  The global cost reduction plan resulted in a 2007 charge to operating income of $14 compared to a charge of $71 in 2006.
 
  The settlement of a supply contract termination in the Tonnage Gases segment increased operating income by $37.
 
  2006 included a gain on sale of a chemical facility of $70.
 
  2006 included an impairment of loans receivable of $66.
 
  2006 included a benefit of $18 from insurance recoveries exceeding estimated business interruption and asset write-offs and other expenses related to Hurricanes Katrina and Rita.
Equity Affiliates’ Income
2008 vs. 2007
Income from equity affiliates of $145.0 increased $30.6, or 27%, reflecting higher income from equity affiliates in Merchant Gases. This increase resulted from solid underlying growth, increased nitrogen injection volumes in Mexico, and from the benefit of adjustments to certain affiliates.
2007 vs. 2006
Income from equity affiliates of $114.4 increased $22.9, or 25%, due to higher income from affiliates across most segments, primarily Asian and Latin American affiliates in the Merchant Gases segment.


 13 

 


 

Selling and Administrative Expense (S&A)
                 
    % Change from Prior Year  
    2008     2007  
     
Acquisitions/divestitures
    2 %     1 %
Currency
    4 %     3 %
Other costs
    3 %     8 %
 
Total S&A Change
    9 %     12 %
 
2008 vs. 2007
S&A expense of $1,090.4 increased 9%, or $90.6. S&A as a percent of sales declined to 10.5% from 10.9%. S&A increased 2% from the acquisition of the Polish industrial gas business of BOC Gazy Sp z o.o. (BOC Gazy) in the third quarter of 2007. Currency effects, driven by the weakening of the U.S. dollar against the Euro, increased S&A by 4%. Underlying costs increased S&A by 3%, as productivity gains were more than offset by inflation and higher costs to support growth.
2007 vs. 2006
S&A expense of $999.8 increased 12%, or $108.3. S&A as a percent of sales declined to 10.9% from 11.3%, primarily due to the benefit of implementing SAP. The acquisitions of BOC Gazy and Tomah3 Products increased S&A by 1%. Unfavorable currency effects, mainly the weakening of the U.S. dollar against the Euro and Pound Sterling, increased S&A by 3%. Underlying costs increased S&A by 8%, as productivity gains were more than offset by inflation and costs to support growth.
Research and Development (R&D)
2008 vs. 2007
R&D expense of $130.7 increased $1.7. R&D decreased as a percent of sales to 1.3% from 1.4%.
2007 vs. 2006
R&D decreased by 8%, or $10.9, as a result of lower spending in Equipment and Energy due to a test program run in 2006 and the Company’s organization simplification efforts. R&D spending declined as a percent of sales to 1.4% from 1.8%.
Pension Settlement
A number of corporate officers and others who were eligible for supplemental pension plan benefits retired in fiscal years 2007 and 2008. The Company’s supplemental pension plan provides for a lump sum benefit payment option at the time of retirement, or for corporate officers six months after the participant’s retirement date.
The Company recognizes pension settlements when payments exceed the sum of service and interest cost components of net periodic pension cost of the plan for the fiscal year. However, a settlement loss is not recognized until the time the pension obligation is settled. Based on the timing of when cash payments were made, the Company recognized $10.3 for settlement losses in 2007 and an additional $30.3 in 2008.
2007 Customer Contract Settlement
In 2007, the Company entered into a settlement with a customer to resolve a dispute related to a dinitrotoluene (DNT) supply agreement. As part of the settlement agreement, the DNT supply agreement was terminated, and certain other agreements between the companies were amended. As a result, the Company recognized a before-tax gain of $36.8 ($23.6 after-tax, or $.11 per share) in 2007.
Global Cost Reduction Plan
Results in 2007 and 2006 included charges related to a global cost reduction plan that comprised severance, pension costs, and asset write-downs related to reorganization and streamlining of certain organizations and activities in Europe, rationalizing product offerings in Electronics, and simplifying management structure and business practices.
The 2007 results from continuing operations included a charge of $13.7 ($8.8 after-tax, or $.04 per share) for the global cost reduction plan. The charge included $6.5 for severance and pension-related costs for the elimination of approximately 125 positions and $7.2 for the write-down of certain investments. Approximately one-half of the position eliminations related to the continuation of European initiatives to streamline certain activities. The remaining position eliminations related to the continued cost reduction and productivity efforts of the Company. As of 30 September 2008, the actions associated with the 2007 charge were complete.
The 2006 results from continuing operations included a charge of $71.0 ($46.1 after-tax, or $.20 per share) for the global cost reduction plan. This charge included $59.5 for severance and pension-related costs for approximately 312 position eliminations and $11.5 for asset disposals and facility closures. As of 30 September 2007, the majority of the planned actions associated with the 2006 charge were completed, with the exception of a small number of position eliminations and/or associated benefit payments. These actions were completed in the first quarter of fiscal 2008.
Cost savings from the plan realized in 2008 and 2007 were approximately $43 and $21, respectively. Beyond 2008, the Company expects the plan to provide annualized cost savings of $46, of which the majority are related to reduced personnel costs. Refer to Note 3 to the Consolidated Financial Statements for additional information on the Global Cost Reduction Plan.


14   AIR PRODUCTS 2008 ANNUAL REPORT | Management’s Discussion and Analysis

 


 

Gain on Sale of a Chemical Facility
In 2006, as part of its announced restructuring of its PUI business, the Company sold its DNT production facility in Geismar, Louisiana to BASF Corporation for $155.0. The Company wrote off the remaining net book value of assets sold, resulting in the recognition of a gain of $70.4 ($42.9 after-tax, or $.19 per share) on the transaction.
Impairment of Loans Receivable
In 2006, the Company recognized a loss of $65.8 ($42.4 after-tax, or $.19 per share) for the impairment of loans receivable from a long-term supplier of sulfuric acid, used in the production of DNT for the Company’s PUI business.
Other (Income) Expense, Net
Items recorded to other (income) expense arise from transactions and events not directly related to the principal income earning activities of the Company. The detail of other (income) expense is presented in Note 20 to the Consolidated Financial Statements.
2008 vs. 2007
Other income of $25.8 was lower by $16.5. Other income in 2008 included a loss of $14.7 related to fire damage at an Electronics production facility in Korea. Other income in 2007 included a gain of $23.7 on the sale of assets. No other items were individually significant in comparison to the prior year.
2007 vs. 2006
Other income of $42.3 was lower by $29.4. Other income in 2007 included a gain of $23.7 for the sale of assets as part of the Company’s ongoing asset management activities, including the sale/donation of a cost-based investment. Other income in 2006 included $56.0 from hurricane insurance recoveries in excess of property damage and related expenses. This net gain does not include the estimated impact related to business interruption. Other income in 2006 also included a gain of $9.5 from the sale of land in Europe. No other items were individually significant in comparison to the prior year.
Interest Expense
                         
    2008     2007     2006  
     
Interest incurred
  $ 184.1     $ 175.3     $ 134.9  
Less: interest capitalized
    22.1       12.9       16.5  
 
Interest Expense
  $ 162.0     $ 162.4     $ 118.4  
 
2008 vs. 2007
Interest incurred increased by $8.8. The increase resulted from a higher average debt balance, excluding currency effects, and the impact of a weaker U.S. dollar on the translation of foreign currency interest, partially offset by lower average interest rates. Capitalized interest increased by $9.2, primarily due to increased project levels in the Tonnage Gases segment.
2007 vs. 2006
Interest incurred increased $40.4. The increase resulted from a higher average debt balance excluding currency effects, higher average interest rates, and the impact of a weaker U.S. dollar on the translation of foreign currency interest. The Company primarily utilized the additional debt for the share repurchase program, the acquisition of BOC Gazy, and in funding its pension plans.
Effective Tax Rate
The effective tax rate equals the income tax provision divided by income from continuing operations before taxes less minority interest. Refer to Note 17 to the Consolidated Financial Statements for details on factors affecting the effective tax rate.
2008 vs. 2007
The effective tax rate was 25.1% and 22.0% in 2008 and 2007, respectively. A tax benefit associated with foreign operations and other higher credits and adjustments from the Company’s ongoing tax planning process are included in the 2008 effective rate. The 2007 tax rate included the settlement of tax audits and related interest income, combined with the donation of a portion of a cost-based investment. The net impact was a 3.1% higher tax rate in 2008.
2007 vs. 2006
The effective tax rate was 22.0% and 26.3% in 2007 and 2006, respectively. In June 2007, the Company settled audits through fiscal year 2004 with the Internal Revenue Service. The audit settlement resulted in a tax benefit of $27.5. In the fourth quarter of 2007, the Company recorded a tax benefit of $11.3 from tax audit settlements and adjustments and related interest income. Additionally, the Company donated a portion of a cost-based investment that resulted in a pretax loss of $4.7 and a tax benefit of $18.3. The net impact was a 4.3% lower tax rate in 2007.


 15 

 


 

Discontinued Operations
The U.S. Healthcare business, Polymer Emulsions business, HPPC business, and Amines business have been accounted for as discontinued operations. The results of operations of these businesses have been removed from the results of continuing operations for all periods presented. Refer to Note 5 to the Consolidated Financial Statements for additional details.
U.S. Healthcare
In July 2008, the Board of Directors authorized management to pursue the sale of the U.S. Healthcare business. Accordingly, beginning in the fourth quarter of 2008, the U.S. Healthcare business was accounted for as discontinued operations.
For the fiscal year 2008, the Company recorded a total charge of $329.2 ($246.2 after-tax, or $1.12 per share) related to the impairment/write-down of the net carrying value of the U.S. Healthcare business.
  In the third quarter of 2008, the Company performed an impairment analysis and recorded a charge of $314.8 ($237.0 after-tax, or $1.09 per share). The charge related to the impairment of goodwill for $294.3, intangible assets for $11.7, plant and equipment for $7.8, and other assets for $1.0. The impairment reduced the carrying amount of the U.S. Healthcare reporting unit goodwill and intangible assets to zero.
 
  In the fourth quarter of 2008, the Company recorded a charge of $14.4 ($9.2 after-tax, or $.04 per share), reflecting an estimate of net realizable value.
Additional charges may be recorded in future periods dependent upon the timing and method of ultimate disposition.
In 2007, the Company implemented several changes to improve performance, including management changes, product and service offering simplification, and other measures. However, market and competitive conditions were more challenging than anticipated and financial results did not meet expectations. In response to the disappointing financial results, during the third quarter 2008 management conducted an evaluation of the strategic alternatives for the business.
In accordance with SFAS No. 142, “Goodwill and Other Intangible Assets,” and SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets,” the Company determined that an interim test for impairment was required for its U.S. Healthcare reporting unit during the third quarter of 2008, based on the combination of events described above. The Company reforecast its cash flows and utilized the expected present value of the future cash flows to calculate fair value of the U.S. Healthcare reporting unit in completing its SFAS No. 142 and 144 impairment tests.
The U.S. Healthcare business generated sales of $239.8, $271.1, and $280.8, and a loss, net of tax, of $259.4, $15.2, and $19.1 in 2008, 2007, and 2006, respectively.
Polymer Emulsions Business
In January 2008, the Company sold its interest in its vinyl acetate ethylene (VAE) polymers joint ventures to Wacker Chemie AG, its long-time joint venture partner. As part of that agreement, the Company received Wacker Chemie AG’s interest in the Elkton, Md. and Piedmont, S.C. production facilities and their related businesses plus cash proceeds of $258.2. The Company recognized a gain of $89.5 ($57.7 after-tax, or $.26 per share) in the second quarter of 2008 for this sale, which consisted of the global VAE polymers operations including production facilities located in Calvert City, Ky.; South Brunswick, N.J.; Cologne, Germany; and Ulsan, Korea; and commercial and research capabilities in Allentown, Pa. and Burghausen, Germany. The business produces VAE for use in adhesives, paints and coatings, paper, and carpet applications.
In June 2008, the Company sold its Elkton, Md. and Piedmont, S.C. production facilities and the related North American atmospheric emulsions and global pressure sensitive adhesives businesses to Ashland Inc. for $92.0. The Company recorded a gain of $30.5 ($18.5 after-tax, or $.08 per share) in connection with the sale, which included the recording of a retained environmental obligation associated with the Piedmont site. The expense to record the environmental obligation was $24.0 ($14.5 after-tax, or $.07 per share). The Piedmont site is under active remediation for contamination caused by an insolvent prior owner. Before the sale, which triggered expense recognition, remediation costs had been capitalized since they improved the property as compared to its condition when originally acquired. The sale of the Elkton and Piedmont facilities completed the disposal of the Company’s Polymer Emulsions business.
The Polymer Emulsion business generated sales of $261.4, $618.6, and $587.0, and income, net of tax, of $11.3, $38.3, and $30.1 in 2008, 2007, and 2006, respectively.
HPPC Business
In 2008, the Company sold its HPPC business, which had previously been reported as part of the Electronics and Performance Materials operating segment, to KMG Chemicals, Inc. The Company’s HPPC business consisted of the development, manufacture, and supply of high-purity process chemicals used in the fabrication of integrated circuits in the United States and Europe. The Company wrote down the assets of the HPPC business to net realizable value as of 30 September 2007, resulting in a loss of $15.3 ($9.3 after-tax, or $.04 per share) in the fourth quarter of 2007.


16   AIR PRODUCTS 2008 ANNUAL REPORT | Management’s Discussion and Analysis

 


 

The sale closed on 31 December 2007 for cash proceeds of $69.3 and included manufacturing facilities in the United States and Europe. Subsequent to the sale, certain receivables and inventories were sold to KMG Chemicals, Inc. In the first quarter of 2008, this business generated sales of $22.9 and income, net of tax, of $.1. Also, the Company recorded an additional loss of $.5 ($.3 after-tax) on the sale of the business.
The HPPC business generated sales of $87.2 and $97.6, and income, net of tax, of $2.2 and $3.2 in 2007 and 2006, respectively.
Amines Business
In 2006, the Company sold its Amines business to Taminco N.V., a producer of methylamines based in Belgium. The sales price was $211.2 in cash, with certain liabilities assumed by the purchaser. The Company recorded a loss of $40.0 ($23.7 after-tax, or $.11 per share) in connection with the sale of the Amines business and the recording of certain environmental and contractual obligations that the Company retained. A charge of $42.0 ($26.2 after-tax, or $.12 per share) was recognized for environmental obligations related to the Pace, Florida facility. In addition, fourth quarter 2006 results also included a charge of $8.3 ($5.2 after-tax, or $.02 per share) for costs associated with a contract termination.
The Amines business produced methylamines and higher amines products used globally in household, industrial, and agricultural products. The sale of the Amines business included the employees and certain assets and liabilities of the production facilities in Pace, Florida; St. Gabriel, Louisiana; and Camaçari, Brazil.
The Amines business generated sales of $308.4 and income, net of tax, of $5.0 in 2006.
Cumulative Effect of an Accounting Change
The Company adopted FASB Interpretation No. 47, “Accounting for Conditional Asset Retirement Obligations” (FIN 47), effective 30 September 2006, and recorded an after-tax charge of $6.2 as the cumulative effect of an accounting change in 2006. FIN 47 clarifies the term, conditional asset retirement obligation, as used in SFAS No. 143, “Accounting for Asset Retirement Obligations,” which refers to a legal obligation to perform an asset retirement activity in which the timing and/or method of settlement are conditional on a future event.
Net Income
2008 vs. 2007
Net income was $909.7, compared to $1,035.6 in 2007. Diluted earnings per share was $4.15, compared to $4.64 in 2007. A summary table of changes in diluted earnings per share is presented on page 12.
2007 vs. 2006
Net income was $1,035.6, compared to $723.4 in 2006. Diluted earnings per share was $4.64, compared to $3.18 in 2006.
Segment Analysis
The Company organizes its operations into four reportable business segments: Merchant Gases, Tonnage Gases, Electronics and Performance Materials, and Equipment and Energy. Refer to the Business Overview discussion beginning on page 10 for a description of the business segments and Note 22 to the Consolidated Financial Statements for additional segment information.
Merchant Gases
                         
    2008     2007     2006  
     
Sales
  $ 4,192.7     $ 3,556.9     $ 3,002.8  
Operating income
    789.5       656.4       517.3  
Equity affiliates’ income
    131.8       97.8       82.4  
 
Merchant Gases Sales
                 
    % Change from Prior Year  
    2008     2007  
     
Underlying business
               
Volume
    4 %     9 %
Price
    4 %     2 %
Acquisitions/divestitures
    3 %     2 %
Currency
    7 %     5 %
 
Total Merchant Gases Sales Change
    18 %     18 %
 
2008 vs. 2007
Merchant Gases Sales
Sales of $4,192.7 increased 18%, or $635.8. Higher volumes across all regions increased sales by 4%. Volumes increased in North America due to record new signings in 2008 and continued strong demand for liquid oxygen (LOX) and liquid nitrogen (LIN). Volume gains in Europe were primarily due to a higher number of Healthcare patients served. In Asia, volumes were higher in generated gases, liquid argon, and liquid helium.
Higher prices increased sales by 4% as a result of actions taken to recover higher power, distribution, and other manufacturing costs in North America and Europe. Price increases in Asia, implemented in the last quarter of 2008, did not have a material impact on full year results.


 17 

 


 

Sales increased by 3% from the full year impact of the acquisition of BOC Gazy in 2007. In addition, sales increased 7% due to favorable currency impacts, primarily the weakening of the U.S. dollar against the Euro.
Merchant Gases Operating Income
Operating income of $789.5 increased by 20%, or $133.1. Favorable operating income variances resulted from improved pricing of $75, higher volumes of $60, and currency effects of $51. Operating income declined by $49 from higher distribution costs and inflation.
Merchant Gases Equity Affiliates’ Income
Equity affiliates’ income of $131.8 increased $34.0, reflecting higher income in all regions. The increases are due to solid underlying growth, increased nitrogen injection volumes in Mexico, and the benefit of adjustments to certain affiliates.
2007 vs. 2006
Merchant Gases Sales
Sales of $3,556.9 increased 18%, or $554.1. Higher volumes across all regions increased sales by 9%. In North America, LOX/LIN volumes increased from higher demand across most end markets. The prior year was negatively impacted by hurricane-related supply disruptions for hydrogen. Volumes were higher in Europe across all businesses. Liquid bulk volumes increased due to higher demand across most end markets. Packaged gases volumes were up due to higher demand for industrial cylinders and new offerings in the business. In the Healthcare business, volumes benefited from the new respiratory care contract in the U.K. LOX/LIN volumes in Asia increased due to solid demand growth and new plants brought onstream.
Pricing increased sales by 2%. Prices for LOX/LIN improved 5% in North America, 4% in Europe, and 2% in Asia from pricing actions to recover higher power, distribution, and other manufacturing costs.
Sales were higher by 2% from the acquisition of BOC Gazy. In addition, favorable currency impacts, primarily the weakening of the U.S. dollar against the Euro and Pound Sterling, added 5% to sales.
Merchant Gases Operating Income
Operating income of $656.4 increased $139.1. Favorable operating income variances resulted from higher volumes of $108; improved pricing, net of variable costs, of $71; and currency impacts of $29. Operating income declined by $64 from higher costs to support growth and due to inflation, partially offset by productivity improvements. Operating income also decreased by $12, as
prior year results included hurricane insurance recoveries that exceeded estimated business interruption, asset write-offs, and other expenses.
Merchant Gases Equity Affiliates’ Income
Merchant Gases equity affiliates’ income of $97.8 increased by $15.4, with higher income reported by equity affiliates across all regions, primarily affiliates in Asia and Latin America.
Tonnage Gases
                         
    2008     2007     2006  
     
Sales
  $ 3,574.4     $ 2,936.7     $ 2,544.7  
Operating income
    482.6       463.2       371.7  
 
Tonnage Gases Sales
                 
    % Change from Prior Year  
    2008     2007  
     
Underlying business
               
Volume
    2 %     17 %
Acquisitions/divestitures
    1 %     1 %
Currency
    3 %     2 %
Natural gas/raw material cost pass-through
    16 %     (5 )%
 
Total Tonnage Gases Sales Change
    22 %     15 %
 
2008 vs. 2007
Tonnage Gases Sales
Sales of $3,574.4 increased 22%, or $637.7. Higher natural gas and raw material cost pass-through accounted for 16% of sales growth in 2008. Volume growth in the underlying business increased sales by 4%, primarily due to new plant start-ups in Asia and Canada, offset by a decline of 2% due to the impacts from hurricane-related business interruption.
The acquisition of BOC Gazy in the third quarter of 2007 improved sales by 1%. Sales increased 3% from favorable currency effects, primarily the weakening of the U.S. dollar against the Euro.
Tonnage Gases Operating Income
Operating income of $482.6 increased $19.4, or 4%. Operating income increased by $20 from higher volumes, $9 from favorable currency effects, and $30 from lower operating costs. Operating income decreased by $11 as a result of hurricane-related impacts. Operating income in 2007 included a gain of $37 from a customer contract settlement related to a DNT supply contract.


18   AIR PRODUCTS 2008 ANNUAL REPORT | Management’s Discussion and Analysis

 


 

2007 vs. 2006
Tonnage Gases Sales
Sales of $2,936.7 increased $392.0, or 15%. Underlying base business volume growth increased sales by 17%. Volumes were higher due to the 2006 start-up of new hydrogen plants supporting the energy industry and current year improved plant loadings. Prior year results were negatively impacted by the effects of Hurricane Katrina.
Sales improved 1% from the acquisition of BOC Gazy. Currency favorably impacted sales by 2% as the U.S. dollar weakened against the Euro and Pound Sterling. Natural gas cost contractually passed through to customers reduced sales by 5%.
Tonnage Gases Operating Income
Operating income of $463.2 increased $91.5, or 25%. Operating income increased $64 from higher volumes; $21 from improved variable costs, efficiencies, and higher operating bonuses; and $7 from favorable currency effects. Operating income also included a gain of $37 from a customer contract settlement related to a DNT supply contract. Costs increased $28 due to higher maintenance and operating costs, costs to support growth, and inflation. Operating income decreased by $8 as prior year results included hurricane insurance recoveries that exceeded estimated business interruption, asset write-offs, and other expenses. Refer to Note 20 to the Consolidated Financial Statements for further information.
Electronics and Performance Materials
                         
    2008     2007     2006  
     
Sales
  $ 2,209.3     $ 2,068.7     $ 1,801.0  
Operating income
    245.9       229.2       190.0  
 
Electronics and Performance Materials Sales
                 
    % Change from Prior Year  
    2008     2007  
     
Underlying business
               
Volume
    5 %     14 %
Price
          (2 )%
Acquisitions/divestitures
          2 %
Currency
    2 %     1 %
 
Total Electronics and Performance
Materials Sales Change
    7 %     15 %
 
2008 vs. 2007
Electronics and Performance Materials Sales
Sales of $2,209.3 increased 7%, or $140.6. Underlying base business growth increased sales by 5%. In Electronics, higher volumes in specialty materials and tonnage gases were partially offset by lower equipment sales and softer volumes due to product rationalization. Higher volumes across Asia and in some key market segments in North America increased sales in Performance Materials. Pricing was flat, as improvements in Performance Materials were offset by lower pricing in electronic specialty materials. Favorable currency effects, primarily the weakening of the U.S. dollar against key European and Asian currencies, improved sales by 2%.
Electronics and Performance Materials Operating Income
Operating income of $245.9 increased 7%, or $16.7. Operating income increased $48 from higher volumes, $19 from lower operating costs, and $18 from favorable currency effects, partially offset by property damage of $15 caused by the fire at an Electronics production facility in Korea. Operating income also declined by $51 from lower electronic specialty materials pricing, net of variable costs.
2007 vs. 2006
Electronics and Performance Materials Sales
Sales of $2,068.7 increased 15%, or $267.7. Underlying base business increased sales by 12%. Higher volumes across most Electronics product lines and all Performance Materials product lines improved sales by 14%. Electronics growth was due to strong industry operating rates and equipment sales in support of fabrication expansions. Performance Materials increases were due to growth in Asia and Europe. Pricing decreased sales by 2%, as electronic specialty materials continued to experience pricing pressure. Sales increased 2% from the full-year impact of the acquisition of Tomah3 Products in 2006. Favorable currency effects, primarily the weakening of the U.S. dollar against key European currencies, increased sales by 1%.
Electronics and Performance Materials Operating Income
Operating income of $229.2 increased 21%, or $39.2. Operating income increased $106 from higher volumes, $6 from the full-year impact of the acquisition of Tomah3 Products in 2006, and $6 from favorable currency effects. Lower pricing, net of variable costs, primarily from lower electronics specialty material pricing, decreased operating income by $48. Operating income also declined by $31 from higher costs to support growth and due to inflation.


 19 

 


 

Equipment and Energy
                         
    2008     2007     2006  
     
Sales
  $ 438.1     $ 585.9     $ 536.5  
Operating income
    38.9       76.8       68.9  
 
2008 vs. 2007
Sales of $438.1 decreased by $147.8, primarily from lower LNG activity and a one-time energy-related equipment sale that occurred in the prior year. Operating income of $38.9 decreased by $37.9, primarily from lower LNG heat exchanger activity.
The sales backlog for the Equipment business at 30 September 2008 was $399, compared to $258 at 30 September 2007. It is expected that approximately $289 of the backlog will be completed during 2009.
2007 vs. 2006
Sales of $585.9 increased $49.4, primarily from a one-time energy-related equipment sale. Operating income of $76.8 increased by $7.9, primarily from higher LNG heat exchanger activity.
The sales backlog for the Equipment business at 30 September 2007 was $258, compared to $446 at 30 September 2006, which reflected a peak level for LNG orders. The business received an order for one new LNG heat exchanger in 2007.
Other
Other operating income includes expense and income that cannot be directly associated with the business segments, including foreign exchange gains and losses, interest income, and costs previously allocated to businesses now reported as discontinued operations. Also included are LIFO inventory adjustments, as the business segments use FIFO and the LIFO pool is kept at corporate. Corporate research and development costs are fully allocated to the business segments.
                         
  2008   2007   2006  
     
Operating (loss)
  $ (30.8 )   $ (26.0 )   $ (35.0 )
 
2008 vs. 2007
Operating loss of $30.8 increased by $4.8. No items were individually significant in comparison to the prior year.
2007 vs. 2006
The operating loss of $26.0 decreased by $9.0, primarily due to the Amines allocated costs that are included in the 2006 results.
PENSION BENEFITS
The Company and certain of its subsidiaries sponsor defined benefit pension plans that cover a substantial portion of its worldwide employees. The principal defined benefit pension plans—the U.S. Salaried Pension Plan and the U.K. Pension Plan—were closed to new participants in 2005 and were replaced with defined contribution plans. The move to defined contribution plans has not had and is not anticipated to have a material impact on retirement program cost levels or funding in the near term. Over the long run, however, the new defined contribution plans are expected to reduce volatility of both expense and contributions.
The amounts recognized in the consolidated financial statements for pension benefits under the defined benefit plans are determined on an actuarial basis utilizing numerous assumptions. The discussion that follows provides information on the funding, significant assumptions, and expense associated with the defined benefit plans. In addition, refer to Note 18 to the Consolidated Financial Statements for comprehensive and detailed disclosures on the Company’s postretirement benefits and Note 2 to the Consolidated Financial Statements for information on the adoption of SFAS No. 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans—an amendment of FASB Statements No. 87, 88, 106, and 132R.”
For 2008, the fair market value of pension plan assets for the Company’s defined benefit plans as of the measurement date decreased to $2,218.2 from $2,600.1, primarily due to investment losses. The projected benefit obligation for these plans as of the measurement date was $2,731.7 and $3,033.1 in 2008 and 2007, respectively. The decrease in the obligation was due principally to an increase in the weighted average discount rate used to measure future benefit obligations to 7.1% from 6.1%.


20   AIR PRODUCTS 2008 ANNUAL REPORT | Management’s Discussion and Analysis

 


 

Pension Funding
Pension funding includes both contributions to funded plans and benefit payments under unfunded plans. With respect to funded plans, the Company’s funding policy is that contributions, combined with appreciation and earnings, will be sufficient to pay benefits without creating unnecessary surpluses.
In addition, the Company makes contributions to satisfy all legal funding requirements while managing its capacity to benefit from tax deductions attributable to plan contributions. The Company analyzes the liabilities and demographics of each plan, which helps guide the level of contributions. During 2008 and 2007, the Company’s cash contributions to funded plans and benefit payments under unfunded plans were $234.0 and $290.0, respectively, the majority of which was voluntary.
Cash contributions and benefit payments for defined benefit plans are estimated to be approximately $170 in 2009, the majority of which is voluntary. Actual future contributions will depend on future funding legislation, discount rates, investment performance, plan design, and various other factors. Refer to the Contractual Obligations discussion on page 25 for a projection of future contributions.
Significant Assumptions
Actuarial models are used in calculating the pension expense and liability related to the various defined benefit plans. These models have an underlying assumption that the employees render service over their service lives on a relatively consistent basis; therefore, the expense of benefits earned should follow a similar pattern.
Several assumptions and statistical variables are used in the models to calculate the expense and liability related to the plans. The Company determines assumptions about the discount rate, the expected rate of return on plan assets, and the rate of compensation increase. Note 18 to the Consolidated Financial Statements includes disclosure of these rates on a weighted average basis, encompassing both the domestic and international plans. The actuarial models also use assumptions on demographic factors such as retirement age, mortality, and turnover rates. The Company believes the actuarial assumptions are reasonable. However, actual results could vary materially from these actuarial assumptions due to economic events and different rates of retirement, mortality, and turnover.
One of the critical assumptions used in the actuarial models is the discount rate. This rate is determined at the annual measurement date for each of the various plans and is therefore subject to change each year. The rate
reflects the prevailing market rate for high-quality, fixed-income debt instruments with maturities corresponding to the expected duration of the benefit obligations on the measurement date. The Citigroup Pension Discount Curve is used in determining the discount rate for each of the U.S. Plans. The rate is used to discount the future cash flows of benefit obligations back to the measurement date. A higher discount rate decreases the present value of the benefit obligations and results in lower pension expense. A 50 basis point increase/decrease in the discount rate decreases/increases pension expense by approximately $23 per year.
The expected rate of return on plan assets represents the average rate of return to be earned by plan assets over the period that the benefits included in the benefit obligation are to be paid. The expected return on plan assets assumption is based on an estimated weighted average of long-term returns of major asset classes. In determining asset class returns, the Company takes into account long-term returns of major asset classes, historical performance of plan assets, and related value-added of active management, as well as the current interest rate environment. Asset allocation is determined by an asset/ liability study that takes into account plan demographics, asset returns, and acceptable levels of risk. Lower returns on the plan assets result in higher pension expense. A 50 basis point increase/decrease in the estimated rate of return on plan assets decreases/increases pension expense by approximately $12 per year.
The weighted average actual compound rate of return earned on plan assets for the last ten years was 5.9% for the U.S. and the U.K. For the last 20 years, the actual rate was 9.1%. The Company uses a market-related valuation method for recognizing investment gains or losses. Investment gains or losses are the difference between the expected and actual return based on the market-related value of assets. This method recognizes investment gains or losses over a five-year period from the year in which they occur, which reduces year-to-year volatility. Expense in future periods will be impacted as gains or losses are recognized in the market-related value of assets over the five-year period.
The expected rate of compensation increase is another key assumption. The Company determines this rate based on review of the underlying long-term salary increase trend characteristic of labor markets, historical experience, as well as comparison to peer companies. A 50 basis point increase/decrease in the expected rate of compensation increases/decreases pension expense by approximately $12 per year.


 21 

 


 

Pension Expense
                         
    2008     2007     2006  
   
Pension expense
  $ 127.0     $ 138.5     $ 154.0  
Special terminations, settlements and
curtailments (included above)
    31.5       12.3       12.9  
Weighted average discount rate
    6.1 %     5.7 %     5.3 %
Weighted average expected rate of return on
plan assets
    8.8 %     8.8 %     8.8 %
Weighted average rate of compensation increase
    4.2 %     4.1 %     4.1 %
 
2008 vs. 2007
The decrease in pension expense was primarily attributable to the 40 basis point increase in the weighted average discount rate. Expense included $31.5 in 2008 and $12.3 in 2007 for special termination, settlement, and curtailment charges.
2007 vs. 2006
The decrease in pension expense was primarily attributable to the 40 basis point increase in the weighted average discount rate.
Pension expense is estimated to be approximately $75 in 2009. This represents a decrease of $20.5, net of special terminations, settlements, and curtailments. This decrease is primarily attributable to a 100 basis point increase in the weighted average discount rate from 6.1% to 7.1% and anticipated contributions to the defined benefit plans in 2009, partially offset by a reduction in the asset return assumption from 8.8% to 8.3% and a decline in the market value of the plan assets.
In 2009, pension expense will include approximately $23.2 of amortization relating to actuarial losses. Future changes in the discount rate and actual returns on plan assets different from expected returns would impact the actuarial gains/losses and resulting amortization in years beyond 2009.
ENVIRONMENTAL MATTERS
The Company is subject to various environmental laws and regulations in the United States of America and foreign countries where it has operations. Compliance with these laws and regulations results in higher capital expenditures and costs. Additionally, from time to time, the Company is involved in proceedings under the Comprehensive Environmental Response, Compensation and Liability Act (the federal Superfund law),
similar state laws, and the Resource Conservation and Recovery Act (RCRA) relating to the designation of certain sites for investigation and possible cleanup. The Company’s accounting policy for environmental expenditures is discussed in Note 1 to the Consolidated Financial Statements, and environmental loss contingencies are discussed in Note 19 to the Consolidated Financial Statements.
The amounts charged to earnings from continuing operations on an after-tax basis related to environmental matters totaled $31.0, $25.1, and $25.8, in 2008, 2007, and 2006, respectively. These amounts represent an estimate of expenses for compliance with environmental laws, as well as remedial activities and costs incurred to meet internal Company standards. Such costs are estimated to be $22 and $23 in 2009 and 2010, respectively.
Although precise amounts are difficult to determine, the Company estimates that in 2008, it spent approximately $7 on capital projects to control pollution versus $11 in 2007. Capital expenditures to control pollution in future years are estimated to be $8 and $7 in 2009 and 2010, respectively.
The Company accrues environmental investigatory, external legal, and remediation costs for identified sites when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. The potential exposure for such costs is estimated to range from $82 to a reasonably possible upper exposure of $95. The balance sheet at 30 September 2008 and 2007 included an accrual of $82.9 and $52.2, respectively. The accrual for the environmental obligations relating to the Pace, Florida and the Piedmont, S.C. facilities is included in these amounts. See Note 19 to the Consolidated Financial Statements for further details on these facilities.
Actual costs to be incurred at identified sites in future periods may vary from the estimates, given inherent uncertainties in evaluating environmental exposures. Subject to the imprecision in estimating future environmental costs, the Company does not expect that any sum it may have to pay in connection with environmental matters in excess of the amounts recorded or disclosed above would have a material adverse impact on its financial position or results of operations in any one year.
Some of the Company’s operations are within jurisdictions that have, or are developing, regulations governing emissions of greenhouse gases (GHGs). These include existing and expanding coverage under the European Union Emissions Trading Scheme; mandatory reporting and reductions at manufacturing facilities in Alberta, Canada; and mandatory reporting and anticipated constraints on GHG emissions in California and Ontario. In the U.S., regional initiatives have been implemented that will regulate GHG emissions from fossil fuel-driven power plants, and some federal legislative proposals also focus on


22   AIR PRODUCTS 2008 ANNUAL REPORT | Management’s Discussion and Analysis

 


 

such power plants. As a large consumer of electric power, the Company could be impacted by increased costs that may arise from such regulatory controls. In addition, federal legislation has been introduced in the U.S. that would regulate production of fluorinated gases manufactured by the Company. Increased public awareness and concern may result in more international, U.S. federal, and/or regional requirements to reduce or mitigate the effects of GHGs.
The Company may also incur costs related to GHG emissions from its hydrogen facilities and other operations such as fluorinated gases production. The Company believes it will be able to mitigate some of the potential costs through its contractual terms, but the lack of definitive legislation or regulatory requirements prevents accurate prediction of the long-term impact on the Company. Any legislation that limits or taxes GHG emissions from Company facilities could impact the Company’s growth by increasing its operating costs or reducing demand for certain of its products.
Regulation of GHGs may also produce new opportunities for the Company. The Company continues to develop technologies to help its facilities and its customers to lower energy consumption, improve efficiency, and lower emissions. The Company is also developing a portfolio of technologies that capture CO2 from power and chemical plants before it reaches the atmosphere, enable cleaner transportation fuels, and facilitate alternate fuel source development. In addition, the potential demand for clean coal and the Company’s carbon capture solutions could increase demand for oxygen, one of the Company’s main products, and the Company’s proprietary technology for delivering low-cost oxygen.
LIQUIDITY AND CAPITAL RESOURCES
The Company maintained a solid financial position throughout 2008. Strong cash flow from operations, supplemented with proceeds from borrowings, provided funding for the Company’s capital spending and share repurchase program. The Company continues to maintain debt ratings of A/A2 (long-term) and A-1/ P-1 (short-term), respectively, by Standard & Poor’s and Moody’s and has had consistent access to commercial paper markets despite the current credit crisis. The current credit environment has not had, and is not expected to have, a significant adverse impact on liquidity.
Cash Flows
The Company’s cash flows from operating, investing, and financing activities, as reflected in the consolidated statements of cash flows, are summarized in the following table:
    2008     2007     2006  
     
Cash provided by (used for):
                       
Operating activities
  $ 1,679.6     $ 1,499.9     $ 1,347.5  
Investing activities
    (919.8 )     (1,483.1 )     (946.7 )
Financing activities
    (698.5 )     (14.9 )     (422.6 )
Effect of exchange rate changes on cash
    1.7       7.6       2.5  
 
Increase (decrease) in cash and cash items
  $ 63.0     $ 9.5     $ (19.3 )
 
Operating Activities
2008 vs. 2007
Net cash provided by operating activities increased $179.7, or 12%. The increase resulted principally from a decrease in the use of cash for working capital of $167.2. Cash increased $156.5, due to a reduction in contracts in progress due to lower equipment activity. Cash used for payables and accrued liabilities decreased by $204.8, due mainly to an increase in customer advances related to equipment sales and lower pension plan contributions. Partially offsetting these favorable impacts was an increase in the use of cash for trade receivables of $97.2 and other receivables of $77.5. The increase in trade receivables was due to higher sales, offset partially by increased collections. The increase in other receivables resulted from the recognition of a deferred tax asset related to the U.S. Healthcare impairment charge. The decline in net income of $125.9 was offset by the favorable impact of adjustments to income of $138.4. Net income included a noncash impairment charge of $314.8 related to the U.S. Healthcare business and an increase in depreciation/amortization expense of $79.2. Net income also included a gain of $105.9 related to the sale of discontinued operations, and adjustments to income included an increase in noncurrent capital lease receivables of $121.8.
2007 vs. 2006
Net cash provided by operating activities increased $152.4, or 11%. This increase was primarily due to higher earnings, partially offset by changes in working capital. Net income increased $312.2. Adjustments to income, principally depreciation and amortization, increased cash from operating activities by $34.9. The use of cash for working capital increased $194.7. There was an increase in the use of cash for payables and accrued liabilities of $319.1, partially offset by a decrease in the use of cash for trade receivables of $82.6 and inventories of $35.7. Cash used for payables and accrued liabilities increased, due mainly to a reduction in customer advances, higher pension plan contributions, payments for the global cost reduction plan, and the timing of payments. Customer advances declined as projects on average were nearer completion. Generally, customer advances are higher at the beginning of projects. The use of cash decreased for trade receivables due to the Company’s focus on collection activities.


 23 

 


 

Investing Activities
2008 vs. 2007
Cash used for investing activities decreased $563.3, principally from lower acquisitions of $467.1 and proceeds from the sale of discontinued operations of $423.0, partially offset by proceeds from the issuance of Industrial Revenue Bonds. The proceeds of the bonds must be held in escrow until related project spending occurs. As of 30 September 2008, $181.2 was classified as a noncurrent asset and reflected as a use of cash in investing activities. In 2007, the Company acquired BOC Gazy from The Linde Group for 380 million Euros or $518.4. During 2008, the Company sold its Polymer Emulsions and HPPC businesses.
2007 vs. 2006
Cash used for investing activities increased $536.4. Additions to plant and equipment decreased $195.5. This decrease is primarily related to the $297.2 repurchase of cryogenic vessel equipment in 2006. Acquisitions in 2007, totaling $539.1, primarily consisted of BOC Gazy from The Linde Group for 380 million Euros or $518.4. Acquisitions in 2006 of $127.0 principally included Tomah3 Products. Proceeds from the sale of assets and investments decreased $117.0, principally due to the sale of the Geismar, Louisiana DNT production facility in 2006. The Company also sold its Amines business in 2006 for $211.2. Additionally, insurance proceeds received for property damage from hurricanes were lower by $37.4.
Capital Expenditures
Capital expenditures are detailed in the following table:
                         
    2008     2007     2006  
     
Additions to plant and equipment
  $ 1,085.1     $ 1,013.2     $ 1,208.7  
Acquisitions, less cash acquired
    72.0       539.1       127.0  
Investments in and advances to unconsolidated
affiliates
    2.2       .2       22.5  
 
Capital Expenditures on a GAAP basis
  $ 1,159.3     $ 1,552.5     $ 1,358.2  
Capital lease expenditures under
                       
EITF No. 01-08(A)
    195.7       82.8       128.3  
 
Capital Expenditures on a non-GAAP basis
  $ 1,355.0     $ 1,635.3     $ 1,486.5  
 
 
(A)   The Company utilizes a non-GAAP measure in the computation of capital expenditures and includes spending associated with facilities accounted for as capital leases. Certain facilities that are built to service a specific customer are accounted for as capital leases in accordance with EITF No. 01-08, “Determining Whether an Arrangement Contains a Lease,” and such spending is reflected as a use of cash within cash provided by operating activities. The presentation of this non-GAAP measure is intended to enhance the usefulness of information by providing a measure which the Company’s management uses internally to evaluate and manage the Company’s expenditures.
Capital expenditures on a GAAP basis in 2008 totaled $1,159.3, compared to $1,552.5 in 2007. Additions to plant and equipment in 2008 increased by $71.9 compared to 2007. As in 2007, additions to plant and equipment in 2008 were largely in support of the worldwide Merchant Gases, Tonnage Gases, and Electronics and Performance Materials segments. Additions to plant and equipment also included support capital of a routine, ongoing nature, including expenditures for distribution equipment and facility improvements. In 2007, the Company acquired BOC Gazy at a cost of $518.4.
Capital expenditures on a non-GAAP basis in 2008 totaled $1,355.0, compared to $1,635.3 in 2007. Capital lease expenditures under EITF No. 01-08 of $195.7 increased by $112.9, reflecting higher project spending primarily in Europe and Asia. In 2007, capital lease expenditures under EITF No. 01-08 of $82.8 declined $45.5 from 2006, mainly due to the completion of a large project in 2006.
Capital expenditures, excluding acquisitions in 2009, are expected to increase $200 to $400, reflecting a strong project workload. It is anticipated that capital expenditures will be funded principally with cash from continuing operations. In addition, the Company intends to continue to evaluate acquisition opportunities and investments in equity affiliates.
Financing Activities
2008 vs. 2007
Cash used for financing activities increased $683.6, due primarily to a net decrease in borrowings of $299.5, an increase in cash used for the purchase of treasury stock of $218.2, and lower proceeds of $115.4 from stock option exercises. Company borrowings (short- and long-term proceeds, net of repayments) totaled $305.5 as compared to $605.0.
2007 vs. 2006
Cash used for financing activities decreased $407.7 in 2007, due primarily to the net increase in Company borrowings (short- and long-term proceeds, net of repayments) of $605.0 as compared to $243.6. Additionally, higher proceeds from stock option exercises of $99.9 were essentially offset by an increase in the use of cash for the purchase of treasury stock of $92.9.


24   AIR PRODUCTS 2008 ANNUAL REPORT | Management’s Discussion and Analysis

 


 

Financing and Capital Structure
Capital needs in 2008 were satisfied with cash from operations, supplemented with proceeds from borrowings. At the end of 2008, total debt outstanding was $4.0 billion compared to $3.7 billion. Total debt at 30 September 2008 and 2007, expressed as a percentage of the sum of total debt, shareholders’ equity, and minority interest, was 43.4% and 39.8%, respectively.
Long-term debt proceeds of $580.1 included $300.0 from the issuance of a fixed-rate 4.15% five-year bond and $220.0 from Industrial Revenue Bonds. Refer to Note 12 to the Consolidated Financial Statements for additional information.
In September 2008, the Company increased the size of its multicurrency committed revolving credit facility, maturing May 2011, from $1,200 to $1,450. Sixteen major global banks provide commitments under this facility, and the Company is confident that funding would be available from these banks if it were necessary to draw on the facility. As of 30 September 2008, no borrowings were outstanding under this facility. Additional commitments of $381.4 are maintained by the Company’s foreign subsidiaries, of which $281.8 was borrowed and outstanding at 30 September 2008. There was $97.2 of commercial paper outstanding at 30 September 2008.
On 20 September 2007, the Board of Directors authorized the repurchase of up to $1,000 of the Company’s outstanding common stock. This action was in addition to an existing $1,500 share repurchase program which was approved on 16 March 2006. As of 30 September 2007, the Company purchased 15.0 million of its outstanding shares at a cost of $1,063.4. During 2008, the Company purchased an additional 8.7 million of its outstanding shares at a cost of $787.4. The Company has completed the 2006 authorization and will continue to purchase shares under the 2007 authorization at its discretion while maintaining sufficient funds for investing in its business and growth opportunities. An additional $649.2 in share repurchase authorization remains.
The Company projects a limited need to access the long-term debt markets in 2009 due to its projected operating cash flows and very low long-term debt maturities. The Company expects that its strong credit rating will continue to ensure its access to the commercial paper and other short-term debt markets.
Dividends
On 20 March 2008, the Board of Directors increased the quarterly cash dividend 16%, from 38 cents per share to 44 cents per share. Dividends are declared by the Board of Directors and are usually paid during the sixth week after the close of the fiscal quarter.


CONTRACTUAL OBLIGATIONS
The Company is obligated to make future payments under various contracts such as debt agreements, lease agreements, unconditional purchase obligations, and other long-term obligations. The following table summarizes these obligations of the Company as of 30 September 2008.
                                                         
    Payments Due by Period  
    Total     2009     2010     2011     2012     2013     Thereafter  
     
Long-term debt obligations
                                                       
Debt maturities
  $ 3,533     $ 31     $ 468     $ 178     $ 476     $ 301     $ 2,079  
Contractual interest
    1,541       155       142       126       112       96       910  
Capital leases
    15       1       1       1       1       1       10  
Operating leases
    238       50       41       32       26       21       68  
Pension obligations
    538       170       70       80       190       28        
Unconditional purchase obligations
    1,728       676       120       100       92       92       648  
 
Total Contractual Obligations
  $ 7,593     $ 1,083     $ 842     $ 517     $ 897     $ 539     $ 3,715  
 
 25 

 


 

Long-Term Debt Obligations
The long-term debt obligations include the maturity payments of long-term debt, including current portion, and the related contractual interest obligations. Refer to Note 12 to the Consolidated Financial Statements for additional information on long-term debt.
Contractual interest is the interest the Company is contracted to pay on the long-term debt obligations without taking into account the interest impact of interest rate swaps related to any of this debt, which at current interest rates would slightly decrease contractual interest. The Company had $1,274 of long-term debt subject to variable interest rates at 30 September 2008, excluding fixed-rate debt that has been swapped to variable-rate debt. The rate assumed for the variable interest component of the contractual interest obligation was the rate in effect at 30 September 2008. Variable interest rates are primarily determined by interbank offer rates and by U.S. short-term tax-exempt interest rates.
Leases
Refer to Note 13 to the Consolidated Financial Statements for additional information on capital and operating leases.
Pension Obligations
The Company and certain of its subsidiaries sponsor defined benefit plans that cover a substantial portion of its worldwide employees. The Company closed its major defined benefit plans to new participants in 2005. The Company’s funding policy is that contributions, combined with appreciation and earnings, will be sufficient to pay benefits without creating unnecessary surpluses. In addition, the Company makes contributions to satisfy all legal funding requirements while managing its capacity to benefit from tax deductions attributable to plan contributions. The amounts in the table represent the current estimated cash payments to be made by the Company that in total equal the recognized liabilities. These payments are based upon current valuation assumptions and, for the U.S., pension legislation effective in 2008.
The total accrued liability for pension benefits is impacted by interest rates, plan demographics, actual return on plan assets, continuation or modification of benefits, and other factors. Such factors can significantly impact the amount of the liability and related contributions.
Unconditional Purchase Obligations
Most of the Company’s long-term unconditional purchase obligations relate to feedstock supply for numerous HyCO (hydrogen, carbon monoxide, and syngas) facilities. The price of feedstock supply is principally related to the price of natural gas. However, long-term take-or-pay sales contracts to HyCO customers are generally matched to the term of the feedstock supply obligations and provide recovery of price increases in the feedstock supply. Due to the matching of most long-term feedstock supply obligations to customer sales contracts, the Company does not believe these purchase obligations would have a material effect on its financial condition or results of operations.
Natural gas supply purchase obligations to HyCO facilities are principally short-term commitments at market prices.
The above unconditional purchase obligations also include the fixed demand charge for electric power under numerous supply contracts. A fixed demand charge is generally included in electric power supply agreement pricing and generally ratchets down to zero over a period of months in the event operations are terminated. Therefore, the fixed obligation is principally included in 2009.
Purchase commitments to spend approximately $485 for additional plant and equipment are included in the unconditional purchase obligations.
The Company also purchases materials, energy, capital equipment, supplies, and services as part of the ordinary course of business under arrangements which are not unconditional purchase obligations. The majority of such purchases are for raw materials and energy, which are obtained under requirements-type contracts at market prices. In total, purchases by the Company approximate $7.5 billion annually, including the unconditional purchase obligations in the table.
Income Tax Liabilities
Noncurrent deferred income tax liabilities as of 30 September 2008 were $626.6. Refer to Note 17 to the Consolidated Financial Statements. Tax liabilities related to FASB Interpretation No. 48, “Accounting for Uncertainty in Income Taxes—an interpretation of FASB Statement No. 109” (FIN 48), as of 30 September 2008 were $184.1. Refer to Note 2 to the Consolidated Financial Statements. These tax liabilities were not included in the Contractual Obligations table as it is impractical to determine a cash impact by year.


26   AIR PRODUCTS 2008 ANNUAL REPORT | Management’s Discussion and Analysis

 


 

OFF-BALANCE SHEET ARRANGEMENTS
The Company has entered into certain guarantee agreements as discussed in Note 19 to the Consolidated Financial Statements. The Company is not a primary beneficiary in any material variable interest entity. The Company does not have any derivative instruments indexed to its own stock. The Company’s off-balance sheet arrangements are not reasonably likely to have a material impact on financial condition, changes in financial condition, results of operations, or liquidity.
RELATED PARTY TRANSACTIONS
The Company’s principal related parties are equity affiliates operating primarily in the industrial gas business. The Company did not engage in any material transactions involving related parties that included terms or other aspects that differ from those which would be negotiated at arm’s length with clearly independent parties.
MARKET RISKS AND SENSITIVITY ANALYSIS
The Company’s earnings, cash flows, and financial position are exposed to market risks relating to fluctuations in interest rates and foreign currency exchange rates. It is the Company’s policy to minimize its cash flow exposure to adverse changes in currency exchange rates and to manage the financial risks inherent in funding with debt capital.
The Company mitigates adverse energy price impacts through its cost pass-through contracts with customers, as well as price increases. The Company has entered into a limited number of commodity swap contracts in order to reduce the cash flow exposure to changes in the price of natural gas relative to certain oil-based feedstocks. The Company has also entered into a number of contracts to hedge the cash flow exposure of changes in the market price of nickel.
The Company addresses these financial exposures through a controlled program of risk management that includes the use of derivative financial instruments. Counterparties to all derivative contracts are major financial institutions, thereby minimizing the risk of credit loss. All instruments are entered into for other than trading purposes. The utilization of these instruments is described more fully in Note 6 to the Consolidated Financial Statements. The major accounting policies for these instruments are described in Note 1 to the Consolidated Financial Statements.
The Company’s derivative and other financial instruments consist of long-term debt (including current portion), interest rate swaps, cross currency interest rate swaps, foreign exchange-forward contracts, foreign exchange-option contracts, and commodity swaps. The net market value of these financial instruments combined is referred to below as the net financial instrument position. The net financial instrument position does not include other investments of $31.9 at 30 September 2008 and $39.8 at 30 September 2007 as disclosed in Note 6 to the Consolidated Financial Statements. These amounts represent investments accounted for by the cost method, including a publicly traded foreign company. The Company assessed the materiality of the market risk exposure on these other investments and determined this exposure to be immaterial.
At 30 September 2008 and 2007, the net financial instrument position was a liability of $3,629 and $3,157, respectively. The increase in the net financial instrument position was due primarily to an increase in the book value of long-term debt as a result of new issuances exceeding repayments.
The analysis below presents the sensitivity of the market value of the Company’s financial instruments to selected changes in market rates and prices. The range of changes chosen reflects the Company’s view of changes which are reasonably possible over a one-year period. Market values are the present value of projected future cash flows based on the market rates and prices chosen. The market values for interest rate risk and foreign currency risk are calculated by the Company using a third-party software model that utilizes standard pricing models to determine the present value of the instruments based on market conditions (interest rates, spot and forward exchange rates, and implied volatilities) as of the valuation date.
Interest Rate Risk
The Company’s debt portfolio, including swap agreements, as of 30 September 2008, primarily comprised debt denominated in Euros (44%) and U.S. dollars (43%), including the effect of currency swaps. This debt portfolio is composed of 49% fixed-rate debt and 51% variable-rate debt. Changes in interest rates have different impacts on the fixed- and variable-rate portions of the Company’s debt portfolio. A change in interest rates on the fixed portion of the debt portfolio impacts the net financial instrument position but has no impact on interest incurred or cash flows. A change in interest rates on the variable portion of the debt portfolio impacts the interest incurred and cash flows but does not impact the net financial instrument position.


 27 

 


 

The sensitivity analysis related to the fixed portion of the Company’s debt portfolio assumes an instantaneous 100 basis point move in interest rates from the levels at 30 September 2008 and 2007, with all other variables held constant. A 100 basis point increase in market interest rates would result in a decrease of $98 and $95 in the net liability position of financial instruments at 30 September 2008 and 2007, respectively. A 100 basis point decrease in market interest rates would result in an increase of $98 and $103 in the net liability position of financial instruments at 30 September 2008 and 2007, respectively.
Based on the variable-rate debt included in the Company’s debt portfolio, including the interest rate swap agreements, as of 30 September 2008 and 2007, a 100 basis point increase in interest rates would result in an additional $20 and $19 in interest incurred per year at 30 September 2008 and 2007, respectively. A 100 basis point decline would lower interest incurred by $20 and $19 per year at 30 September 2008 and 2007, respectively.
Foreign Currency Exchange Rate Risk
The sensitivity analysis assumes an instantaneous 10% change in the foreign currency exchange rates from their levels at 30 September 2008 and 2007, with all other variables held constant. A 10% strengthening of the functional currency of an entity versus all other currencies would result in a decrease of $356 and $366 in the net liability position of financial instruments at 30 September 2008 and 2007, respectively. A 10% weakening of the functional currency of an entity versus all other currencies would result in an increase of $352 and $366 in the net liability position of financial instruments at 30 September 2008 and 2007, respectively.
The primary currencies for which the Company has exchange rate exposure are the U.S. dollar versus the Euro, and the U.S. dollar versus the U.K. Pound Sterling. Foreign currency debt, cross currency interest rate swaps and foreign exchange-forward contracts are used in countries where the Company does business, thereby reducing its net asset exposure. Foreign exchange-forward contracts also are used to hedge the Company’s firm and highly anticipated foreign currency cash flows, along with foreign exchange-option contracts. Thus, there is either an asset/liability or cash flow exposure related to all of the financial instruments in the above sensitivity analysis for which the impact of a movement in exchange rates would be in the opposite direction and materially equal (or more favorable in the case of purchased foreign exchange-option contracts) to the impact on the instruments in the analysis.
Commodity Price Risk
The sensitivity analysis assumes an instantaneous 50% change in the price of natural gas, oil-based feedstocks, and nickel from their levels at 30 September 2008 and 2007, with all other variables held constant. The impact of a 50% change in these prices would not have a significant impact on the net liability position of financial instruments at 30 September 2008 and 2007.
INFLATION
The financial statements are presented in accordance with U.S. generally accepted accounting principles and do not fully reflect the impact of prior years’ inflation. While the U.S. inflation rate has been modest for several years, the Company operates in many countries with both inflation and currency issues. The ability to pass on inflationary cost increases is an uncertainty due to general economic conditions and competitive situations. It is estimated that the cost of replacing the Company’s plant and equipment today is greater than its historical cost. Accordingly, depreciation expense would be greater if the expense were stated on a current cost basis.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
Note 1 to the Consolidated Financial Statements describes the Company’s major accounting policies. Judgments and estimates of uncertainties are required in applying the Company’s accounting policies in many areas. However, application of the critical accounting policies discussed below requires management’s significant judgments, often as the result of the need to make estimates of matters that are inherently uncertain. If actual results were to differ materially from the estimates made, the reported results could be materially affected. The Company’s management has reviewed these critical accounting policies and estimates and related disclosures with its audit committee.
Depreciable Lives of Plant and Equipment
Plant and equipment is recorded at cost and depreciated using the straight-line method, which deducts equal amounts of the cost of each asset from earnings every year over its estimated economic useful life. Net plant and equipment at 30 September 2008 totaled $6,614.8, and depreciation expense totaled $848.0 during 2008.
Economic useful life is the duration of time an asset is expected to be productively employed by the Company, which may be less than its physical life. Assumptions on the following factors,


28   AIR PRODUCTS 2008 ANNUAL REPORT | Management’s Discussion and Analysis

 


 

among others, affect the determination of estimated economic useful life: wear and tear, obsolescence, technical standards, contract life, market demand, competitive position, raw material availability, and geographic location.
The estimated economic useful life of an asset is monitored to determine its appropriateness, especially in light of changed business circumstances. For example, changes in technology, changes in the estimated future demand for products, or excessive wear and tear may result in a shorter estimated useful life than originally anticipated. In these cases, the Company would depreciate the remaining net book value over the new estimated remaining life, thereby increasing depreciation expense per year on a prospective basis. Likewise, if the estimated useful life is increased, the adjustment to the useful life decreases depreciation expense per year on a prospective basis.
The Company has numerous long-term customer supply contracts, particularly in the gases on-site business within the Tonnage Gases segment. These contracts principally have initial contract terms of 15 to 20 years. There are also long-term customer supply contracts associated with the tonnage gases business within the Electronics and Performance Materials segment. These contracts principally have initial terms of 10 to 15 years. Depreciable lives of the production assets related to long-term contracts are matched to the contract lives. Extensions to the contract term of supply frequently occur prior to the expiration of the initial term. As contract terms are extended, the depreciable life of the remaining net book value of the production assets is adjusted to match the new contract term.
The depreciable lives of production facilities within the Merchant Gases segment are principally 15 years. Customer contracts associated with products produced at these types of facilities typically have a much shorter term. The depreciable lives of production facilities within the Electronics and Performance Materials segment, where there is not an associated long-term supply agreement, range from 10 to 15 years. These depreciable lives have been determined based on historical experience combined with judgment on future assumptions such as technological advances, potential obsolescence, competitors’ actions, etc. Management monitors its assumptions and may potentially need to adjust depreciable life as circumstances change.
A change in the depreciable life by one year for production facilities within the Merchant Gases and Electronics and Performance Materials segments for which there is not an associated long-term customer supply agreement would impact annual depreciation expense as summarized below:
                 
    Decrease Life     Increase Life  
    by 1 Year     by 1 Year  
   
Merchant Gases
    $19       $(14 )
Electronics and Performance Materials
    $18       $(12 )
 
Impairment of Long-Lived Assets
Plant and Equipment
Net plant and equipment at 30 September 2008 totaled $6,614.8. Plant and equipment held for use is grouped for impairment testing at the lowest level for which there are identifiable cash flows. Impairment testing of the asset group occurs whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. The Company assesses recoverability by comparing the carrying amount of the asset group to the estimated undiscounted future cash flows expected to be generated by the assets. If an asset group is considered impaired, the impairment loss to be recognized would be measured as the amount by which the asset group’s carrying amount exceeds its fair value. Assets to be disposed of by sale are reported at the lower of carrying amount or fair value less cost to sell.
The estimate of plant and equipment fair value is based on estimated discounted future cash flows expected to be generated by the asset group. The assumptions underlying cash flow projections represent management’s best estimates at the time of the impairment review. Factors that management must estimate include: industry and market conditions, sales volume and prices, costs to produce, inflation, etc. Changes in key assumptions or actual conditions that differ from estimates could result in an impairment charge. The Company uses reasonable and supportable assumptions when performing impairment reviews and cannot predict the occurrence of future events and circumstances that could result in impairment charges.
During the third quarter of 2008, the Company determined an interim test for impairment was required for its U.S. Healthcare business, and the impairment test resulted in a charge of $7.8. Refer to Note 5 to the Consolidated Financial Statements for further detail.
As part of the actions taken in the Company’s global cost reduction plan, recognized impairment of assets to be sold or abandoned was $7.7 in 2006. Refer to Note 3 to the Consolidated Financial Statements for additional information.


 29

 


 

Goodwill
The purchase method of accounting for business combinations requires the Company to make use of estimates and judgments to allocate the purchase price paid for acquisitions to the fair value of the net tangible and identifiable intangible assets. Goodwill represents the excess of the aggregate purchase price over the fair value of net assets of an acquired entity. Goodwill, including goodwill associated with equity affiliates, was $991.5 as of 30 September 2008. The majority of the Company’s goodwill is assigned to reporting units within the Merchant Gases and Electronics and Performance Materials segments. Disclosures related to goodwill are included in Note 10 to the Consolidated Financial Statements.
The Company performs an impairment test annually in the fourth quarter of the fiscal year. In addition, goodwill would be tested more frequently if changes in circumstances or the occurrence of events indicated that potential impairment exists. The impairment test requires the Company to compare the fair value of business reporting units to carrying value, including assigned goodwill.
During the third quarter of 2008, the Company determined an interim test for impairment was required for its U.S. Healthcare reporting unit, and the impairment test resulted in a charge of $294.3. The impairment reduced the carrying amount of the U.S. Healthcare reporting unit goodwill to zero. Refer to Note 5 to the Consolidated Financial Statements for additional information.
In the fourth quarter of 2008, the Company conducted the required annual test of goodwill for impairment. There were no indications of impairment.
The Company primarily uses the present value of future cash flows to determine fair value. The Company’s valuation model assumes a five-year growth period for the business and an estimated exit trading multiple. Management judgment is required in the estimation of future operating results and to determine the appropriate exit multiple. The exit multiple is determined from comparable industry transactions. Future operating results and exit multiples could differ from the estimates.
Equity Investments
Investments in and advances to equity affiliates totaled $822.6 at 30 September 2008. The majority of the Company’s investments are non-publicly traded ventures with other companies in the industrial gas business. Summarized financial information of equity affiliates is included in
Note 8 to the Consolidated Financial Statements. Equity investments are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment may not be recoverable.
In the event that a decline in fair value of an investment occurs, and the decline in value is considered to be other than temporary, an impairment loss would be recognized. Management’s estimate of fair value of an investment is based on estimated discounted future cash flows expected to be generated by the investee. Changes in key assumptions about the financial condition of an investee or actual conditions that differ from estimates could result in an impairment charge.
Income Taxes
The Company accounts for income taxes under the liability method. Under this method, deferred tax assets and liabilities are recognized for the tax effects of temporary differences between the financial reporting and tax bases of assets and liabilities measured using the enacted tax rate. At 30 September 2008, accrued income taxes and deferred tax liabilities amounted to $87.0 and $626.6, respectively. Tax liabilities related to FIN 48 as of 30 September 2008 were $184.1. Current and noncurrent deferred tax assets equaled $264.4 at 30 September 2008. Income tax expense was $365.3 for the year ended 30 September 2008. Management judgment is required in determining income tax expense and the related balance sheet amounts. Judgments are required concerning the ultimate outcome of tax contingencies and the realization of deferred tax assets.
Actual income taxes paid may vary from estimates, depending upon changes in income tax laws, actual results of operations, and the final audit of tax returns by taxing authorities. Tax assessments may arise several years after tax returns have been filed. The Company believes that its recorded tax liabilities adequately provide for the probable outcome of these assessments.
Deferred tax assets are recorded for operating losses and tax credit carryforwards. However, when there are not sufficient sources of future taxable income to realize the benefit of the operating loss or tax credit carryforwards, these deferred tax assets are reduced by a valuation allowance. A valuation allowance is recognized if, based on the weight of available evidence, it is considered more likely than not that some portion or all of the deferred tax asset will not be realized. The factors used to assess the likelihood of realization include forecasted future taxable income and available tax planning strategies that could be implemented to realize or renew net deferred tax assets in order to avoid the potential loss of future tax benefits. The effect of a change in the valuation allowance is reported in the current period tax expense.
A 1% point increase (decrease) in the Company’s effective tax rate would have decreased (increased) net income by approximately $15.


30   AIR PRODUCTS 2008 ANNUAL REPORT | Management’s Discussion and Analysis

 


 

Pension Benefits
The Company sponsors defined benefit pension plans in various forms for employees who meet eligibility requirements. Several assumptions and statistical variables are used in actuarial models to calculate the pension expense and liability related to the various plans. Assumptions about the discount rate, the expected rate of return on plan assets, and the future rate of compensation increases are determined by the Company. The actuarial models also use assumptions on demographic factors such as retirement age, mortality, and turnover. Management considers the accounting for pension benefits critical because of the significance and number of assumptions used. Depending on the assumptions selected, pension expense could vary significantly and could have a material effect on reported earnings. The assumptions used can also materially affect the measurement of benefit obligations. For a detailed discussion of the Company’s pension benefits, see Pension Benefits on page 20 and Note 18 to the Consolidated Financial Statements.
Loss Contingencies
In the normal course of business the Company encounters contingencies, i.e., situations involving varying degrees of uncertainty as to the outcome and effect on the Company. The Company accrues a liability for loss contingencies when it is considered probable that a liability has been incurred and the amount of loss can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued.
Contingencies include those associated with litigation and environmental matters for which the Company’s accounting policy is discussed in Note 1 to the Consolidated Financial Statements, and particulars are provided in Note 19 to the Consolidated Financial Statements. Significant judgment is required in both determining probability and whether the amount of loss associated with a contingency can be reasonably estimated. These determinations are made based on the best available information at the time. As additional information becomes available, the Company reassesses probability and estimates of loss contingencies. Revisions in the estimates associated with loss contingencies could have a significant impact on the Company’s results of operations in the period in which an accrual for loss contingencies is recorded or adjusted. For example, due to the inherent uncertainties related to environmental exposures, a significant increase to environmental liabilities could occur if a new site is designated, the scope of remediation is increased, or the Company’s proportionate share is increased. Similarly, a future charge for regulatory fines or damage awards associated with litigation could have a significant impact on the Company’s net income in the period in which it is recorded.
NEW ACCOUNTING STANDARDS
See Note 2 to the Consolidated Financial Statements for information concerning the Company’s implementation and impact of new accounting standards.
FORWARD-LOOKING STATEMENTS
This document contains “forward-looking statements” within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s reasonable expectations and assumptions as of the date of this document regarding important risk factors. Actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors, including, without limitation, continuing deterioration in economic and business conditions; weakening demand for the Company’s products; future financial and operating performance of major customers and industries served by the Company; unanticipated contract terminations or customer cancellations or postponement of projects and sales; asset impairments due to economic conditions or specific product or customer events; the impact of competitive products and pricing; interruption in ordinary sources of supply of raw materials; the ability to recover unanticipated increased energy and raw material costs from customers; costs and outcomes of litigation or regulatory activities; consequences of acts of war or terrorism impacting the United States’ and other markets; the effects of a pandemic or epidemic or a natural disaster; charges related to current portfolio management and cost reduction actions; the success of implementing cost reduction programs and achieving anticipated acquisition synergies; the timing, impact, and other uncertainties of future acquisitions or divestitures; the ability to attract, hire, and retain qualified personnel in all regions of the world where the Company operates; significant fluctuations in interest rates and foreign currencies from that currently anticipated; the continued availability of capital funding sources in all of the Company’s foreign operations; the impact of new or changed environmental, healthcare, tax or other legislation and regulations in jurisdictions in which the Company and its affiliates operate; the impact of new or changed financial accounting standards; and the timing and rate at which tax credits can be utilized. The Company disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained in this document to reflect any change in the Company’s assumptions, beliefs or expectations or any change in events, conditions, or circumstances upon which any such forward-looking statements are based.


 31

 


 

Managements Report on Internal Control over Financial Reporting

Air Products’ management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting, which is defined in the following sentences, is a process designed to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles and includes those policies and procedures that:
  (i)   pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;
 
  (ii)   provide reasonable assurance that the transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and
 
  (iii)   provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.
Because of inherent limitations, internal control over financial reporting can only provide reasonable assurance and may not prevent or detect misstatements. Further, because of changes in conditions, the effectiveness of our internal control over financial reporting may vary over time. Our processes contain self-monitoring mechanisms, and actions are taken to correct deficiencies as they are identified.
Management has evaluated the effectiveness of its internal control over financial reporting based on the framework in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on this evaluation, management concluded that, as of 30 September 2008, the Company’s internal control over financial reporting was effective.
KPMG LLP, an independent registered public accounting firm, has issued an attestation report on the Company’s internal control over financial reporting, which appears herein.
     
-s- John E. McGlade
  -s- Paul E. Huck
John E. McGlade
  Paul E. Huck
Chairman, President and
  Senior Vice President and
Chief Executive Officer
  Chief Financial Officer
25 November 2008
  25 November 2008


32   AIR PRODUCTS 2008 ANNUAL REPORT

 


 

Report of Independent Registered Public Accounting Firm
on Internal Control over Financial Reporting

To the Shareholders and Board of Directors of Air Products and Chemicals, Inc.:
We have audited Air Products and Chemicals, Inc. and subsidiaries’ internal control over financial reporting as of 30 September 2008, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Air Products and Chemicals, Inc. and subsidiaries’ management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying “Management’s Report on Internal Control over Financial Reporting.” Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
In our opinion, Air Products and Chemicals, Inc. and subsidiaries maintained, in all material respects, effective internal control over financial reporting as of 30 September 2008, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Air Products and Chemicals, Inc. and subsidiaries as of 30 September 2008 and 2007, and the related consolidated income statements and consolidated statements of shareholders’ equity and cash flows for each of the years in the three-year period ended 30 September 2008, and our report dated 25 November 2008 expressed an unqualified opinion on those consolidated financial statements.
(KPMG LLP)
Philadelphia, Pennsylvania
25 November 2008


 33

 


 

Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Directors of Air Products and Chemicals, Inc.:
We have audited the accompanying consolidated balance sheets of Air Products and Chemicals, Inc. and subsidiaries (the Company) as of 30 September 2008 and 2007, and the related consolidated income statements and consolidated statements of shareholders’ equity and cash flows for each of the years in the three-year period ended 30 September 2008. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Air Products and Chemicals, Inc. and subsidiaries as of 30 September 2008 and 2007, and the results of their operations and their cash flows for each of the years in the three-year period ended 30 September 2008, in conformity with U.S. generally accepted accounting principles.
As discussed in Note 2 to the consolidated financial statements, the Company adopted Financial Accounting Standards Board (FASB) Interpretation No. 48, “Accounting for Uncertainty in Income Taxes,” effective 1 October 2007; Statement of Financial Accounting Standards No. 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans,” as of 30 September 2007; and FASB Interpretation No. 47, “Accounting for Conditional Asset Retirement Obligations,” effective 30 September 2006.
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), Air Products and Chemicals, Inc. and subsidiaries’ internal control over financial reporting as of 30 September 2008, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), and our report dated 25 November 2008 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.
(KPMG LLP)
Philadelphia, Pennsylvania
25 November 2008


34   AIR PRODUCTS 2008 ANNUAL REPORT

 


 

The Consolidated Financial Statements
Air Products and Chemicals, Inc. and Subsidiaries
CONSOLIDATED INCOME STATEMENTS
                         
Year ended 30 September (millions of dollars, except for share data)   2008     2007     2006  
     
Sales
  $ 10,414.5     $ 9,148.2     $ 7,885.0  
 
Cost of sales
    7,693.1       6,698.9       5,817.0  
Selling and administrative
    1,090.4       999.8       891.5  
Research and development
    130.7       129.0       139.9  
Pension settlement
    30.3       10.3        
Customer contract settlement
          (36.8 )      
Global cost reduction plan
          13.7       71.0  
Gain on sale of a chemical facility
                (70.4 )
Impairment of loans receivable
                65.8  
Other (income) expense, net
    (25.8 )     (42.3 )     (71.7 )
 
Operating Income
    1,495.8       1,375.6       1,041.9  
Equity affiliates’ income
    145.0       114.4       91.5  
Interest expense
    162.0       162.4       118.4  
 
Income from Continuing Operations before Taxes and Minority Interest
    1,478.8       1,327.6       1,015.0  
Income tax provision
    365.3       287.2       262.0  
Minority interest in earnings of subsidiary companies
    23.0       20.8       18.9  
 
Income from Continuing Operations
    1,090.5       1,019.6       734.1  
Income (Loss) from Discontinued Operations, net of tax
    (180.8 )     16.0       (4.5 )
 
Income before Cumulative Effect of Accounting Change
    909.7       1,035.6       729.6  
Cumulative effect of accounting change, net of tax
                (6.2 )
 
Net Income
  $ 909.7     $ 1,035.6     $ 723.4  
 
Weighted Average of Common Shares Outstanding (in millions)
    212.2       216.2       221.7  
Weighted Average of Common Shares Outstanding Assuming Dilution (in millions)
    219.2       223.2       227.5  
 
Basic Earnings per Common Share
                       
Income from continuing operations
    $5.14       $4.72       $3.31  
Income (loss) from discontinued operations
    (.85 )     .07       (.02 )
 
Income before cumulative effect of accounting change
    4.29       4.79       3.29  
Cumulative effect of accounting change
                (.03 )
 
Net Income
    $4.29       $4.79       $3.26  
 
Diluted Earnings per Common Share
                       
Income from continuing operations
    $4.97       $4.57       $3.23  
Income (loss) from discontinued operations
    (.82 )     .07       (.02 )
 
Income before cumulative effect of accounting change
    4.15       4.64       3.21  
Cumulative effect of accounting change
                (.03 )
 
Net Income
    $4.15       $4.64       $3.18  
 
The accompanying notes are an integral part of these statements.
 35

 


 

Air Products and Chemicals, Inc. and Subsidiaries
CONSOLIDATED BALANCE SHEETS
                 
30 September (millions of dollars, except for share data)   2008     2007  
     
Assets
               
 
Current Assets
               
Cash and cash items
  $ 103.5     $ 40.5  
Trade receivables, less allowances for doubtful accounts of $28.9 in 2008 and $23.7 in 2007
    1,575.2       1,512.8  
Inventories
    503.7       476.7  
Contracts in progress, less progress billings
    152.0       259.6  
Prepaid expenses
    107.7       105.7  
Other receivables and current assets
    349.4       238.9  
Current assets of discontinued operations
    56.6       224.2  
 
Total Current Assets
    2,848.1       2,858.4  
 
Investment in Net Assets of and Advances to Equity Affiliates
    822.6       778.1  
Plant and Equipment, at cost
    14,988.6       14,438.6  
Less accumulated depreciation
    8,373.8       7,909.8  
 
Plant and Equipment, net
    6,614.8       6,528.8  
 
Goodwill
    928.1       906.8  
Intangible Assets, net
    289.6       260.5  
Noncurrent Capital Lease Receivables
    505.3       326.1  
Other Noncurrent Assets
    504.1       311.8  
Noncurrent Assets of Discontinued Operations
    58.7       689.0  
 
Total Noncurrent Assets
    9,723.2       9,801.1  
 
Total Assets
  $ 12,571.3     $ 12,659.5  
 
 
               
Liabilities and Shareholders’ Equity
               
 
Current Liabilities
               
Payables and accrued liabilities
  $ 1,665.6     $ 1,543.2  
Accrued income taxes
    87.0       108.6  
Short-term borrowings
    419.3       593.3  
Current portion of long-term debt
    32.1       99.8  
Current liabilities of discontinued operations
    8.0       77.8  
 
Total Current Liabilities
    2,212.0       2,422.7  
 
Long-Term Debt
    3,515.4       2,974.7  
Deferred Income and Other Noncurrent Liabilities
    1,049.2       872.0  
Deferred Income Taxes
    626.6       705.6  
Noncurrent Liabilities of Discontinued Operations
    1.2       11.6  
 
Total Noncurrent Liabilities
    5,192.4       4,563.9  
 
Total Liabilities
    7,404.4       6,986.6  
 
Minority interest in subsidiary companies
    136.2       92.9  
Minority interest of discontinued operations
          84.4  
 
Total Minority Interest
    136.2       177.3  
Commitments and Contingencies—See Note 19
               
Shareholders’ Equity
               
Common stock (par value $1 per share; issued 2008 and 2007—249,455,584 shares)
    249.4       249.4  
Capital in excess of par value
    811.7       759.5  
Retained earnings
    6,990.2       6,458.5  
Accumulated other comprehensive income (loss)
    (549.3 )     (142.9 )
Treasury stock, at cost (2008—40,120,957 shares; 2007—34,099,899 shares)
    (2,471.3 )     (1,828.9 )
 
Total Shareholders’ Equity
    5,030.7       5,495.6  
 
Total Liabilities and Shareholders’ Equity
  $ 12,571.3     $ 12,659.5  
 
The accompanying notes are an integral part of these statements.
36   AIR PRODUCTS 2008 ANNUAL REPORT | The Consolidated Financial Statements

 


 

Air Products and Chemicals, Inc. and Subsidiaries
CONSOLIDATED STATEMENTS OF CASH FLOWS
                         
Year ended 30 September (millions of dollars)   2008     2007     2006  
     
Operating Activities
                       
Net income
  $ 909.7     $ 1,035.6     $ 723.4  
Adjustments to reconcile income to cash provided by operating activities:
                       
Depreciation and amortization
    869.0       789.8       704.7  
Impairment of long-lived assets of discontinued operations
    314.8              
(Gain) loss on sale of discontinued operations
    (105.9 )     15.3       40.0  
Deferred income taxes
    36.9       13.7       6.6  
Undistributed earnings of unconsolidated affiliates
    (77.8 )     (59.5 )     (37.8 )
Loss (gain) on sale of assets and investments
    .3       (27.6 )     (9.3 )
Gain on sale of a chemical facility
                (70.4 )
Impairment of loans receivable
                65.8  
Share-based compensation
    61.4       70.9       76.2  
Noncurrent capital lease receivables
    (192.6 )     (70.8 )     (126.7 )
Pension and other postretirement costs
    139.0       150.3       166.6  
Other
    (85.2 )     (60.6 )     (29.1 )
Working capital changes that provided (used) cash, excluding effects of acquisitions and divestitures:
                       
Trade receivables
    (97.4 )     (.2 )     (82.8 )
Inventories
    (34.9 )     (6.0 )     (41.7 )
Contracts in progress
    95.2       (61.3 )     (63.0 )
Other receivables
    (120.6 )     (43.1 )     (70.0 )
Payables and accrued liabilities
    (14.7 )     (219.5 )     99.6  
Other
    (17.6 )     (27.1 )     (4.6 )
 
Cash Provided by Operating Activities
    1,679.6       1,499.9       1,347.5  
 
Investing Activities
                       
Additions to plant and equipment
    (1,085.1 )     (1,013.2 )     (1,208.7 )
Acquisitions, less cash acquired
    (72.0 )     (539.1 )     (127.0 )
Investment in and advances to unconsolidated affiliates
    (2.2 )     (.2 )     (22.5 )
Proceeds from sale of assets and investments
    19.6       97.2       214.2  
Proceeds from sale of discontinued operations
    423.0             211.2  
Proceeds from insurance settlements
          14.9       52.3  
Change in restricted cash
    (183.6 )            
Other
    (19.5 )     (42.7 )     (66.2 )
 
Cash Used for Investing Activities
    (919.8 )     (1,483.1 )     (946.7 )
 
Financing Activities
                       
Long-term debt proceeds
    580.1       855.9       290.7  
Payments on long-term debt
    (95.7 )     (429.4 )     (157.0 )
Net (decrease) increase in commercial paper and short-term borrowings
    (178.9 )     178.5       109.9  
Dividends paid to shareholders
    (349.3 )     (312.0 )     (293.6 )
Purchase of treasury stock
    (793.4 )     (575.2 )     (482.3 )
Proceeds from stock option exercises
    87.4       202.8       102.9  
Excess tax benefit from share-based compensation/other
    51.3       64.5       6.8  
 
Cash Used for Financing Activities
    (698.5 )     (14.9 )     (422.6 )
 
Effect of Exchange Rate Changes on Cash
    1.7       7.6       2.5  
 
Increase (Decrease) in Cash and Cash Items
    63.0       9.5       (19.3 )
 
Cash and Cash Items—Beginning of Year
    40.5       31.0       50.3  
 
Cash and Cash Items—End of Year
  $ 103.5     $ 40.5     $ 31.0  
 
The accompanying notes are an integral part of these statements.
 37

 


 

Air Products and Chemicals, Inc. and Subsidiaries
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
                                                         
    Number of                             Accumulated              
    Common             Capital in             Other              
(millions of dollars,   Shares     Common     Excess of     Retained     Comprehensive     Treasury        
except for share data)   Outstanding     Stock     Par Value     Earnings     Income (Loss)     Stock     Total  
     
Balance 30 September 2005
    221,898,233       $249.4     $ 573.6     $ 5,317.2       $(433.2 )   $ (1,161.5 )   $ 4,545.5  
 
Comprehensive income:
                                                       
Net income
                            723.4                       723.4  
Net gain on derivatives, net of tax of $1.1
                                    2.0               2.0  
Translation adjustments, net of tax benefit of $(15.7)
                                    133.9               133.9  
Net change in unrealized holding gains, net of tax of $ .2
                                    .5               .5  
Change in minimum pension liability, net of tax of $42.1
                                    75.1               75.1  
 
Comprehensive income
                                                    934.9  
Purchase of treasury shares
    (7,658,000 )                                     (496.1 )     (496.1 )
Share-based compensation expense
                    69.3                               69.3  
Issuance of treasury shares for stock option and award plans
    3,010,339               (23.7 )                     127.9       104.2  
Tax benefit of stock option and award plans
                    33.3                               33.3  
Cash dividends ($1.34 per share)
                            (296.1 )                     (296.1 )
Reclassification to permanent equity/other
                    30.0       (1.0 )                     29.0  
 
Balance 30 September 2006
    217,250,572       $249.4     $ 682.5     $ 5,743.5       $(221.7 )   $ (1,529.7 )   $ 4,924.0  
 
Comprehensive income:
                                                       
Net income
                            1,035.6                       1,035.6  
Net gain on derivatives, net of tax of $3.7
                                    8.2               8.2  
Translation adjustments, net of tax benefit of $(45.8)
                                    272.8               272.8  
Unrealized holding gains, net of tax of $4.2
                                    8.1               8.1  
Reclassification adjustment for realized gains included in net income, net of tax of $20.1
                                    (36.6 )             (36.6 )
Change in minimum pension liability, net of tax of $83.4
                                    159.3               159.3  
 
Comprehensive income
                                                    1,447.4  
Adjustment to initially apply SFAS No. 158, net of tax benefit of $(169.6)
                                    (333.0 )             (333.0 )
Purchase of treasury shares
    (7,328,482 )                                     (567.3 )     (567.3 )
Share-based compensation expense
                    66.6                               66.6  
Issuance of treasury shares for stock option and award plans
    5,433,595               (70.3 )                     268.1       197.8  
Tax benefit of stock option and award plans
                    80.7                               80.7  
Cash dividends ($1.48 per share)
                            (319.8 )                     (319.8 )
Other
                            (.8 )                     (.8 )
 
Balance 30 September 2007
    215,355,685       $249.4     $ 759.5     $ 6,458.5       $(142.9 )   $ (1,828.9 )   $ 5,495.6  
 
Comprehensive income:
                                                       
Net income
                            909.7                       909.7  
Net loss on derivatives, net of tax benefit of $(11.0)
                                    (23.7 )             (23.7 )
Translation adjustments, net of tax of $7.9
                                    (186.3 )             (186.3 )
Reclassification adjustment for currency translation adjustment realized in net income
                                    (53.7 )             (53.7 )
Unrealized holding loss, net of tax benefit of $(2.4)
                                    (4.5 )             (4.5 )
Retirement benefit plans, net of tax benefit of $(67.5)
                                    (138.2 )             (138.2 )
 
Comprehensive income
                                                    503.3  
Purchase of treasury shares
    (8,676,029 )                                     (787.4 )     (787.4 )
Share-based compensation expense
                    62.5                               62.5  
Issuance of treasury shares for stock option and award plans
    2,654,971               (74.2 )                     145.0       70.8  
Tax benefit of stock option and award plans
                    63.9                               63.9  
Cash dividends ($1.70 per share)
                            (359.6 )                     (359.6 )
Adoption of FIN 48/other
                            (18.4 )                     (18.4 )
 
Balance 30 September 2008
    209,334,627       $249.4     $ 811.7     $ 6,990.2       $(549.3 )   $ (2,471.3 )   $ 5,030.7  
 
The accompanying notes are an integral part of these statements.
38   AIR PRODUCTS 2008 ANNUAL REPORT | The Consolidated Financial Statements

 


 

Notes to the Consolidated Financial Statements
(Millions of dollars, except for share data)

             
1.
  Major Accounting Policies     39  
2.
  New Accounting Standards     44  
3.
  Global Cost Reduction Plan     46  
4.
  Acquisitions     47  
5.
  Discontinued Operations     47  
6.
  Financial Instruments     50  
7.
  Inventories     52  
8.
  Summarized Financial Information of Equity Affiliates     52  
9.
  Plant and Equipment     52  
10.
  Goodwill     53  
11.
  Intangible Assets     53  
12.
  Debt     53  
13.
  Leases     54  
14.
  Capital Stock     55  
15.
  Share-Based Compensation     55  
16.
  Earnings per Share     57  
17.
  Income Taxes     58  
18.
  Retirement Benefits     59  
19.
  Commitments and Contingencies     62  
20.
  Supplemental Information     65  
21.
  Summary by Quarter (unaudited)     67  
22.
  Business Segment and Geographic Information     68  
1. MAJOR ACCOUNTING POLICIES
Consolidation Principles
The consolidated financial statements include the accounts of Air Products and Chemicals, Inc. and its majority-owned subsidiary companies (the Company). The Company consolidates all entities that it controls. Intercompany transactions and balances are eliminated in consolidation.
Financial Accounting Standards Board (FASB) Interpretation No. 46R (FIN 46R) addresses the consolidation of variable interest entities to which the usual condition of consolidating an entity based on control does not apply. An entity that will absorb the majority of a variable interest entity’s expected losses or expected residual returns, as defined in FIN 46R, is considered a primary beneficiary of that entity. The primary beneficiary is required to consolidate the variable interest entity. The Company has determined that it is not a primary beneficiary in any material variable interest entity.
Estimates and Assumptions
The preparation of financial statements in accordance with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Revenue Recognition
Revenue from product sales is recognized as risk and title to the product transfers to the customer (which generally occurs at the time shipment is made), the sales price is fixed or determinable, and collectibility is reasonably assured. Sales returns and allowances are not a business practice in the industry.
Revenues from equipment sale contracts are recorded primarily using the percentage-of-completion method. Under this method, revenues from the sale of major equipment, such as liquefied natural gas (LNG) heat exchangers and large air separation units, are recognized primarily based on labor hours incurred to date compared with total estimated labor hours. Changes to total estimated labor hours and anticipated losses, if any, are recognized in the period determined.
Amounts billed for shipping and handling fees are classified as sales in the consolidated income statements.
Amounts billed for sales and use taxes, value-added taxes, and certain excise and other specific transactional taxes imposed on revenue-producing transactions are presented on a net basis and excluded from sales in the consolidated income statements. The Company records a liability until remitted to the respective taxing authority.
Certain contracts associated with facilities that are built to service a specific customer are accounted for as leases in accordance with Emerging Issues Task Force (EITF) Issue No. 01-08, “Determining Whether an Arrangement Contains a Lease.” In cases where operating-lease treatment is necessary, there is no difference in revenue recognition over the life of the contract as compared to accounting for the contract as product sales. In cases where capital-lease treatment is necessary, the timing of revenue and expense recognition is impacted. Revenue and expense is recognized up front for the sale of equipment component of the contract as compared to revenue recognition over the life of the arrangement under contracts not qualifying as capital leases. Additionally, a portion of the revenue representing interest income from the financing component of the lease receivable is reflected as sales over the life of the contract.
If an arrangement involves multiple deliverables, the delivered items are considered separate units of accounting if the items have value on a stand-alone basis and there is objective


 39

 


 

and reliable evidence of their fair values. Revenues from the arrangement are allocated to the separate units of accounting based on their relative fair values.
Cost of Sales
Cost of sales predominantly represents the cost of tangible products sold. These costs include labor, raw materials, plant engineering and purchasing department overhead, power, depreciation, production supplies and materials packaging costs, and maintenance costs. Costs incurred for shipping and handling are also included in cost of sales.
Depreciation
Depreciation is recorded using the straight-line method, which deducts equal amounts of the cost of each asset from earnings every year over its expected economic useful life. The principal lives for major classes of plant and equipment are summarized in the table below:
     
    Principal
    Estimated
    Useful Lives
Buildings
  30 years
Production facilities(1)
   
Merchant Gases
  15 years
Tonnage Gases
  15 to 20 years
Electronics and Performance Materials
  10 to 15 years
Distribution equipment(2)
  5 to 25 years
Other machinery and equipment
      10 to 25 years
 
(1)   Depreciable lives of production facilities related to long-term customer supply contracts associated with the gases tonnage business are matched to the contract lives.
(2)   The depreciable lives for various types of distribution equipment are: 10 to 25 years for cylinders, depending on the nature and properties of the product; 20 years for tanks; 7.5 years for customer stations; 5 to 15 years for tractors and trailers.
Selling and Administrative
The principal components of selling and administrative expenses are salaries, advertising, and promotional costs.
Postemployment Benefits
The Company has substantive ongoing severance arrangements. Termination benefits provided to employees as part of the global cost reduction plan (discussed in Note 3) are consistent with termination benefits in previous, similar arrangements. Because the Company’s plan met the definition of an ongoing benefit arrangement, it was accounted for in accordance with Statement of Financial Accounting Standards (SFAS) No. 112, “Employers’ Accounting for Postemployment Benefits.” To recognize a liability under SFAS No. 112, the expense must be probable and estimable. These criteria are met when management, with the appropriate level of authority, approves and commits to its plan of action for termination; the plan identifies
the employees to be terminated and their related benefits; and the plan is to be completed within one year. During periods of operations where terminations are made on an as-needed basis, absent a detailed committed plan, terminations are accounted for on an individual basis and a liability is recognized when probable and estimable.
Financial Instruments
The Company addresses certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments. The types of derivative financial instruments permitted for such risk management programs are specified in policies set by management.
The Company currently enters into foreign exchange contracts, including forward, option combination, and purchased option contracts, to reduce the effects of fluctuating foreign currency exchange rates. The Company currently enters into interest rate swap contracts to reduce interest rate risks and to modify the interest rate characteristics of its outstanding debt. The Company is also currently party to cross currency interest rate swap agreements.
The Company has entered into a limited number of commodity swap contracts in order to reduce the cash flow exposure to changes in the price of natural gas relative to certain oil-based feedstocks. The Company has also entered into a number of contracts to hedge the cash flow exposure of changes in the market price of nickel.
Major financial institutions are counterparties to all of these derivative contracts. The Company has established counterparty credit guidelines and only enters into transactions with financial institutions of investment grade or better. Management believes the risk of incurring losses related to credit risk is remote, and any losses would be immaterial to the consolidated financial results, financial condition, or liquidity.
The Company recognizes derivatives on the balance sheet at fair value. On the date the derivative instrument is entered into, the Company generally designates the derivative as either (1) a hedge of the fair value of a recognized asset or liability or of an unrecognized firm commitment (fair value hedge), (2) a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge), or (3) a hedge of a net investment in a foreign operation.
Changes in the fair value of a derivative that is designated as and meets all the required criteria for a fair value hedge, along with the gain or loss on the hedged asset or liability that is attributable to the hedged risk, are recorded in current period earnings.


40   AIR PRODUCTS 2008 ANNUAL REPORT | Notes to the Consolidated Financial Statements

 


 

Changes in the fair value of a derivative that is designated as and meets all the required criteria for a cash flow hedge are recorded in accumulated other comprehensive income and reclassified into earnings as the underlying hedged item affects earnings.
Changes in the fair value of a derivative, foreign currency debt, or other foreign currency liabilities that are designated as and meet all the required criteria for a hedge of a net investment are recorded as translation adjustments in accumulated other comprehensive income.
Changes in the fair value of a derivative that is not designated as a hedge are recorded immediately in earnings.
The Company formally documents the relationships between hedging instruments and hedged items, as well as its risk management objective and strategy for undertaking various hedge transactions. This process includes relating derivatives that are designated as fair value or cash flow hedges to specific assets and liabilities on the balance sheet or to specific firm commitments or forecasted transactions. The Company also formally assesses, both at the inception of the hedge and on an ongoing basis, whether each derivative is highly effective in offsetting changes in fair values or cash flows of the hedged item. If it is determined that a derivative is not highly effective as a hedge, or if a derivative ceases to be a highly effective hedge, the Company will discontinue hedge accounting with respect to that derivative prospectively.
Foreign Currency
The value of the U.S. dollar rises and falls day-to-day on foreign currency exchanges. Since the Company does business in many foreign countries, these fluctuations affect the Company’s financial position and results of operations.
For most foreign operations, local currencies are considered the functional currency. Generally, foreign subsidiaries translate their assets and liabilities into U.S. dollars at current exchange rates—that is, the rates in effect at the end of the fiscal period. The gains or losses that result from this process are shown in accumulated other comprehensive income in the shareholders’ equity section of the balance sheet.
The revenue and expense accounts of foreign subsidiaries are translated into U.S. dollars at the average exchange rates that prevailed during the period. Therefore, the U.S. dollar value of these items on the income statement fluctuates from period to period, depending on the value of the dollar against foreign currencies. Some transactions are made in currencies different from an entity’s functional currency. Gains and losses from these foreign currency transactions are generally included in earnings as they occur.
Environmental Expenditures
Accruals for environmental loss contingencies are recorded when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. Remediation costs are capitalized if the costs improve the Company’s property as compared with the condition of the property when originally constructed or acquired, or if the costs prevent environmental contamination from future operations. The Company expenses environmental costs related to existing conditions resulting from past or current operations and from which no current or future benefit is discernible.
The measurement of environmental liabilities is based on an evaluation of currently available information with respect to each individual site and considers factors such as existing technology, presently enacted laws and regulations, and prior experience in remediation of contaminated sites. An environmental liability related to cleanup of a contaminated site might include, for example, a provision for one or more of the following types of costs: site investigation and testing costs, cleanup costs, costs related to soil and water contamination resulting from tank ruptures, post-remediation monitoring costs, and outside legal fees. These liabilities include costs related to other potentially responsible parties to the extent that the Company has reason to believe such parties will not fully pay their proportionate share. They do not take into account any claims for recoveries from insurance or other parties and are not discounted.
As assessments and remediation progress at individual sites, the amount of projected cost is reviewed periodically, and the liability is adjusted to reflect additional technical and legal information that becomes available. Management has a well-established process in place to identify and monitor the Company’s environmental exposures. An environmental accrual analysis is prepared and maintained that lists all environmental loss contingencies, even where an accrual has not been established. This analysis assists in monitoring the Company’s overall environmental exposure and serves as a tool to facilitate ongoing communication among the Company’s technical experts, environmental managers, environmental lawyers, and financial management to ensure that required accruals are recorded and potential exposures disclosed.
Actual costs to be incurred at identified sites in future periods may vary from the estimates, given inherent uncertainties in evaluating environmental exposures. Refer to Note 19 for additional information on the Company’s environmental loss contingencies.
The accruals for environmental liabilities are reflected in the consolidated balance sheet, primarily as part of other noncurrent liabilities, and will be paid over a period of up to 30 years.


 41

 


 

Litigation
In the normal course of business, the Company is involved in legal proceedings. The Company accrues a liability for such matters when it is probable that a liability has been incurred and the amount can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. The accrual for a litigation loss contingency includes estimates of potential damages and other directly related costs expected to be incurred.
Share-Based Compensation
The Company has various share-based compensation programs, which include stock options, deferred stock units, and restricted stock. Refer to Note 15. The Company expenses the grant-date fair value of these awards over the vesting period during which employees perform related services.
Effective 1 October 2005, the Company adopted SFAS No. 123 (revised 2004), “Share-Based Payment” (SFAS No. 123R), and related interpretations and began expensing the grant-date fair value of employee stock options. The Company adopted SFAS No. 123R using the modified prospective transition method and did not restate prior periods. Under this transition method, compensation cost associated with employee stock options recognized in 2006 included amortization related to the remaining unvested portion of stock option awards granted prior to 1 October 2005 and amortization related to new awards granted on or after 1 October 2005. Prior to 1 October 2005, the Company applied Accounting Principles Board (APB) Opinion No. 25, “Accounting for Stock Issued to Employees,” and related interpretations in accounting for its stock option plans. Accordingly, no compensation expense was recognized in net income for employee stock options.
Income Taxes
The Company accounts for income taxes under the liability method. Under this method, deferred tax assets and liabilities are recognized for the tax effects of temporary differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates. A principal temporary difference results from the excess of tax depreciation over book depreciation because accelerated methods of depreciation and shorter useful lives are used for income tax purposes. The cumulative impact of a change in tax rates or regulations is included in income tax expense in the period that includes the enactment date.
Effective 1 October 2007, the Company adopted FIN 48, “Accounting for Uncertainty in Income Taxes – an interpretation of FASB Statement No. 109”. Under FIN 48, the Company recognizes the benefit of an income tax position when it is more likely than not, based on the technical merits, that it will be sustained upon examination. See Note 2 for additional information relating to the adoption of FIN 48 and required disclosures.
Cash and Cash Items
Cash and cash items include cash, time deposits, and certificates of deposit acquired with an original maturity of three months or less.
Allowances for Doubtful Accounts
The allowances for doubtful accounts represent estimated uncollectible receivables associated with potential customer defaults on contractual obligations. A provision for customer defaults is made on a general formula basis when it is determined that the risk of some default is probable and estimable but cannot yet be associated with specific customers. The assessment of the likelihood of customer defaults is based on various factors, including the length of time the receivables are past due, historical experience, and existing economic conditions. The allowances also include amounts for certain customers where a risk of default has been specifically identified. Provisions to the allowances for doubtful accounts recorded as expense were $10.1, $6.6, and $8.7 in 2008, 2007, and 2006, respectively.
Inventories
Inventories are stated at the lower of cost or market. The Company writes down its inventories for estimated obsolescence or unmarketable inventory based upon assumptions about future demand and market conditions.
The Company utilizes the last-in, first-out (LIFO) method for determining the cost of inventories in the Merchant Gases, Tonnage Gases, and Electronics and Performance Materials segments in the United States. Inventories for these segments outside of the United States are accounted for on the first-in, first-out (FIFO) method, as the LIFO method is not generally permitted in the foreign jurisdictions where these segments operate. The inventories of the Equipment and Energy segment on a worldwide basis, as well as all other inventories, are accounted for on the FIFO basis.
At the business segment level, inventories are recorded at FIFO, and the LIFO pool is kept at corporate.
Equity Investments
The equity method of accounting is used when the Company has a 20% or greater interest in other companies and exercises significant influence but does not have operating control. Under the equity method, original investments are recorded at cost and adjusted by the Company’s share of undistributed earnings or losses of these companies. Equity investments are reviewed


42   AIR PRODUCTS 2008 ANNUAL REPORT | Notes to the Consolidated Financial Statements

 


 

for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment may not be recoverable.
Plant and Equipment
Plant and equipment is stated at cost less accumulated depreciation. Construction costs, labor, and applicable overhead related to installations are capitalized. Expenditures for additions and improvements that extend the lives or increase the capacity of plant assets are capitalized. The costs of maintenance and repairs of plant and equipment are charged to expense as incurred.
Fully depreciated assets are retained in the gross plant and equipment and accumulated depreciation accounts until they are removed from service. In the case of disposals, assets and related depreciation are removed from the accounts, and the net amounts, less proceeds from disposal, are included in income.
Capitalized Interest
As the Company builds new plant and equipment, it includes in the cost of these assets a portion of the interest payments it makes during the year. The amount of capitalized interest was $22.1, $12.9, and $16.5 in 2008, 2007, and 2006, respectively.
Asset Retirement Obligations
The fair value of a liability for an asset retirement obligation is recognized in the period in which it is incurred. The liability is measured at discounted fair value and is adjusted to its present value in subsequent periods as accretion expense is recorded. The corresponding asset retirement costs are capitalized as part of the carrying amount of the related long-lived asset and depreciated over the asset’s useful life. The Company’s asset retirement obligations are primarily associated with Tonnage Gases on-site long-term supply contracts, under which the Company has built a facility on land leased from the customer and is obligated to remove the facility at the end of the contract term. The Company’s asset retirement obligations totaled $41.3 and $37.5 at 30 September 2008 and 2007, respectively. The Company adopted FIN 47, “Accounting for Conditional Asset Retirement Obligations,” effective 30 September 2006 as discussed in Note 2.
Computer Software
The Company capitalizes costs incurred to purchase or develop software for internal use. Capitalized costs include purchased computer software packages, payments to vendors/consultants for development and implementation or modification to a purchased package to meet Company requirements, payroll and related costs for employees directly involved in development, and interest incurred while software is being developed. Capitalized computer software costs are included in the balance sheet classification plant
and equipment and depreciated over the estimated useful life of the software, generally a period of three to ten years. The Company’s SAP system is being depreciated over a ten-year life.
Impairment of Long-Lived Assets
Long-lived assets are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company assesses recoverability by comparing the carrying amount of the asset to estimated undiscounted future cash flows expected to be generated by the asset. If an asset is considered impaired, the impairment loss to be recognized is measured as the amount by which the asset’s carrying amount exceeds its fair value. Long-lived assets to be disposed of are reported at the lower of carrying amount or fair value less cost to sell.
Goodwill
Acquisitions are accounted for using the purchase method. The purchase price is allocated to the assets acquired and liabilities assumed based on their estimated fair market values. Any excess purchase price over the fair market value of the net assets acquired, including identified intangibles, is recorded as goodwill. Preliminary purchase price allocations are made at the date of acquisition and finalized when information needed to affirm underlying estimates is obtained, within a maximum allocation period of one year.
Goodwill is subject to impairment testing at least annually. In addition, goodwill is tested more frequently if a change in circumstances or the occurrence of events indicates that potential impairment exists.
Intangible Assets
Intangible assets with determinable lives primarily consist of customer relationships, noncompete covenants, and purchased patents and technology. The Company has no acquired intangible assets with indefinite lives. The cost of intangible assets with determinable lives is amortized on a straight-line basis over the estimated period of economic benefit. No residual value is estimated for these intangible assets.
Customer relationships are generally amortized over periods of five to twenty-five years. Noncompete covenants are generally amortized over periods of three to five years based on contractual terms. Purchased patents and technology and other intangibles are amortized based on contractual terms, ranging generally from five to twenty years. Amortizable lives are adjusted whenever there is a change in the estimated period of economic benefit.


 43

 


 

Retirement Benefits
The cost of retiree benefits is recognized over the employees’ service period. The Company is required to use actuarial methods and assumptions in the valuation of defined benefit obligations and the determination of expense. Differences between actual and expected results or changes in the value of obligations and plan assets are not recognized in earnings as they occur but, rather, systematically and gradually over subsequent periods. Refer to Note 18 for disclosures related to the Company’s pension and other postretirement benefits.
2006 Adjustments
In the fourth quarter of 2006, adjustments were recorded which related to prior periods.
  The U.S. Healthcare business, which is now reported as a discontinued operation as discussed in Note 5, recorded an adjustment to reduce its inventories to actual based on physical counts, of which $7.0 ($4.4 after-tax) related to prior periods.
 
  In 2006, the Company sold its Amines business, which included its Pace, Florida, facility. The Amines business is also accounted for as a discontinued operation as discussed in Note 5. A liability was recognized for retained environmental obligations related to the Pace facility, of which $34.6 ( $21.6 after-tax) related to prior periods.
 
  The results were favorably impacted by a $20.0 benefit recorded to income taxes related to adjustments of current and deferred tax assets and liabilities related to prior periods.
 
  The results benefited from a favorable adjustment of $4.2 ($2.6 after-tax) related to the over-accrual of accounts payable related to prior periods.
The Company did not consider the effect of the above adjustments to be material to its financial position, results of operations, or liquidity.
2. NEW ACCOUNTING STANDARDS
New Standards to Be Implemented
Hierarchy of Generally Accepted Accounting Principles
In May 2008, the FASB issued SFAS No. 162, “The Hierarchy of Generally Accepted Accounting Principles.” SFAS No. 162 identifies the sources of accounting principles and the framework for selecting the principles to be used in the preparation of financial statements of nongovernmental entities that are presented in conformity with generally accepted accounting principles in the United States. This Statement will become effective 60 days following the SEC’s approval of the Public Company Accounting Oversight Board (PCAOB) amendments to AU Section 411,
“The Meaning of Present Fairly in Conformity With Generally Accepted Accounting Principles.” The Company does not anticipate a material impact on its consolidated financial statements from the adoption of SFAS No. 162.
Disclosures about Derivatives and Hedging
In March 2008, the FASB issued SFAS No. 161, “Disclosures about Derivative Instruments and Hedging Activities—an amendment of FASB Statement No. 133.” SFAS No. 161 requires enhanced disclosures about how and why an entity uses derivative instruments, how derivative instruments and related hedged items are accounted for, and how they affect an entity’s financial position, financial performance, and cash flows. The Statement is effective for financial statements issued for fiscal years and interim periods beginning after 15 November 2008, with early application encouraged. The Company is currently evaluating the effect of SFAS No. 161.
Business Combinations and Noncontrolling Interests
In December 2007, the FASB issued SFAS No. 141 (revised 2007), “Business Combinations,” and No. 160, “Noncontrolling Interests in Consolidated Financial Statements—an amendment of ARB No. 51.” SFAS No. 141R requires the acquiring entity in a business combination to recognize at full fair value all the assets acquired and liabilities assumed in the transaction, establishes the acquisition-date fair value as the measurement objective for all assets acquired and liabilities assumed, and requires the acquirer to disclose information needed to evaluate and understand the nature and financial effect of the business combination. SFAS No. 160 requires entities to report noncontrolling (minority) interests in subsidiaries as equity in the consolidated financial statements. These Statements are effective for fiscal years beginning after 15 December 2008 and are to be applied prospectively, except for the presentation and disclosure requirements of SFAS No. 160 which are applied retrospectively for all periods presented. The Company is currently evaluating the effect of these Statements.
Fair Value Option
In February 2007, the FASB issued SFAS No. 159, “The Fair Value Option for Financial Assets and Financial Liabilities—Including an amendment of FASB Statement No. 115.” This Statement permits companies to elect to measure certain financial instruments at fair value on an instrument-by-instrument basis, with changes in fair value recognized in earnings each reporting period. In addition, SFAS No. 159 establishes financial statement presentation and disclosure requirements for assets and liabilities reported at fair value under the election. The Company will adopt SFAS No. 159 as of 1 October 2008 and will not elect to measure any items at fair value under the Statement.


44   AIR PRODUCTS 2008 ANNUAL REPORT | Notes to the Consolidated Financial Statements

 


 

Fair Value Measurements
In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements.” This Statement defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. This Statement applies under other accounting pronouncements that require or permit fair value measurements and does not require any new fair value measurements. This Statement is effective for financial statements issued for fiscal years beginning after 15 November 2007, and interim periods within those fiscal years. In February 2008, the FASB issued FASB Staff Position No. FAS 157-2, which delayed the effective date of SFAS No. 157 for nonfinancial assets and nonfinancial liabilities, except for items that are recognized or disclosed at fair value in the financial statements on a recurring basis, to fiscal years beginning after 15 November 2008. The Company does not anticipate a material impact on its consolidated financial statements from the adoption of SFAS No. 157.
Standards Implemented
Uncertainty in Income Taxes
In July 2006, the FASB issued FIN 48, “Accounting for Uncertainty in Income Taxes—an interpretation of FASB Statement No. 109.” This Interpretation prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This Interpretation also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition.
The Company adopted FIN 48 on 1 October 2007. Upon adoption, the Company recognized a $25.1 increase to its liability for uncertain tax positions. This increase was recorded as an adjustment to beginning retained earnings for $13.3 and goodwill for $11.8.
At 30 September 2008, the Company had $184.1 of unrecognized tax benefits, including $22.6 for the payment of interest and penalties. Interest and penalties of $3.1 were recognized in 2008. The Company classifies interest and penalties related to unrecognized tax benefits as a component of income tax expense. At 30 September 2008, $111.8 of the liability for unrecognized tax benefits, if recognized, would impact the effective tax rate.
The Company is currently under examination in a number of tax jurisdictions. The Company is currently undergoing an IRS audit for its 2005 and 2006 tax years. This audit may be resolved in the next twelve months. As a result, it is reasonably possible that a change in the unrecognized tax benefits may occur during the next twelve months. However, quantification of an estimated range cannot be made at this time.
A reconciliation of the beginning and ending amount of the unrecognized tax benefits is as follows:
         
Unrecognized Tax Benefits, 1 October 2007
  $ 116.5  
Additions for tax positions of the current year
    58.3  
Additions for tax positions of prior years
    20.1  
Reductions for tax positions of prior years
    (5.2 )
Settlements
    (4.6 )
Statute of limitations expiration
    (3.4 )
Foreign currency translation
    2.4  
 
Balance at 30 September 2008
  $ 184.1  
 
The Company remains subject to examination in the following major tax jurisdictions for the years indicated below.
         
Major Tax Jurisdiction       Open Tax Fiscal Years  
 
     
North America
       
United States
    2005–2007  
Canada
    2006–2007  
 
       
Europe
       
United Kingdom
    2005–2007  
Germany
    2006–2007  
Netherlands
    2005–2007  
Poland
    2002–2007  
Spain
    2003–2007  
 
       
Asia
       
Taiwan
    2002–2007  
Korea
    2003–2007  
 
Postretirement Benefits
In September 2006, the FASB issued SFAS No. 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans—an amendment of FASB Statements No. 87, 88, 106, and 132R.” This Statement requires recognition of the funded status of benefit plans in the balance sheet, with changes in the funded status recognized in comprehensive income within shareholders’ equity in the year in which the changes occur. SFAS No. 158 also requires plan assets and obligations to be measured as of the balance sheet date. This Statement does not allow prior periods to be restated.
The requirement to recognize the funded status of benefit plans and the related disclosure requirements were effective for the Company as of 30 September 2007. Upon adoption of the recognition provisions of SFAS No. 158, the Company recorded an increase in other noncurrent liabilities of $372.3, a decrease in other noncurrent assets of $130.3, a decrease in deferred income taxes of $169.6, and a $333.0 decrease in accumulated other comprehensive income in shareholders’ equity.
The requirement to measure plan assets and benefit obligations as of fiscal year end is effective for fiscal years ending after 15 December 2008. Accordingly, as of the beginning of fiscal year 2009, the Company will change the measurement date for


 45

 


 

the plan assets and benefit obligations of its U.K. and Belgium plans from 30 June to 30 September. As a result of this change in measurement date, the Company will record an estimated after-tax $8 reduction to retained earnings on 1 October 2008.
Refer to Note 18 for disclosures related to the Company’s pension and other postretirement benefits.
Asset Retirement Obligations
The Company adopted FIN 47, “Accounting for Conditional Asset Retirement Obligations,” effective 30 September 2006, and recorded an after-tax charge of $6.2 as the cumulative effect of an accounting change. FIN 47 clarifies the term, conditional asset retirement obligation, as used in SFAS No. 143, “Accounting for Asset Retirement Obligations,” which refers to a legal obligation to perform an asset retirement activity in which the timing and/or method of settlement are conditional on a future event. Uncertainty about the timing and/or method of settlement of a conditional asset retirement obligation should be factored into the measurement of the liability when sufficient information exists. On 30 September 2006, the Company recognized transition amounts for existing asset retirement obligation liabilities, associated capitalizable costs, and accumulated depreciation.
3. GLOBAL COST REDUCTION PLAN
The 2007 results from continuing operations included a charge of $13.7 ($8.8 after-tax, or $.04 per share) for the global cost reduction plan. The charge included $6.5 for severance and pension-related costs for the elimination of approximately 125 positions and $7.2 for the write-down of certain investments. Approximately one-half of the position eliminations related to continuation of European initiatives to streamline certain activities. The remaining position eliminations related to the continued cost reduction and productivity efforts of the Company.
As of 30 September 2008, the actions associated with the 2007 charge were complete.
The charge recorded in 2007 was excluded from segment operating profit. The table below displays how this charge related to the businesses at the segment level.
                         
    Severance and     Asset        
    Other Benefits     Impairments     Total  
     
Merchant Gases
  $ 3.6     $ .4     $ 4.0  
Tonnage Gases
    .4             .4  
Electronics and Performance
Materials
    2.3       3.8       6.1  
Equipment and Energy
    .2       .3       .5  
Other
          2.7       2.7  
 
2007 Charge
  $ 6.5     $ 7.2     $ 13.7  
 
The 2006 results from continuing operations included a charge of $71.0 ($46.1 after-tax, or $.20 per share) for the global cost reduction plan. This charge included $59.5 for severance and pension-related costs for approximately 312 position eliminations and $11.5 for asset disposals and facility closures. As of 30 September 2007, the majority of the planned actions associated with the 2006 charge were completed, with the exception of a small number of position eliminations and/or associated benefit payments. These actions were completed in the first quarter of fiscal 2008. Details of the charge taken in 2006 are provided below.
Several cost reduction initiatives in Europe resulted in the elimination of about two-thirds of the 312 positions at a cost of $37.6. The Company reorganized and streamlined certain organizations/activities in Europe to focus on improving effectiveness and efficiency. Additionally, in anticipation of the sale of a small business, which occurred in the first quarter of 2007, a charge of $1.4 was recognized to write down the assets to net realizable value.
The Company completed a strategy review of its Electronics business in 2006 and decided to rationalize some products and assets, reflecting a simpler portfolio. A charge of $10.1 was recognized, principally for an asset disposal and the write-down of certain investments/assets. Additionally, a charge of $3.8 was recognized for severance and pension-related costs.
In addition to the Europe and Electronics initiatives, the Company implemented cost reduction and productivity-related efforts to simplify its management structure and business practices. A charge of $18.1 for severance and related pension costs was recognized for these efforts.
The charge recorded in 2006 was excluded from segment operating profit. The table below displays how this charge related to the businesses at the segment level.
                         
    Severance and     Asset        
    Other Benefits     Impairments     Total  
     
Merchant Gases
  $ 48.2     $ 1.4     $ 49.6  
Tonnage Gases
    2.9             2.9  
Electronics and Performance
Materials
    7.2       10.1       17.3  
Equipment and Energy
    .9             .9  
Other
    .3             .3  
 
2006 Charge
  $ 59.5     $ 11.5     $ 71.0  
 


46   AIR PRODUCTS 2008 ANNUAL REPORT | Notes to the Consolidated Financial Statements

 


 

The following table summarizes changes to the carrying amount of the accrual for the global cost reduction plan:
                              
    Severance and     Asset        
    Other Benefits     Impairments     Total  
     
2006 Charge
  $ 59.5     $ 11.5     $ 71.0  
Noncash Expenses
    (13.0 )     (11.5 )     (24.5 )
Cash Expenditures
    (1.1 )           (1.1 )
 
30 September 2006
    45.4             45.4  
2007 Charge
    6.5       7.2       13.7  
Noncash Expenses
    (1.2 )     (7.2 )     (8.4 )
Cash Expenditures
    (42.3 )           (42.3 )
 
30 September 2007
    8.4             8.4  
Cash Expenditures
    (8.4 )           (8.4 )
 
30 September 2008
  $     $     $  
 
4. ACQUISITIONS
BOC Gazy in 2007
On 30 April 2007, a Spanish affiliate of the Company acquired 98.1% of the Polish industrial gas business of BOC Gazy Sp z o.o. (BOC Gazy) from The Linde Group. During the fourth quarter of 2007, this affiliate increased its ownership percentage to 99.9%. The total acquisition cost, less cash acquired, was 380 million Euros or $518.4. The results of operations for BOC Gazy were included in the Company’s consolidated income statement after the acquisition date. The purchase price allocation, including the recognition of deferred taxes, was completed in 2008 with assigned values for plant and equipment equal to $170.0, identified intangibles of $176.9, and goodwill of $190.7 (which is tax-deductible for Spanish tax reporting purposes).
With this acquisition, the Company obtained a significant market position in Central Europe’s industrial gases market. The BOC Gazy business had sales of $82.5 for the five months ended 30 September 2007. The business had approximately 750 employees, five major industrial gas plants, and six cylinder transfills serving customers across a diverse range of industries, including chemicals, steel, and base metals, among others.
Tomah3 Products in 2006
On 31 March 2006, the Company acquired Tomah3 Products of Milton, Wisconsin, in a cash transaction valued at $120.5. Goodwill recognized in this transaction amounted to $73.1 and was not deductible for tax purposes. Identified intangibles included in this transaction amounted to $24.1. Results for 2006 included sales of $39.8 for the six months ended 30 September 2006. Tomah3 Products produces specialty surfactants and processing aids primarily for the institutional and industrial cleaning, mining, and oil field industries, among others.
5. DISCONTINUED OPERATIONS
The U.S. Healthcare business, Polymer Emulsions business, High Purity Process Chemicals (HPPC) business, and Amines business have been accounted for as discontinued operations. The results of operations of these businesses have been removed from the results of continuing operations for all periods presented. The assets and liabilities of discontinued operations have been reclassified and are segregated in the consolidated balance sheets.
U.S. Healthcare
In July 2008, the Board of Directors authorized management to pursue the sale of the U.S. Healthcare business. Accordingly, beginning in the fourth quarter of 2008, the U.S. Healthcare business was accounted for as discontinued operations.
For the fiscal year 2008, the Company recorded a total charge of $329.2 ($246.2 after-tax, or $1.12 per share) related to the impairment/write-down of the net carrying value of the U.S. Healthcare business.
  In the third quarter of 2008, the Company performed an impairment analysis and recorded a charge of $314.8 ($237.0 after-tax, or $1.09 per share). The charge related to the impairment of goodwill for $294.3, intangible assets for $11.7, plant and equipment for $7.8, and other assets for $1.0. The impairment reduced the carrying amount of the U.S. Healthcare reporting unit goodwill and intangible assets to zero.
 
  In the fourth quarter of 2008, the Company recorded a charge of $14.4 ($9.2 after-tax, or $.04 per share), reflecting an estimate of net realizable value.
Additional charges may be recorded in future periods dependent upon the timing and method of ultimate disposition.
In 2007, the Company implemented several changes to improve performance, including management changes, product and service offering simplification, and other measures. However, market and competitive conditions were more challenging than anticipated and financial results did not meet expectations. In response to the disappointing financial results, during the third quarter 2008 management conducted an evaluation of the strategic alternatives for the business.
In accordance with SFAS No. 142, “Goodwill and Other Intangible Assets,” and SFAS No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets,” the Company determined that an interim test for impairment was required for its U.S. Healthcare reporting unit during the third quarter of 2008, based on the combination of events described


 47

 


 

above. The Company reforecast its cash flows and utilized the expected present value of the future cash flows to calculate fair value of the U.S. Healthcare reporting unit in completing its SFAS No. 142 and 144 impairment tests.
The operating results of the U.S. Healthcare business classified as discontinued operations are summarized below:
                         
    2008     2007     2006  
   
Sales
  $ 239.8     $ 271.1     $ 280.8  
 
Income (loss) before taxes
  $ (350.6 )   $ (24.4 )   $ (30.6 )
Income tax (benefit) provision
    (91.2 )     (9.2 )     (11.5 )
 
Income (loss) from operations of discontinued
operations
    (259.4 )     (15.2 )     (19.1 )
Gain (loss) on sale of business and write-down to
estimated net realizable value, net of tax
    (8.7 )            
 
Income (Loss) from Discontinued Operations, net of tax
  $ (268.1 )   $ (15.2 )   $ (19.1 )
 
Details of balance sheet items for the U.S. Healthcare business are summarized below:
                 
30 September   2008     2007  
   
Trade receivables, less allowances
  $ 47.7     $ 65.7  
Inventories
    7.2       9.9  
Prepaid expenses
    1.4       2.5  
Other receivables
    .2       1.2  
 
Total Current Assets
  $ 56.5     $ 79.3  
 
Plant and equipment, net
  $ 58.7     $ 74.9  
Goodwill
          293.1  
Intangible assets, net
          15.7  
Other noncurrent assets
          .7  
 
Total Noncurrent Assets
  $ 58.7     $ 384.4  
 
Payables and accrued liabilities
  $ 6.8     $ 7.7  
Current portion long-term debt
    1.0       1.3  
 
Total Current Liabilities
  $ 7.8     $ 9.0  
 
Long-term debt
  $ 1.2     $ 1.8  
 
Total Noncurrent Liabilities
  $ 1.2     $ 1.8  
 
Polymer Emulsions Business
On 31 January 2008, the Company closed on the sale of its interest in its vinyl acetate ethylene (VAE) polymers joint ventures to Wacker Chemie AG, its long-time joint venture partner. As part of that agreement, the Company received Wacker Chemie AG’s interest in the Elkton, Md., and Piedmont, S.C., production facilities and their related businesses plus cash proceeds of $258.2. The Company recognized a gain of $89.5 ($57.7 after-tax, or $.26 per share) in the second quarter of 2008 for this sale, which consisted of the global VAE polymers operations including production facilities located in Calvert City, Ky.;
South Brunswick, N.J.; Cologne, Germany; and Ulsan, Korea; and commercial and research capabilities in Allentown, Pa., and Burghausen, Germany. The business produces VAE for use in adhesives, paints and coatings, paper, and carpet applications.
On 30 June 2008, the Company sold its Elkton, Md., and Piedmont, S.C., production facilities and the related North American atmospheric emulsions and global pressure sensitive adhesives businesses to Ashland Inc. for $92.0. The Company recorded a gain of $30.5 ($18.5 after-tax, or $.08 per share) in connection with the sale, which included the recording of a retained environmental obligation associated with the Piedmont site. The expense to record the environmental obligation was $24.0 ($14.5 after-tax, or $.07 per share). The Piedmont site is under active remediation for contamination caused by an insolvent prior owner. Before the sale, which triggered expense recognition, remediation costs had been capitalized since they improved the property as compared to its condition when originally acquired. The sale of the Elkton and Piedmont facilities completed the disposal of the Company’s Polymer Emulsions business.
The operating results of the Polymer Emulsions business classified as discontinued operations are summarized below:
                         
    2008     2007     2006  
   
Sales
  $ 261.4     $ 618.6     $ 587.0  
 
Income before taxes
  $ 17.7     $ 61.4     $ 48.7  
Income tax provision
    6.4       23.1       18.6  
 
Income from operations of discontinued
operations
    11.3       38.3       30.1  
Gain on sale of business, net of tax
    76.2              
 
Income from Discontinued
Operations,
net of tax
  $ 87.5     $ 38.3     $ 30.1  
 
Details of balance sheet items for the Polymer Emulsions business are summarized below:
                 
30 September   2008     2007  
     
Cash and cash items
  $     $ 1.8  
Trade receivables, less allowances
          78.5  
Inventories
          30.1  
Prepaid expenses
          1.3  
Other receivables
          4.7  
 
Total Current Assets
  $     $ 116.4  
 
Investment in net assets of and advances to equity affiliates
  $     $ 67.9  
Plant and equipment, net
          166.3  
Goodwill
          29.7  
Other noncurrent assets
          .9  
 
Total Noncurrent Assets
  $     $ 264.8  
 


48   AIR PRODUCTS 2008 ANNUAL REPORT | Notes to the Consolidated Financial Statements

 


 

                 
30 September   2008     2007  
Payables and accrued liabilities
  $     $ 53.4  
Accrued income taxes
          2.2  
Short-term borrowings
          6.3  
 
Total Current Liabilities
  $     $ 61.9  
 
Deferred income taxes
  $     $ 6.9  
Other noncurrent liabilities
          2.9  
 
Total Noncurrent Liabilities
  $     $ 9.8  
 
Minority Interest
  $     $ 84.4  
 
Cumulative Translation Adjustments
  $     $ 45.9  
 
HPPC Business
In September 2007, the Company’s Board of Directors approved the sale of its HPPC business, which had previously been reported as part of the Electronics and Performance Materials operating segment. The Company’s HPPC business consisted of the development, manufacture, and supply of high-purity process chemicals used in the fabrication of integrated circuits in the United States and Europe. The Company wrote down the assets of the HPPC business to net realizable value as of 30 September 2007, resulting in a loss of $15.3 ($ 9.3 after-tax, or $.04 per share) in the fourth quarter of 2007.
In October 2007, the Company executed an agreement of sale with KMG Chemicals, Inc. The sale closed on 31 December 2007 for cash proceeds of $69.3 and included manufacturing facilities in the United States and Europe. Subsequent to the sale, certain receivables and inventories were sold to KMG Chemicals, Inc.
The operating results of the HPPC business classified as discontinued operations are summarized below:
                         
    2008     2007     2006  
Sales
  $ 22.9     $ 87.2     $ 97.6  
 
                       
Income before taxes
  $ .1     $ 3.7     $ 5.3  
Income tax provision
          1.5       2.1  
 
Income from operations of discontinued operations
    .1       2.2       3.2  
Loss on sale of business, net of tax
    (.3 )     (9.3 )      
 
Income (Loss) from Discontinued Operations,
net of tax
  $ (.2 )   $ (7.1 )   $ 3.2  
 
Assets and liabilities of the discontinued HPPC business are summarized below:
                 
30 September   2008     2007  
Trade receivables, less allowances
  $ .1     $ 13.1  
Inventories
          15.4  
Prepaid expenses
           
 
Total Current Assets
  $ .1     $ 28.5  
 
Plant and equipment, net
  $     $ 33.5  
Goodwill
          5.4  
Other noncurrent assets
          .9  
 
Total Noncurrent Assets
  $     $ 39.8  
 
Payables and accrued liabilities
  $ .2     $ 6.9  
 
Total Current Liabilities
  $ .2     $ 6.9  
 
Amines Business
On 29 September 2006, the Company sold its Amines business to Taminco N.V. The sales price was $211.2 in cash, with certain liabilities assumed by the purchaser. The Company recorded a loss of $40.0 ($23.7 after-tax, or $.11 per share) in connection with the sale of the Amines business and the recording of certain environmental and contractual obligations that the Company retained. A charge of $42.0 ($26.2 after-tax, or $.12 per share) was recognized for environmental obligations related to the Pace, Florida, facility, of which $34.6 pertained to prior years (see Note 1). In addition, 2006 fourth quarter results included a charge of $8.3 ($5.2 after-tax, or $.02 per share) for costs associated with a contract termination.
The Amines business produced methylamines and higher amines products used globally in household, industrial, and agricultural products. The sale of the Amines business included the employees and certain assets and liabilities of the production facilities located in Pace, Florida; St. Gabriel, Louisiana; and Camaçari, Brazil.
The operating results of the Amines business classified as discontinued operations are summarized below:
                         
    2008     2007     2006  
Sales
  $     $     $ 308.4  
 
                       
Income before taxes
  $     $     $ 8.0  
Income tax provision
                3.0  
 
Income from operations of discontinued
operations
                5.0  
Loss on sale of Amines business and
environmental/contractual obligations, net of
tax
                (23.7 )
 
Income (Loss) from Discontinued Operations,
net of tax
  $     $     $ (18.7 )
 


49

 


 

Total Discontinued Operations
                         
    2008     2007     2006  
Sales
  $ 524.1     $ 976.9     $ 1,273.8  
 
                       
Income (loss) before taxes
  $ (332.8 )   $ 40.7     $ 31.4  
Income tax (benefit) provision
    (84.8 )     15.4       12.2  
 
Income (loss) from operations of discontinued
operations
    (248.0 )     25.3       19.2  
Gain (loss) on sale of businesses,
environmental/contractual obligations, and
write-down to net realizable value, net of tax
    67.2       (9.3 )     (23.7 )
 
Income (Loss) from Discontinued
Operations,
net of tax
  $ (180.8 )   $ 16.0     $ (4.5 )
 
6. FINANCIAL INSTRUMENTS
Currency Risk Management
The Company does business in many foreign countries. Therefore, its earnings, cash flows, and financial position are exposed to foreign currency risk from foreign currency denominated transactions and net investments in foreign operations.
It is the policy of the Company to minimize its cash flow exposure to adverse changes in currency and exchange rates. This is accomplished by identifying and evaluating the risk that the Company’s cash flows will decline in value due to changes in exchange rates, and by determining the appropriate strategies necessary to manage such exposures. The Company’s objective is to maintain economically balanced currency risk management strategies that provide adequate downside protection.
The Company enters into a variety of foreign exchange contracts, including forward, option combination, and purchased option contracts, to hedge its exposure to fluctuations in foreign currency exchange rates. These agreements generally involve the exchange of one currency for a second currency at some future date.
The Company enters into foreign exchange contracts, including forward, option combination, and purchased option contracts, to reduce the cash flow exposure to foreign currency fluctuations associated with certain monetary assets and liabilities, as well as highly anticipated cash flows and certain firm commitments. Examples of such exposures are the purchase of plant and equipment and export sales transactions. Forward exchange contracts are also used to hedge the value of investments in certain foreign subsidiaries and affiliates by creating a liability in a currency in which the Company has a net equity position. The Company also uses foreign currency denominated debt to hedge certain net investments in and future cash flows from foreign operations.
Certain forward exchange contracts entered into by the Company are not designated as hedging instruments. Contracts used to hedge the exposure to foreign currency fluctuations associated with certain monetary assets and liabilities are not designated as hedging instruments, and changes in the fair value of these items are recorded in earnings to offset the foreign exchange gains and losses of the monetary assets and liabilities. Other forward exchange contracts may be used to economically hedge foreign currency exposures and not be designated as hedging instruments due to the immaterial amount of the underlying hedged exposures. Changes in the fair value of these contracts are also recorded in earnings.
Debt Portfolio Management
It is the policy of the Company to identify on a continuing basis the need for debt capital and evaluate the financial risks inherent in funding the Company with debt capital. Reflecting the result of this ongoing review, the debt portfolio and hedging program of the Company is managed with the objectives and intent to (1) reduce funding risk with respect to borrowings made or to be made by the Company to preserve the Company’s access to debt capital and provide debt capital as required for funding and liquidity purposes, and (2) manage the aggregate interest rate risk of the debt portfolio in accordance with certain debt management parameters.
The Company enters into interest rate swap agreements to change the fixed/variable interest rate mix of its debt portfolio in order to maintain the percentage of fixed- and variable-rate debt within the parameters set by management. In accordance with these parameters, the agreements are used to reduce interest rate risks and costs inherent in the Company’s debt portfolio. In addition, the Company uses interest rate swap agreements to hedge the interest rate on anticipated fixed-rate debt issuance. The notional amount of the interest rate swap agreements is equal to or less than the designated debt instrument being hedged. When variable-rate debt is hedged, the variable-rate indices of the swap instruments and the debt to which they are designated are the same. It is the Company’s policy not to enter into any interest rate swap contracts which lever a move in interest rates on a greater than one-to-one basis.
The Company also enters into cross currency interest rate swap contracts. These contracts entail both the exchange of fixed- and floating-rate interest payments periodically over the life of the agreement and the exchange of one currency for another currency at inception and at a specified future date. These contracts effectively convert the currency denomination of a debt instrument into another currency in which the Company has a net equity position while changing the interest rate character-


50   AIR PRODUCTS 2008 ANNUAL REPORT | Notes to the Consolidated Financial Statements

 


 

istics of the instrument. The contracts are used to hedge intercompany and third-party borrowing transactions and certain net investments in foreign operations.
Commodity Price Risk Management
The Company has entered into a limited number of commodity swap contracts in order to reduce the cash flow exposure to changes in the price of natural gas relative to certain oil-based feedstocks and changes in the market price of nickel.
Fair Value Hedges
For the years ended 30 September 2008 and 2007, there was no material gain or loss recognized in earnings resulting from hedge ineffectiveness or from excluding a portion of derivative instruments’ gain or loss from the assessment of hedge effectiveness related to derivatives designated as fair value hedges. Also, the amount recognized in earnings in 2008 and 2007 as a result of a hedged firm commitment no longer qualifying as a fair value hedge was not material.
Cash Flow Hedges
For the years ended 30 September 2008 and 2007, there was no material gain or loss recognized in earnings resulting from hedge ineffectiveness or from excluding a portion of derivative instruments’ gain or loss from the assessment of hedge effectiveness related to derivatives designated as cash flow hedges.
The amount reclassified from accumulated other comprehensive income into earnings as a result of the discontinuance of foreign currency cash flow hedges due to the probability of the original forecasted transactions not occurring by the original specified time period was not material in 2008 and 2007. The amount in other comprehensive income expected to be reclassified into earnings in 2009 is also not material.
As of 30 September 2008, the maximum length of time over which the Company is hedging its exposure to the variability in future cash flows for forecasted transactions is three years.
Hedges of Net Investments in Foreign Operations
For the years ended 30 September 2008 and 2007, net (gains) losses related to hedges of net investments in foreign operations of $(72.5) and $218.5, respectively, were included in accumulated other comprehensive income within shareholders’ equity.
Fair Value of Financial Instruments
Summarized below are the carrying values and fair values of the Company’s financial instruments as of 30 September 2008 and 2007:
                                 
    2008     2008     2007     2007  
    Carrying     Fair     Carrying     Fair  
30 September   Value     Value     Value     Value  
Assets
                               
Other investments
  $ 31.9     $ 31.9     $ 39.8     $ 39.8  
Interest rate swap agreements
    .9       .9              
Cross currency interest rate swap
contracts
    1.2       1.2              
Currency option contracts
    1.7       1.7              
Commodity swap contracts
    4.8       4.8       2.5       2.5  
 
Liabilities
                               
Interest rate swap agreements
  $     $     $ 4.1     $ 4.1  
Cross currency interest rate swap
contracts
                8.0       8.0  
Forward exchange contracts
    56.0       56.0       38.7       38.7  
Long-term debt, including current
portion
    3,547.5       3,581.5       3,074.5       3,109.0  
 
The carrying amounts reported in the balance sheet for cash and cash items, accounts receivable, payables and accrued liabilities, accrued income taxes, and short-term borrowings approximate fair value due to the short-term nature of these instruments. Accordingly, these items have been excluded from the above table. The fair value of other investments is based principally on quoted market prices.
The fair values of the Company’s debt, interest rate swap agreements, and foreign exchange contracts are based on estimates using standard pricing models that take into account the present value of future cash flows as of the balance sheet date. The computation of the fair values of these instruments is generally performed by the Company. The fair value of commodity swaps is based on current market price, as provided by the financial institutions with whom the commodity swaps have been executed.
The fair value of other investments is reported within other noncurrent assets on the balance sheet. The fair value of foreign exchange contracts, cross currency interest rate swaps, interest rate swaps, and commodity swaps is reported in the balance sheet in the following line items: other receivables and current assets, other noncurrent assets, payables and accrued liabilities, and deferred income and other noncurrent liabilities.
Changes in the fair value of foreign exchange and commodity swap contracts designated as hedges are recorded or reclassified into earnings and are reflected in the income statement classification of the corresponding hedged item (e.g., hedges of purchases are recorded to cost of sales; hedges of sales


51

 


 

transactions are recorded to sales). The changes in fair value of foreign exchange contracts not designated as hedging instruments are reported in the income statement as other (income) expense, offsetting the fair value changes of foreign currency denominated monetary assets and liabilities also recorded to other (income) expense. Fair value changes of interest rate swaps are recorded to interest expense, offsetting changes in the fair value of associated debt instruments, which are also recorded to interest expense.
The cash flows related to all derivative contracts are reported in the operating activities section of the cash flow statement.
7. INVENTORIES
The components of inventories are as follows:
                 
30 September   2008     2007  
Inventories at FIFO Cost
               
Finished goods
  $ 365.1     $ 328.7  
Work in process
    22.4       23.4  
Raw materials and supplies
    183.5       178.7  
 
 
    571.0       530.8  
Less excess of FIFO cost over LIFO cost
    (67.3 )     (54.1 )
 
 
  $ 503.7     $ 476.7  
 
Inventories valued using the LIFO method comprised 35.8% and 37.0% of consolidated inventories before LIFO adjustment at 30 September 2008 and 2007, respectively. Liquidation of prior years’ LIFO inventory layers in 2008, 2007, and 2006 did not materially affect results of operations in any of these years.
FIFO cost approximates replacement cost. The Company’s inventories have a high turnover, and as a result, there is little difference between the original cost of an item and its current replacement cost.
8. SUMMARIZED FINANCIAL INFORMATION OF EQUITY AFFILIATES
The following table presents summarized financial information on a combined 100% basis of the principal companies accounted for by the equity method. Amounts presented include the accounts of the following equity affiliates:
Air Products South Africa (50%);
Bangkok Cogeneration Company Limited (49%);
Bangkok Industrial Gases Company Ltd. (49%);
Daido Air Products Electronics, Inc. (20%);
DuPont Air Products Nanomaterials, LLC (50%);
Europoort Utility Partners V.O.F. (50%);
Helap S.A. (50%);
High-Tech Gases (Beijing) Co., Ltd. (50%);
INFRA Group (40%);
INOX Air Products Limited (INOX) (49%);
Island Pipeline Gas (33%);
Kulim Industrial Gases Sdn. Bhd (50%);
Sapio Produzione Idrogeno Ossigeno S.r.l. (49%);
SembCorp Air Products (HyCO) Pte. Ltd. (40%);
Stockton CoGen Company (50%);
Tecnologia en Nitrogeno S. de R.L. de C.V. (50%);
Tyczka Industrie-Gases GmbH (50%);
WuXi Hi-Tech Gas Co., Ltd. (50%);
and principally, other industrial gas producers.
                 
    2008     2007  
Current assets
  $ 1,133.6     $ 946.7  
Noncurrent assets
    1,877.9       1,840.5  
Current liabilities
    598.3       599.8  
Noncurrent liabilities
    694.3       606.7  
Net sales
    2,256.5       2,016.1  
Sales less cost of sales
    886.0       741.4  
Net income
    306.4       250.4  
 
Dividends received from equity affiliates were $65.3, $54.8, and $53.7 in 2008, 2007, and 2006, respectively.
The investment in net assets of and advances to equity affiliates as of 30 September 2008 and 2007 included investment in foreign affiliates of $785.8 and $743.7, respectively.
As of 30 September 2008 and 2007, the amount of investment in companies accounted for by the equity method included goodwill in the amount of $63.4 and $61.3, respectively.
9. PLANT AND EQUIPMENT
The major classes of plant and equipment, at cost, are as follows:
                 
30 September   2008     2007  
Land
  $ 170.0     $ 178.7  
Buildings
    873.4       860.5  
Production facilities
               
Merchant Gases
    3,195.8       3,186.6  
Tonnage Gases
    4,944.6       4,469.6  
Electronics and Performance Materials
    1,502.7       1,503.0  
Equipment and Energy
    193.1       203.5  
 
Total production facilities
    9,836.2       9,362.7  
Distribution equipment
    2,622.4       2,478.3  
Other machinery and equipment
    877.3       887.0  
Construction in progress
    609.3       671.4  
 
 
  $ 14,988.6     $ 14,438.6  
 
Depreciation expense was $848.0, $770.1, and $692.4 in 2008, 2007, and 2006, respectively.


52   AIR PRODUCTS 2008 ANNUAL REPORT | Notes to the Consolidated Financial Statements

 


 

10. GOODWILL
Changes to the carrying amount of consolidated goodwill by segment are as follows:
                                         
                    Acquisitions     Currency        
            FIN     and     Translation        
30 September   2007     48     Adjustments     and Other     2008  
Merchant Gases
  $ 577.6     $ 11.8     $ 33.2     $ 3.9     $ 626.5  
Tonnage Gases
    21.1                   (3.1 )     18.0  
Electronics and
Performance
                                       
Materials
    308.1             .5       (25.0 )     283.6  
 
 
  $ 906.8     $ 11.8     $ 33.7     $ (24.2 )   $ 928.1  
 
The 2008 increase in goodwill in the Merchant Gases segment was related to the adoption of FIN 48 and the acquisition of Cryoservice Limited.
                                 
            Acquisitions     Currency        
            and     Translation        
30 September   2006     Adjustments     and Other     2007  
Merchant Gases
  $ 353.9     $ 176.1     $ 47.6     $ 577.6  
Tonnage Gases
    10.3       10.6       .2       21.1  
Electronics and
Performance
                               
Materials
    300.2       .3       7.6       308.1  
 
 
  $ 664.4     $ 187.0     $ 55.4     $ 906.8  
 
The 2007 increase in goodwill in the Merchant Gases and Tonnage Gases segments was related to the acquisition of BOC Gazy.
Goodwill is subject to impairment testing at least annually. In addition, goodwill is tested more frequently if a change in circumstances or the occurrence of events indicates that potential impairment exists.
  During the third quarter of 2008, the Company determined an interim test for impairment was required for its U.S. Healthcare reporting unit, and the impairment test resulted in a charge of $294.3. The U.S. Healthcare business is now reported as discontinued operations as discussed in Note 5.
 
  In the fourth quarter of 2008, the Company conducted the required annual test of goodwill for impairment. There were no indications of impairment.
11. INTANGIBLE ASSETS
The tables below provide details of acquired intangible assets at the end of 2008 and 2007:
                                 
                    Currency        
            Accumulated     Translation        
30 September 2008   Gross     Amortization     and Other     Net  
Customer relationships
  $ 248.3     $ (36.7 )   $ 7.3     $ 218.9  
Patents and technology
    106.9       (69.1 )           37.8  
Noncompete covenants
    6.1       (6.4 )     3.1       2.8  
Other
    50.5       (21.1 )     .7       30.1  
 
 
  $ 411.8     $ (133.3 )   $ 11.1     $ 289.6  
 
                                 
                    Currency        
            Accumulated     Translation        
30 September 2007   Gross     Amortization     and Other     Net  
Customer relationships
  $ 230.9     $ (43.6 )   $ 8.6     $ 195.9  
Patents and technology
    103.4       (64.6 )     .3       39.1  
Noncompete covenants
    3.6       (5.5 )     3.9       2.0  
Other
    42.4       (19.1 )     .2       23.5  
 
 
  $ 380.3     $ (132.8 )   $ 13.0     $ 260.5  
 
Amortization expense for intangible assets was $21.0, $19.7, and $12.3 in 2008, 2007, and 2006, respectively.
Projected annual amortization expense for intangible assets as of 30 September 2008 is as follows:
         
2009
  $ 20.4  
2010
    20.0  
2011
    18.7  
2012
    17.6  
2013
    17.3  
Thereafter
    195.6  
 
 
  $ 289.6  
 
12. DEBT
The tables below summarize the Company’s outstanding debt at the end of 2008 and 2007.
Total Debt
                 
30 September   2008     2007  
Short-term borrowings
  $ 419.3     $ 593.3  
Current portion of long-term debt
    32.1       99.8  
Long-term debt
    3,515.4       2,974.7  
 
Total Debt
  $ 3,966.8     $ 3,667.8  
 


53

 


 

Short-Term Borrowings
                 
30 September   2008     2007  
Bank obligations
  $ 322.1     $ 259.3  
Commercial paper
    97.2       334.0  
 
 
  $ 419.3     $ 593.3  
 
The weighted average interest rate of short-term borrowings outstanding as of 30 September 2008 and 2007 was 4.7% and 5.1%, respectively.
Long-Term Debt
                         
30 September   Maturities     2008     2007  
Payable in U.S. Dollars:
                       
Debentures: (effective rate)
                       
8.75% (8.95%)
    2021     $ 18.4     $ 18.4  
Medium-term Notes:
                       
Weighted average rate
                       
Series D 6.8%
    2011 to 2016       63.1       104.0  
Series E 7.6%
    2026       17.2       17.4  
Series F 6.2%
    2010       50.0       50.0  
Series G 4.1%
    2011       125.0       125.0  
Note 4.15%
    2013       300.0        
Other:
                       
Variable-rate industrial revenue bonds 4.4%
    2021 to 2043       743.3       523.3  
Other 2.2%
    2009 to 2021       65.7       111.6  
Less: Unamortized discount
            (16.0 )     (18.9 )
Payable in Other Currencies:
                       
Eurobonds 5.09% (floating rate)
    2010       352.0       355.5  
Eurobonds 4.25%
    2012       422.5       426.7  
Eurobonds 3.75%
    2014       422.5       426.7  
Eurobonds 3.875%
    2015       422.5       426.7  
Eurobonds 4.625%
    2017       422.5       426.7  
Other 4.9%
    2009 to 2014       125.7       72.3  
Capital Lease Obligations:
                       
United States 5.1%
    2009 to 2018       7.0       8.7  
Foreign 7.5%
    2018       6.1       .4  
 
 
          $ 3,547.5     $ 3,074.5  
Less Current Portion
            (32.1 )     (99.8 )
 
 
          $ 3,515.4     $ 2,974.7  
 
Maturities of long-term debt in each of the next five years are as follows: $32.1 in 2009, $469.1 in 2010, $178.8 in 2011, $477.4 in 2012, and $302.3 in 2013.
On 6 February 2008, the Company issued a $300.0 medium-term fixed-rate 4.15% note which matures on 1 February 2013.
During fiscal 2008, the Company issued Industrial Revenue Bonds of $220.0, the proceeds of which are held in escrow until related project spending occurs. As of 30 September 2008, proceeds of $181.2 were held in escrow and classified as a noncurrent asset.
On 3 July 2007, the Company issued a Euro 250.0 million ($340.1) floating rate Eurobond (initial interest rate of 4.315%) which matures on 2 July 2010. A portion of the proceeds were used to repay a Euro 153.5 million fixed 6.5% Eurobond. The balance of the net proceeds of the new Eurobond (after repayment of the 6.5% Eurobond principal and interest) was converted to U.S. dollars and used to repay U.S. commercial paper.
On 12 March 2007, the Company issued Euro 300.0 million ($395.1) of 4.625% Eurobonds maturing 15 March 2017, the proceeds of which were used to fund a portion of the acquisition of BOC Gazy.
Various debt agreements to which the Company is a party include certain financial covenants and other restrictions, including restrictions pertaining to the ability to create property liens and enter into certain sale and leaseback transactions. The Company is in compliance with its financial debt covenants.
The Company has obtained the commitment of a number of commercial banks to lend money at market rates whenever needed. This committed line of credit provides a source of liquidity and is used to support the issuance of commercial paper. The Company’s total multicurrency revolving facility, maturing in May 2011, amounted to $1,450 at 30 September 2008. On 22 September 2008, the Company increased the size of its revolving facility from $1,200 to $1,450 with no changes in the terms and conditions of the arrangement. No borrowings were outstanding under this commitment at the end of 2008. Additional commitments totaling $381.4 are maintained by the Company’s foreign subsidiaries, of which $281.8 was borrowed and outstanding at 30 September 2008.
13. LEASES
Lessee Accounting
Capital leases, primarily for the right to use machinery and equipment, are included with owned plant and equipment on the balance sheet in the amount of $29.2 and $39.5 at the end of 2008 and 2007, respectively. Related amounts of accumulated depreciation are $17.1 and $23.9, respectively.
Operating leases principally relate to distribution equipment and real estate. Certain leases include escalation clauses, renewal, and/or purchase options. Rent expense is recognized on a straight-line basis over the minimum lease term. Rent expense under operating leases, including month-to-month agreements, was $97.2 in 2008, $110.2 in 2007, and $105.6 in 2006.


54   AIR PRODUCTS 2008 ANNUAL REPORT | Notes to the Consolidated Financial Statements

 


 

At 30 September 2008, minimum payments due under leases are as follows:
                 
    Capital     Operating  
    Leases     Leases  
2009
  $ 1.2     $ 49.7  
2010
    1.0       41.0  
2011
    .9       32.1  
2012
    .9       25.7  
2013
    .9       21.5  
Thereafter
    10.1       68.1  
 
 
  $ 15.0     $ 238.1  
 
The present value of the above future capital lease payments is included in the liability section of the balance sheet. At the end of 2008, $.9 was classified as current and $12.2 as long-term.
Lessor Accounting
As discussed under Revenue Recognition in Note 1, certain contracts associated with facilities that are built to service a specific customer are accounted for as leases in accordance with EITF Issue No. 01-08, “Determining Whether an Agreement Contains a Lease.”
Lease receivables, net, were included in the Company’s consolidated balance sheets as follows:
                 
30 September   2008     2007  
Trade receivables
  $ 1.0     $ .6  
Other receivables and current assets
    24.2       17.8  
Noncurrent capital lease receivables
    505.3       326.1  
 
Lease receivables are reflected net of unearned interest income of $138.6 in 2008 and $118.8 in 2007.
Lease payments to be collected over the next five years are as follows: $58.4 in 2009, $63.3 in 2010, $78.8 in 2011, $78.3 in 2012, and $76.6 in 2013.
14. CAPITAL STOCK
Authorized capital stock consists of 25 million preferred shares with a par value of $1 per share, none of which was outstanding at 30 September 2008, and 300 million shares of common stock with a par value of $1 per share.
On 20 September 2007, the Board of Directors authorized the repurchase of up to $1,000 of the Company’s outstanding common stock. This action was in addition to an existing $1,500 share repurchase program which was approved on 16 March 2006. The Company began the original share repurchase program in the third quarter of 2006 pursuant to Rules 10b5-1
and 10b-18 under the Securities Exchange Act of 1934, as amended, through a 10b5-1 written repurchase plan established with several brokers.
As of 30 September 2007, the Company had purchased 15.0 million of its outstanding shares at a cost of $1,063.4. During fiscal year 2008, the Company purchased an additional 8.7 million of its outstanding shares at a cost of $787.4. The Company has completed the 2006 authorization and will continue to purchase shares under the 2007 authorization at its discretion while maintaining sufficient funds for investing in its businesses and growth opportunities. An additional $649.2 in share repurchase authorization remains.
15. SHARE-BASED COMPENSATION
The Company has various share-based compensation programs, which include stock options, deferred stock units, and restricted stock. Under all programs, the terms of the awards are fixed at the grant date. The Company issues shares from treasury stock upon the exercise of stock options, the payout of deferred stock units, and the issuance of restricted stock awards. As of 30 September 2008, 5.8 million shares were available for future grant under the Company’s Long-Term Incentive Plan, which is shareholder approved.
Share-based compensation cost recognized in the income statement is summarized below:
                 
    2008     2007  
Cost of sales
  $ 8.7     $ 9.5  
Selling and administrative
    47.0       57.0  
Research and development
    5.7       4.4  
 
Before-Tax Share-Based Compensation Cost
    61.4       70.9  
Income tax benefit
    (23.6 )     (27.3 )
 
After-Tax Share-Based Compensation Cost
  $ 37.8     $ 43.6  
 
The amount of share-based compensation cost capitalized in 2008 and 2007 was not material.
Total before-tax share-based compensation cost by type of program was as follows:
                 
    2008     2007  
Stock options
  $ 36.5     $ 36.0  
Deferred stock units
    22.6       30.2  
Restricted stock
    2.3       4.7  
 
Before-Tax Share-Based Compensation Cost
  $ 61.4     $ 70.9  
 


55

 


 

Stock Options
The Company has granted awards of options to purchase common stock to executives, selected employees, and outside directors. The exercise price of stock options equals the market price of the Company’s stock on the date of the grant. Options generally vest incrementally over three years, and remain exercisable for ten years from the date of grant. Options have not been issued to directors since 2005. Options outstanding with directors are exercisable six months after the grant date.
The fair value of options granted was estimated using a lattice-based option valuation model that used the assumptions noted in the table below. Expected volatility and expected dividend yield are based on actual historical experience of the Company’s stock and dividends over the historical period equal to the option term. The expected life represents the period of time that options granted are expected to be outstanding based on an analysis of Company-specific historical exercise data. The range given below results from certain groups of employees exhibiting different behavior. Separate groups of employees that have similar historical exercise behavior were considered separately for valuation purposes. The risk-free rate is based on the U.S. Treasury Strips with terms equal to the expected time of exercise as of the grant date.
                         
    2008     2007     2006  
Expected volatility
    30.4 %     30.6 %     30.6 %
Expected dividend yield
    2.1 %     2.1 %     2.1 %
Expected life (in years)
    6.8–8.0       7.0–9.0       7.0–9.0  
Risk-free interest rate
    4.5%–4.6 %     4.5%–4.7 %     4.3%–5.1 %
 
The weighted-average grant-date fair value of options granted during 2008 and 2007 was $31.84 and $22.45 per option, respectively.
A summary of stock option activity is presented below:
                 
            Weighted  
    Shares     Average  
Stock Options   (000)     Exercise Price  
Outstanding at 30 September 2007
    18,622     $ 44.95  
Granted
    1,207       98.85  
Exercised
    (2,204 )     37.46  
Forfeited
    (88 )     68.71  
 
Outstanding at 30 September 2008
    17,537     $ 49.48  
 
Exercisable at 30 September 2008
    14,679     $ 44.18  
 
                 
    Weighted        
    Average        
    Remaining     Aggregate  
    Contractual     Intrinsic  
Stock Options   Terms (in years)     Value  
Outstanding at 30 September 2008
    4.8     $ 333  
 
Exercisable at 30 September 2008
    4.2     $ 357  
 
The aggregate intrinsic value represents the difference between the Company’s closing stock price of $68.49 as of 30 September 2008 and the exercise price multiplied by the number of options outstanding as of that date.
The total intrinsic value of stock options exercised during 2008, 2007, and 2006 was $138.0, $218.8, and $83.6, respectively.
Compensation cost is generally recognized over the stated vesting period consistent with the terms of the arrangement (i.e., either on a straight-line or graded-vesting basis). For awards granted on or after 1 October 2005, expense recognition is accelerated for retirement-eligible individuals who would meet the requirements for vesting of awards upon their retirement.
As of 30 September 2008, there was $9.2 of unrecognized compensation cost related to nonvested stock options, which is expected to be recognized over a weighted-average period of 1.2 years.
Cash received from option exercises during 2008 was $87.4, generating a total tax benefit of $52.2. The excess tax benefit (i.e., the tax deduction in excess of that which would have been recognized had SFAS No. 123R been applied in previous periods) was $41.2 in 2008.
Deferred Stock Units and Restricted Stock
The grant-date fair value of deferred stock units and restricted stock is estimated on the date of grant based on the market price of the stock, and compensation cost is generally amortized to expense on a straight-line basis over the vesting period during which employees perform related services. For awards granted on or after 1 October 2005, expense recognition is accelerated for retirement-eligible individuals who would meet the requirements for vesting of awards upon their retirement.
Deferred Stock Units
The Company has granted deferred stock units to executives, selected employees, and outside directors. These deferred stock units entitle the recipient to one share of common stock upon vesting, which is conditioned on continued employment during the deferral period and may also be conditioned on earn-out against certain performance targets. The deferral period for some units ends after death, disability, or retirement.


56   AIR PRODUCTS 2008 ANNUAL REPORT | Notes to the Consolidated Financial Statements

 


 

However, for a portion of the performance-based deferred stock units, the deferral period ends at the end of the performance period (one to three years) or up to two years thereafter. Certain of the performance-based deferred stock units provide for one-half of the earned shares to be paid in cash at the end of the performance period. Additionally, the Company has granted deferred stock units, subject to a three- or four-year deferral period, to selected employees. Deferred stock units issued to directors are paid after service on the Board of Directors ends at the time elected by the director (not to exceed 10 years after service ends).
                 
            Weighted  
            Average  
    Shares     Grant-Date  
Deferred Stock Units   (000)     Fair Value  
Outstanding at 30 September 2007
    2,283     $ 50.90  
Granted
    283       100.62  
Paid out
    (726 )     48.33  
Forfeited
    (123 )     63.41  
 
Outstanding at 30 September 2008
    1,717     $ 58.94  
 
Cash payments made for performance-based deferred stock units were $8.3 in 2008. As of 30 September 2008, there was $30.8 of unrecognized compensation cost related to deferred stock units. The cost is expected to be recognized over a weighted-average period of 2.3 years.
Restricted Stock
The Company has issued shares of restricted stock to certain officers. Participants are entitled to cash dividends and to vote their respective shares. Shares granted prior to 2007 are subject to forfeiture if employment is terminated other than due to death, disability, or retirement. Shares granted since 2007 vest in four years or upon earlier retirement, death, or disability. The shares are nontransferable while subject to forfeiture.
                 
            Weighted  
            Average  
    Shares     Grant-Date  
Restricted Stock   (000)     Fair Value  
Outstanding at 30 September 2007
    169     $ 56.81  
Granted
    26       96.44  
Vested
    (110 )     55.85  
Forfeited
           
 
Outstanding at 30 September 2008
    85     $ 70.12  
 
As of 30 September 2008, there was $1.8 of unrecognized compensation cost related to restricted stock awards. The cost is expected to be recognized over a weighted-average period of 4.1 years.
16. EARNINGS PER SHARE
The calculation of basic and diluted earnings per share (EPS) is as follows:
                         
30 September   2008     2007     2006  
Numerator
                       
Used in basic and diluted EPS
                       
Income from continuing operations
  $ 1,090.5     $ 1,019.6     $ 734.1  
Income (loss) from discontinued operations,
net of tax
    (180.8 )     16.0       (4.5 )
 
Income before cumulative effect of
accounting change
    909.7       1,035.6       729.6  
Cumulative effect of accounting change, net
of tax
                (6.2 )
 
Net Income
  $ 909.7     $ 1,035.6     $ 723.4  
 
Denominator (in millions)
                       
Weighted average number of common shares
used in basic EPS
    212.2       216.2       221.7  
Effect of dilutive securities:
                       
Employee stock options
    5.9       5.8       4.9  
Other award plans
    1.1       1.2       .9  
 
 
    7.0       7.0       5.8  
 
Weighted average number of common shares
and dilutive potential common shares used in
diluted EPS
    219.2       223.2       227.5  
 
Basic EPS
                       
Income from continuing operations
  $ 5.14     $ 4.72     $ 3.31  
Income (loss) from discontinued operations
    (.85 )     .07       (.02 )
 
Income before cumulative effect of
accounting change
    4.29       4.79       3.29  
Cumulative effect of accounting change
                (.03 )
 
Net Income
  $ 4.29     $ 4.79     $ 3.26  
 
Diluted EPS
                       
Income from continuing operations
  $ 4.97     $ 4.57     $ 3.23  
Income (loss) from discontinued operations
    (.82 )     .07       (.02 )
 
Income before cumulative effect of
accounting change
    4.15       4.64       3.21  
Cumulative effect of accounting change
                (.03 )
 
Net Income
  $ 4.15     $ 4.64     $ 3.18  
 
Diluted EPS reflects the potential dilution that could occur if stock options or other share-based awards were exercised or converted into common stock. The dilutive effect is computed using the treasury stock method, which assumes all share-based awards are exercised and the hypothetical proceeds from exercise are used by the Company to purchase common stock at the average market price during the period. The incremental


57

 


 

\

shares (difference between shares assumed to be issued versus purchased), to the extent they would have been dilutive, are included in the denominator of the diluted EPS calculation. Options on 1.2 million shares, .8 million shares, and 1.2 million shares were antidilutive and therefore excluded from the computation of diluted earnings per share for 2008, 2007, and 2006, respectively.
17. INCOME TAXES
The following table shows the components of the provision for income taxes:
                         
    2008     2007     2006  
Federal
                       
Current
  $ 131.7     $ 94.0     $ 122.0  
Deferred
    3.1       (19.0 )     4.4  
 
 
    134.8       75.0       126.4  
 
State
                       
Current
    2.8       10.5       12.1  
Deferred
    11.0       7.2       1.6  
 
 
    13.8       17.7       13.7  
 
Foreign
                       
Current
    193.9       169.0       121.3  
Deferred
    22.8       25.5       .6  
 
 
    216.7       194.5       121.9  
 
 
  $ 365.3     $ 287.2     $ 262.0  
 
The significant components of deferred tax assets and liabilities are as follows:
                 
30 September   2008     2007  
Gross Deferred Tax Assets
               
Pension and other compensation accruals
  $ 383.2     $ 323.3  
Tax loss carryforwards
    91.1       74.4  
Tax credits
    65.2       3.3  
Reserves and accruals
    30.0       19.2  
Unremitted earnings of foreign entities
    6.9        
U.S. Healthcare impairment
    64.8        
Other
    114.8       98.1  
Currency losses
    83.0       83.7  
Valuation allowance
    (60.7 )     (32.5 )
 
Deferred Tax Assets
    778.3       569.5  
 
Gross Deferred Tax Liabilities
               
Plant and equipment
    887.0       882.9  
Employee benefit plans
    89.2       67.3  
Investment in partnerships
    9.4       10.2  
Unrealized gain on cost investment
    4.6       6.9  
Unremitted earnings of foreign entities
          9.7  
Intangible assets
    30.0       62.2  
Other
    120.3       110.9  
 
Deferred Tax Liabilities
    1,140.5       1,150.1  
 
Net Deferred Income Tax Liability
  $ 362.2     $ 580.6  
 
Net current deferred tax assets of $193.3 and net noncurrent deferred tax assets of $71.1 were included in other receivables and current assets and other noncurrent assets at 30 September 2008, respectively. Net current deferred tax assets of $78.0 and net noncurrent deferred tax assets of $47.0 were included in other receivables and current assets and other noncurrent assets at 30 September 2007, respectively.
Federal, foreign, and state loss carryforwards as of 30 September 2008 were $89.5, $138.7, and $248.8, respectively. The federal capital losses expire in 2013. The foreign losses have expiration periods beginning in 2020. State operating loss carryforwards have expiration periods that range between 2009 and 2027.
The valuation allowance as of 30 September 2008 primarily relates to the tax loss carryforwards referenced above. If events warrant the reversal of the $60.7 valuation allowance, it would result in a reduction of tax expense. The Company believes it is more likely than not that future earnings will be sufficient to utilize the Company’s deferred tax asset, net of existing valuation allowance, at 30 September 2008.
Major differences between the United States federal statutory tax rate and the effective tax rate are:
                         
(percent of income before taxes)   2008     2007     2006  
U.S. federal statutory tax rate
    35.0 %     35.0 %     35.0 %
State taxes, net of federal benefit
    .8       1.2       .9  
Income from equity affiliates
    (3.4 )     (2.8 )     (3.2 )
Foreign taxes and credits
    (6.3 )     (4.4 )     (3.7 )
Export tax benefit and domestic production
    (.6 )     (.8 )     (.7 )
Repatriation
                (1.6 )
Tax audit settlements and adjustments
          (2.6 )     (1.9 )
Donation of investments
          (1.2 )      
Other
    (.4 )     (2.4 )     1.5  
 
Effective Tax Rate after Minority Interest
    25.1 %     22.0 %     26.3 %
Minority interest
    (.4 )     (.4 )     (.5 )
 
Effective Tax Rate
    24.7 %     21.6 %     25.8 %
 
In the fourth quarter of 2007, the Company recorded a tax benefit of $11.3, primarily from tax audit settlements and adjustments and related interest income. In June 2007, the Company settled tax audits through fiscal year 2004 with the Internal Revenue Service. This audit settlement resulted in a tax benefit of $27.5 in the third quarter of 2007. For 2007, tax audit settlements and adjustments totaled $38.8.
In the fourth quarter of 2007, a charge related to the Company’s annual reconciliation and analysis of its current and deferred tax assets and liabilities was recorded and is included in tax audit settlements and adjustments in the above table.


58   AIR PRODUCTS 2008 ANNUAL REPORT | Notes to the Consolidated Financial Statements

 


 

In the fourth quarter of 2006, the Company recorded a tax benefit of $20.0 related to its reconciliation and analysis of its current and deferred tax assets and liabilities. The adjustment pertains to prior years (See Note 1) and is included in tax audit settlements and adjustments in the previous table.
The following table summarizes the income of U.S. and foreign operations, before taxes and minority interest:
                         
    2008     2007     2006  
     
Income from continuing operations:
                       
United States
  $ 479.5     $ 583.1     $ 486.9  
Foreign
    854.3       630.1       436.6  
Income from equity affiliates
    145.0       114.4       91.5  
 
 
  $ 1,478.8     $ 1,327.6     $ 1,015.0  
 
The Company does not pay or record U.S. income taxes on the undistributed earnings of its foreign subsidiaries and corporate joint ventures as long as those earnings are permanently reinvested in the companies that produced them. These cumulative undistributed earnings are included in retained earnings on the consolidated balance sheet and amounted to $2,775.5 at the end of 2008. An estimated $606.1 in U.S. income and foreign withholding taxes would be due if these earnings were remitted as dividends after payment of all deferred taxes.
18. RETIREMENT BENEFITS
The Company and certain of its subsidiaries sponsor defined benefit pension plans and defined contribution plans that cover a substantial portion of its worldwide employees. The principal defined benefit pension plans are the U.S. Salaried Pension Plan and the U.K. Pension Plan. These plans were closed to new participants in 2005 and were replaced with defined contribution plans. The principal defined contribution plan is the Retirement Savings Plan, in which a substantial portion of the U.S. employees participate; a similar plan is offered to U.K. employees. The Company also provides other postretirement benefits consisting primarily of healthcare benefits to U.S. retirees who meet age and service requirements.
At 30 September 2007, the Company adopted the provision of SFAS No. 158 which requires recognition of the overfunded or underfunded projected benefit obligation (PBO) as an asset or liability in the consolidated balance sheet. Refer to Note 2 for a discussion on the impact of adopting SFAS No. 158.
Defined Benefit Pension Plans
Pension benefits earned are generally based on years of service and compensation during active employment. The cost of the Company’s defined benefit pension plans included the following components:
                         
    2008     2007     2006  
   
Service cost
  $ 77.7     $ 81.6     $ 78.9  
Interest cost
    180.9       168.3       147.7  
Expected return on plan assets
    (206.8 )     (188.1 )     (157.1 )
Amortization:
                       
Prior service cost
    3.2       4.2       3.1  
Transition
    .1       .1       .1  
Actuarial loss
    37.9       57.5       65.5  
Settlements and curtailments
    30.3       10.3       .2  
Special termination benefits
    1.2       2.0       12.7  
Other
    2.5       2.6       2.9  
 
Net Periodic Pension Cost
  $ 127.0     $ 138.5     $ 154.0  
 
The Company calculates net periodic pension cost for a given fiscal year based on assumptions developed at the end of the previous fiscal year. The following table sets forth the weighted average assumptions used in the calculation of net periodic pension cost:
                         
    2008     2007     2006  
     
Discount rate
    6.1 %     5.7 %     5.3 %
Expected return on plan assets
    8.8 %     8.8 %     8.8 %
Rate of compensation increase
    4.2 %     4.1 %     4.1 %
 
The decrease in net periodic pension cost from 2007 to 2008 was primarily attributable to the increase in the discount rate.
A number of corporate officers and others who were eligible for supplemental pension plan benefits retired in fiscal years 2007 and 2008. The Company’s supplemental pension plan provides for a lump sum benefit payment option at the time of retirement, or for corporate officers six months after the participant’s retirement date. The Company recognizes pension settlements when payments exceed the sum of service and interest cost components of net periodic pension cost of the plan for the fiscal year. However, a settlement loss may not be recognized until the time the pension obligation is settled. Based on the timing of when cash payments were made, the Company recognized $10.3 for settlement losses in 2007 and an additional $30.3 in 2008.
The projected benefit obligation (PBO) is the actuarial present value of benefits attributable to employee service rendered to date, including the effects of estimated future salary increases. The following table sets forth the weighted average assumptions used in the calculation of the PBO:
                 
    2008     2007  
   
Discount rate
    7.1 %     6.1 %
Rate of compensation increase
    4.3 %     4.2 %
 


59

 


 

The following table reflects the change in the PBO and the change in the fair value of plan assets based on the plan year measurement date, as well as the amounts recognized in the balance sheet. The Company used a measurement date of 30 September for all plans except for plans in the U.K. and Belgium. These plans were measured as of 30 June.
                 
    2008     2007  
     
Change in Pension Benefit Obligation
               
Obligation at beginning of year
  $ 3,033.1     $ 2,933.1  
Service cost
    77.7       81.6  
Interest cost
    180.9       168.3  
Amendments
    1.3       1.8  
Actuarial gain
    (275.8 )     (136.5 )
Special termination benefits, settlements, and
curtailments
    15.5       (.9 )
Participant contributions
    4.6       7.4  
Benefits paid
    (174.8 )     (124.6 )
Currency translation/other
    (130.8 )     102.9  
 
Obligation at End of Year
  $ 2,731.7     $ 3,033.1  
 
 
               
Change in Plan Assets
               
Fair value at beginning of year
  $ 2,600.1     $ 2,052.0  
Actual return on plan assets
    (333.0 )     301.9  
Company contributions
    231.4       288.1  
Participant contributions
    4.6       7.4  
Benefits paid
    (174.8 )     (124.6 )
Currency translation/other
    (110.1 )     75.3  
 
Fair Value at End of Year
  $ 2,218.2     $ 2,600.1  
 
 
               
Funded Status at End of Year
  $ (513.5 )   $ (433.0 )
Employer contributions for U.K. and Belgium after the
measurement date
    2.6       1.9  
 
Net Amount Recognized
  $ (510.9 )   $ (431.1 )
 
 
               
Amounts Recognized
               
Noncurrent assets
  $ 26.6     $ 43.7  
Accrued liabilities
    (123.5 )     (92.0 )
Noncurrent liabilities
    (414.0 )     (382.8 )
 
Net Amount Recognized
  $ (510.9 )   $ (431.1 )
 
The changes in plan assets and benefit obligation that have been recognized in accumulated other comprehensive income (AOCI) on a pretax basis during 2008 consist of the following:
         
Net actuarial loss arising during the period
  $ 277.2  
Amortization of net actuarial loss
    (68.2 )
Prior service cost arising during the period
    1.1  
Amortization of prior service cost
    (3.2 )
Amortization of net transition liability
    (.1 )
 
Total Recognized in AOCI
  $ 206.8  
 
The net actuarial loss represents the actual changes in the estimated obligation and plan assets that have not yet been recognized in the income statement and are included in AOCI. Actuarial losses arising during 2008 are primarily attributable to lower than expected actual returns on plan assets, partially offset by higher discount rates. Actuarial gains and losses are not recognized immediately, but instead are accumulated as a part of the unrecognized net loss balance and amortized into net periodic pension cost over the average remaining service period of participating employees as certain thresholds are met.
The components recognized in AOCI on a pretax basis as of 30 September consisted of:
                 
    2008     2007  
   
Net actuarial loss
  $ 720.1     $ 511.1  
Prior service cost
    27.6       29.7  
Net transition liability
    .4       .5  
 
Total Recognized in AOCI
  $ 748.1     $ 541.3  
 
The amount of AOCI at 30 September 2008 that is expected to be recognized as a component of net periodic pension cost during fiscal year 2009 is as follows:
         
Net actuarial loss
  $ 23.2  
Prior service cost
    3.9  
Net transition liability
    .1  
 
The assets of the Company’s defined benefit pension plans consist primarily of equity and fixed-income securities. Except where the Company’s equity is a component of an index fund, the defined benefit plans are prohibited by Company policy from holding shares of Company stock.
Asset allocation targets are established based on the long-term return and volatility characteristics of the investment classes and recognize the benefit of diversification and the profiles of the plans’ liabilities. The actual and target allocations at the measurement date are as follows:
                         
    2008     2008     2007  
    Target     Actual     Actual  
Asset Category   Allocation     Allocation     Allocation  
     
Equity securities
    63–70 %     64 %     69 %
Debt securities
    25–31       28       26  
Real estate/other
    1–8       6       4  
Cash
    0–3       2       1  
 
Total
            100 %     100 %
 
The Company employs a mix of active and passive investment strategies. Over a full market cycle, the total return on plan assets is expected to exceed that of a passive strategy tracking index returns in each asset category.


60   AIR PRODUCTS 2008 ANNUAL REPORT | Notes to the Consolidated Financial Statements

 


 

The expected return on plan assets assumption is based on an estimated weighted average of long-term returns of major asset classes. In determining asset class returns, the Company takes into account long-term returns of major asset classes, historical performance of plan assets, and related value-added of active management, as well as the current interest rate environment.
The Company anticipates contributing approximately $170 to the defined benefit pension plans in 2009.
Projected benefit payments, which reflect expected future service, are as follows:
         
2009
  $ 124.7  
2010
    130.9  
2011
    138.5  
2012
    150.0  
2013
    158.4  
2014–2018
    964.8  
 
These estimated benefit payments are based on assumptions about future events. Actual benefit payments may vary significantly from these estimates.
The accumulated benefit obligation (ABO) is the actuarial present value of benefits attributed to employee service rendered to a particular date, based on current salaries. The ABO for all defined benefit pension plans was $2,268.3 and $2,481.2 at the end of 2008 and 2007, respectively.
The following table provides information on pension plans where the ABO exceeds the value of plan assets:
                 
    2008     2007  
     
PBO
  $ 1,186.0     $ 310.3  
ABO
    980.3       252.1  
Plan assets
    731.8       38.7  
 
Included in the table above are several pension arrangements that are not funded because of jurisdictional practice. The ABO and PBO related to these plans for 2008 were $95.8 and $137.3, respectively.
Defined Contribution Plans
The Company maintains a nonleveraged employee stock ownership plan (ESOP) which forms part of the Air Products and Chemicals, Inc. Retirement Savings Plan (RSP). The ESOP was established in May of 2002. The balance of the RSP is a qualified defined contribution plan including a 401(k) elective deferral component. A substantial portion of U.S. employees are eligible and participate.
Dividends paid on ESOP shares are treated as ordinary dividends by the Company. Under existing tax law, the Company may deduct dividends which are paid with respect to shares held by the plan. Shares of the Company’s common stock in the ESOP totaled 5,746,677 as of 30 September 2008.
The Company matches a portion of the participants’ contributions to the RSP and other various worldwide defined contribution plans. The Company’s contributions to the RSP include a Company core contribution for eligible employees (not participating in the defined benefit pension plans), with the core contribution based on a percentage of pay, and the percentage is based on years of service. For the RSP, the Company also makes matching contributions on overall employee contributions as a percentage of the employee contribution and includes an enhanced contribution for eligible employees (not participating in the defined benefit pension plans). Worldwide contributions expensed to income in 2008, 2007, and 2006 were $30.1, $28.6, and $25.9, respectively.
Other Postretirement Benefits
The Company provides other postretirement benefits consisting primarily of healthcare benefits to certain U.S. retirees who meet age and service requirements. The healthcare benefit is a continued medical benefit until the retiree reaches age 65. Healthcare benefits are contributory, with contribution percentages adjusted periodically. The retiree medical costs are capped at a specified dollar amount, with the retiree contributing the remainder.
The cost of the Company’s other postretirement benefit plans included the following components:
                         
    2008     2007     2006  
   
Service cost
  $ 5.9     $ 5.9     $ 6.3  
Interest cost
    5.8       5.4       5.1  
Amortization:
                       
Prior service cost
    (1.4 )     (1.8 )     (2.3 )
Actuarial loss
    1.7       2.3       3.5  
 
Net Periodic Postretirement Cost
  $ 12.0     $ 11.8     $ 12.6  
 
The Company calculates net periodic postretirement cost for a given fiscal year based on assumptions developed at the end of the previous fiscal year. The discount rate assumption used in the calculation of net periodic postretirement cost for 2008, 2007, and 2006 was 5.7%, 5.3%, and 4.8%, respectively.
The Company measures the other postretirement benefits as of 30 September. The discount rate assumption used in the calculation of the accumulated postretirement benefit obligation was 7.4% and 5.7% for 2008 and 2007, respectively.


61

 


 

The following table reflects the change in the accumulated postretirement benefit obligation and the amounts recognized in the consolidated balance sheet:
                 
    2008     2007  
   
Obligation at Beginning of Year
  $ 107.2     $ 111.2  
Service cost
    5.9       5.9  
Interest cost
    5.8       5.4  
Actuarial gain
    (10.1 )     (5.0 )
Benefits paid
    (10.0 )     (10.3 )
 
Obligation at End of Year
  $ 98.8     $ 107.2  
 
Amounts Recognized
               
Accrued liabilities
  $ 11.3     $ 11.7  
Noncurrent liabilities
    87.5       95.5  
 
The changes in benefit obligation that have been recognized in accumulated other comprehensive income (AOCI) on a pretax basis during 2008 for the Company’s other postretirement benefit plans consist of the following:
         
Net actuarial gain arising during the period
  $ (10.1 )
Amortization of net actuarial loss
    (1.7 )  
Amortization of prior service credit
    1.4  
 
Total Recognized in AOCI
  $ (10.4 )
 
The components recognized in AOCI on a pretax basis as of 30 September consisted of:
                 
    2008     2007  
   
Net actuarial loss
  $ 12.0     $ 23.8  
Prior service credit
    (1.5 )     (2.9 )
 
Amount Recognized in AOCI
  $ 10.5     $ 20.9  
 
Of the 30 September 2008 actuarial loss and prior service credit, it is estimated that $.3 and $(1.4), respectively, will be amortized into net periodic postretirement cost over fiscal year 2009.
The assumed healthcare trend rates are as follows:
                 
    2008     2007  
   
Healthcare trend rate
    10.0 %     10.0 %
Ultimate trend rate
    5.0 %     5.0 %
Year the ultimate trend rate is reached
    2013       2012  
 
The effect of a change in the healthcare trend rate is slightly tempered by a cap on the average retiree medical cost. The impact of a one percentage point change in the assumed healthcare cost trend rate on net periodic postretirement cost and the obligation is not material.
Projected benefit payments are as follows:
         
2009
  $ 11.8  
2010
    12.2  
2011
    12.7  
2012
    12.8  
2013
    12.6  
2014–2018
    61.0  
 
These estimated benefit payments are based on assumptions about future events. Actual benefit payments may vary significantly from these estimates.
19. COMMITMENTS AND CONTINGENCIES
Litigation
The Company is involved in various legal proceedings, including competition, environmental, health, safety, product liability, and insurance matters. During the third quarter of 2008, a unit of the Brazilian Ministry of Justice issued a report (previously issued in January 2007, and then withdrawn) on its investigation of the Company’s Brazilian subsidiary, Air Products Brazil Ltda., and several other Brazilian industrial gas companies. The report recommended that the Brazilian Administrative Council for Economic Defense impose sanctions on Air Products Brazil Ltda. and the other industrial gas companies for alleged anticompetitive activities. The Company intends to defend this action and cannot, at this time, reasonably predict the ultimate outcome of the proceedings or sanctions, if any, that will be imposed. While the Company does not expect that any sums it may have to pay in connection with this or any other legal proceeding would have a materially adverse effect on its consolidated financial position or net cash flows, a future charge for regulatory fines or damage awards could have a significant impact on the Company’s net income in the period in which it is recorded.
Environmental
In the normal course of business, the Company is involved in legal proceedings under the federal Superfund law, similar state environmental laws, and RCRA relating to the designation of certain sites for investigation or remediation. Presently, there are approximately 31 sites on which a final settlement has not been reached where the Company, along with others, has been designated a potentially responsible party by the Environmental Protection Agency or is otherwise engaged in investigation or remediation. In addition, the Company is also involved in cleanup activities at certain of its manufacturing sites. The Company continually monitors these sites for which it has environmental exposure.


62   AIR PRODUCTS 2008 ANNUAL REPORT | Notes to the Consolidated Financial Statements

 


 

Accruals for environmental loss contingencies are recorded when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated consistent with the policy set forth in Note 1. The consolidated balance sheet at 30 September 2008 and 2007 included an accrual of $82.9 and $52.2, respectively, primarily as part of other noncurrent liabilities. The environmental liabilities will be paid over a period of up to 30 years. The Company estimates the exposure for environmental loss contingencies to range from $82 to a reasonably possible upper exposure of $95 as of 30 September 2008.
Actual costs to be incurred at identified sites in future periods may vary from the estimates, given inherent uncertainties in evaluating environmental exposures. Using reasonably possible alternative assumptions of the exposure level could result in an increase to the environmental accrual. Due to the inherent uncertainties related to environmental exposures, a significant increase to the reasonably possible upper exposure level could occur if a new site is designated, the scope of remediation is increased, a different remediation alternative is identified, or a significant increase in the Company’s proportionate share occurs. While the Company does not expect that any sums it may have to pay in connection with environmental exposures would have a materially adverse effect on its consolidated financial position or net cash flows, a future charge for any damage award could have a significant impact on the Company’s net income in the period in which it is recorded.
Pace
At 30 September 2008, $39.3 of the environmental accrual was related to the Pace, Florida, facility.
In the fourth quarter of 2006, the Company sold its Amines business, which included operations at Pace, and recognized a liability for retained environmental obligations associated with remediation activities at Pace. The Company is required by the Florida Department of Environmental Protection (FDEP) and the United States Environmental Protection Agency (USEPA) to continue its remediation efforts. As of 30 September 2006, the Company estimated that it would take an additional 20 years to complete the groundwater remediation, and the costs through completion were estimated to range from $42 to $50. As no amount within the range was a better estimate than another, the Company recognized a pretax expense in the fourth quarter of 2006 of $42.0 as a component of income from discontinued operations and recorded an environmental accrual of $42.0 in continuing operations on the consolidated balance sheet. Since 30 September 2006, there has been no change to the estimated exposure range related to the Pace facility.
The Company has implemented many of the remedial corrective measures at the Pace, Florida, facility required under 1995 Consent Orders issued by the FDEP and the USEPA. Contaminated soils have been bioremediated, and the treated soils have been secured in a lined on-site disposal cell. Several groundwater recovery systems have been installed to contain and remove contamination from groundwater. The Company completed an extensive assessment of the site to determine how well existing measures are working, what additional corrective measures may be needed, and whether newer remediation technologies that were not available in the 1990s might be suitable to more quickly and effectively remove groundwater contaminants. Based on our assessment results, the Company recently completed a focused feasibility study to identify new approaches to more effectively remove contaminants and will begin to seek the necessary approvals from the FDEP to implement those new approaches.
Piedmont
At 30 September 2008, $23.7 of the environmental accrual was related to the Piedmont site.
On 30 June 2008, the Company sold its Elkton, Md., and Piedmont, S.C., production facilities and the related North American atmospheric emulsions and global pressure sensitive adhesives businesses. In connection with the sale, the Company recognized a liability for retained environmental obligations associated with remediation activities at the Piedmont site. This site is under active remediation for contamination caused by an insolvent prior owner. Before the sale, which triggered expense recognition, remediation costs had been capitalized since they improved the property as compared to its condition when originally acquired. The Company is required by the South Carolina Department of Health and Environmental Control to address both contaminated soil and groundwater. Numerous areas of soil contamination have been addressed, and contaminated groundwater is being recovered and treated. At 30 June 2008, the Company estimated that it would take until 2015 to complete source area remediation and another 15 years thereafter to complete groundwater recovery, with costs through completion estimated to be $24. The Company recognized a pretax expense in the third quarter of 2008 of $24.0 as a component of income from discontinued operations and recorded an environmental liability of $24.0 in continuing operations on the consolidated balance sheet. There has been no change to the estimated exposure.


63

 


 

Guarantees and Warranties
The Company is a party to certain guarantee agreements, including debt guarantees of equity affiliates and equity support agreements. These guarantees are contingent commitments that are related to activities of the Company’s primary businesses.
The Company has guaranteed repayment of some additional borrowings of certain foreign equity affiliates. At 30 September 2008, these guarantees have terms in the range of one to seven years, with maximum potential payments of $23.
The Company has entered into an equity support agreement and operations guarantee related to an air separation facility constructed in Trinidad for a venture in which the Company, through equity affiliates, owns 50%. At 30 September 2008, maximum potential payments under joint and several guarantees were $84. Exposures under the guarantee decline over time and are completely extinguished by 2024.
To date, no equity contributions or payments have been required since the inception of these guarantees. The fair value of the above guarantees is not material.
The Company, in the normal course of business operations, has issued product warranties in its Equipment business. Also, contracts often contain standard terms and conditions which typically include a warranty and indemnification to the buyer that the goods and services purchased do not infringe on third-party intellectual property rights. The provision for estimated future costs relating to warranties is not material to the consolidated financial statements.
The Company does not expect that any sum it may have to pay in connection with guarantees and warranties will have a materially adverse effect on its consolidated financial condition, liquidity, or results of operations.
Put Option Agreements
The Company has entered into put option agreements with certain affiliated companies as discussed below. The Company accounts for the put options as contingent liabilities to purchase an asset. Since the inception of these agreements and through 30 September 2008, the Company determined that it was not certain that these options would be exercised by the other shareholders.
In 2008, the Company entered into a put option agreement as part of the purchase of an additional interest in CryoServices Limited, a cryogenic and specialty gases company in the U.K. The Company increased its ownership from 25% to 72%. Put options were issued which gave the other shareholders the right to require the Company to purchase their shares of CryoServices Limited. The options are effective from January
2010 through January 2078 and are exercisable only within a twenty-day option period each year. The option price is based on the lower of a multiple of earnings formula or 396 Pound Sterling per share, escalated up to 5% each year. The estimated U.S. dollar price of purchasing the remaining stock based on the exchange rate at 30 September 2008 would be approximately $50.
In 1999, the Company made an investment in INOX, an Indian industrial gases company. As part of that transaction, put options were issued which gave the other (joint 50%) shareholders the right to require the Company to purchase their shares (approximately 5.1 million) of INOX (renamed INOXAP) at a predefined price. The option period began January 2004 and extended through January 2006. On 22 January 2005, the Company and the other shareholders extended and revised the terms of the option agreement. The other shareholders may give notice to exercise the revised put option between October and December 2010. The option, if exercised, would be effective on 31 July 2011. The revised option may also be exercised within six months of the death or permanent incapacity of the current Managing Director of INOXAP. The revised option price is based on a multiple of earnings formula, but not less than 630 Rupees per share. The U.S. dollar price of purchasing all 5.1 million shares at the minimum per share amount based on the exchange rate at 30 September 2008 would have been approximately $69.
In 2002, the Company entered into a put option agreement as part of the purchase of an additional interest in San Fu Gas Company, Ltd., renamed Air Products San Fu Company, Ltd. (San Fu), an industrial gas company in Taiwan. Currently, the Company has an ownership interest of 74% in San Fu. Put options were issued which give other shareholders the right to sell San Fu stock to the Company at market price when exercised. The options are effective from January 2005 through January 2015 and allow for the sale of all stock owned by other shareholders to the Company. The estimated U.S. dollar price of purchasing the stock owned by other shareholders based on the exchange rate at 30 September 2008 would be approximately $225.
Purchase Obligations
The Company is obligated to make future payments under unconditional purchase obligations as summarized below:
         
2009
  $ 675.8  
2010
    120.4  
2011
    100.1  
2012
    91.5  
2013
    92.1  
Thereafter
    648.3  
 
Total
  $ 1,728.2  
 


64    AIR PRODUCTS 2008 ANNUAL REPORT | Notes to the Consolidated Financial Statements

 


 

Most of the Company’s long-term unconditional purchase obligations relate to feedstock supply for numerous HyCO (hydrogen, carbon monoxide, and syngas) facilities. The price of feedstock supply is principally related to the price of natural gas. However, long-term take-or-pay sales contracts to HyCO customers are generally matched to the term of the feedstock supply obligations and provide recovery of price increases in the feedstock supply. Due to the matching of most feedstock supply obligations to customer sales contracts, the Company does not believe these purchase obligations would have a material effect on its financial condition or results of operations.
Purchase commitments to spend approximately $485 for additional plant and equipment are included in the unconditional purchase obligations.
20. SUPPLEMENTAL INFORMATION
Other Receivables and Current Assets
                 
30 September   2008     2007  
   
Deferred tax assets
  $ 193.3     $ 78.0  
Other receivables
    131.7       142.4  
Current capital lease receivables
    24.2       17.8  
Other current assets
    .2       .7  
 
 
  $ 349.4     $ 238.9  
 
Other Noncurrent Assets
                 
30 September   2008     2007  
   
Restricted cash
  $ 214.1     $ 27.7  
Derivative instruments
    25.8       8.1  
Other long-term receivables
    10.8       36.4  
Cost investments
    31.9       39.8  
Deferred tax assets
    71.1       47.0  
Prepaid pension benefit cost
    26.6       43.7  
Other deferred charges
    123.8       109.1  
 
 
  $ 504.1     $ 311.8  
 
Payables and Accrued Liabilities
                 
30 September   2008     2007  
   
Trade creditors
  $ 755.2     $ 779.6  
Customer advances
    122.0       90.2  
Accrued payroll and employee benefits
    203.7       182.4  
Pension benefits
    123.5       92.0  
Dividends payable
    92.1       81.8  
Outstanding payments in excess of certain cash balances
    56.1       54.1  
Accrued interest expense
    64.9       62.5  
Derivative instruments
    81.9       27.6  
Global cost reduction plan accrual
          8.4  
Miscellaneous
    166.2       164.6  
 
 
  $ 1,665.6     $ 1,543.2  
 
Deferred Income and Other Noncurrent Liabilities
                 
30 September   2008     2007  
   
Pension benefits
  $ 414.0     $ 382.8  
Postretirement benefits
    87.5       95.5  
Other employee benefits
    91.9       102.7  
FIN 48 tax contingencies
    152.8        
Advance payments
    99.0       122.3  
Environmental liabilities
    81.0       47.1  
Derivative instruments
    33.7       49.7  
Miscellaneous
    89.3       71.9  
 
 
  $ 1,049.2     $ 872.0  
 
Accumulated Other Comprehensive Income (Loss)
                 
30 September   2008     2007  
   
Gain (loss) on derivatives
  $ (19.9 )   $ 3.8  
Cumulative translation adjustments, net of reclassification
adjustment
    (28.3 )     211.7  
Unrealized holding gain on investment, net of reclassification
adjustment for realized gains
    8.1       12.6  
Retirement benefit plans
    (509.2 )     (371.0 )
 
 
  $ (549.3 )   $ (142.9 )
 
In 2008, the Company completed the sale of its Polymer Emulsions business as discussed in Note 5. Accordingly, the related foreign currency translation results of this business totaling $53.7 were reclassified from other comprehensive income to earnings. In 2007, $36.6 of an unrealized gain on an investment was realized as a result of the donation and sale of a cost-based investment. In 2008, a net loss of $68.2 for the defined benefit pension plans was amortized from other comprehensive income to net periodic pension expense. Other amounts reclassified from other comprehensive income into earnings in 2008 and 2007 were not material.
Other (Income) Expense, Net
                         
    2008     2007     2006  
   
Technology and royalty income
  $ (18.6 )   $ (15.9 )   $ (14.1 )
Interest income
    (8.2 )     (8.2 )     (8.1 )
Foreign exchange
    (3.6 )     4.5       2.0  
Gain on sale of assets and investments
    (6.5 )     (23.7 )     (12.8 )
Amortization of intangibles
    9.8       11.2       11.1  
Property damage and related expenses, net of
insurance recoveries
    13.5       (.4 )     (56.5 )
Miscellaneous
    (12.2 )     (9.8 )     6.7  
 
 
  $ (25.8 )   $ (42.3 )   $ (71.7 )
 


65

 


 

Loss from Property Damage
In the fourth quarter of 2008, a fire at the Company’s Ulsan, Korea nitrogen trifluoride (NF3) production facility required the plant to be shut down. The Company has been able to continue supplying NF3 to its customers. The Company anticipates bringing the Ulsan plant back online beginning in January 2009.
Other (income) expense in 2008 included a net loss of $14.7 ($10.7 after-tax, or $.05 per share) related to property damage. The net book value of the damaged property was written off and a receivable was recorded for expected property damage insurance recoveries.
Hurricanes
In the fourth quarter of 2005, the Company’s New Orleans industrial gas complex sustained extensive damage from Hurricane Katrina. Other industrial gases and chemicals facilities in the Gulf Coast region also sustained damages from Hurricanes Katrina and Rita in fiscal 2005.
Insurance recoveries for property damages and business interruption are recognized when claims are settled. Insurance recoveries of $73.3 were recognized in 2006. Other (income) expense included a net gain of $56.0 for insurance recoveries, net of property damage and other expenses. This net gain does not include the estimated impact of costs related to business interruption. During 2006, the Company collected insurance proceeds of $67.0.
The Company closed out its insurance claim related to the hurricanes by the end of fiscal 2006. In the first quarter of 2007, the Company collected $19.1 of insurance proceeds.
Additional Income Statement Information
2007 Customer Contract Settlement
In 2007, the Company entered into a settlement with a customer to resolve a dispute related to a dinitrotoluene (DNT) supply agreement. As part of the settlement agreement, the DNT supply agreement was terminated, and certain other agreements between the companies were amended. As a result, the Company recognized a before-tax gain of $36.8 ($ 23.6 after-tax, or $.11 per share) in 2007.
2007 Donation/Sale of Cost Investment
The Company has a cost-basis investment in a publicly traded foreign company which has been classified as an available-for-sale investment, with holding gains and losses recorded to other comprehensive income, net of income tax. On 19 September 2007, the Company donated 65% of its investment to a tax-exempt charitable organization and sold 15% of
its investment for cash. The Company deducted the fair value of the donation in its fiscal 2007 income tax returns. As a result of the donation, the Company recognized a tax benefit of $18.3 in the fourth quarter of 2007 and pretax expense of $4.7 for the carrying value of the investment. As a result of the sale, the Company recognized a pretax gain of $9.7. In combination, the donation and sale had a favorable net impact of $5.0 on operating income, $19.8 on net income, and $.09 on earnings per share.
2006 Gain on Sale of a Chemical Facility
On 31 March 2006, as part of its announced restructuring of its Polyurethane Intermediates business, the Company sold its DNT production facility in Geismar, Louisiana, to BASF Corporation for $155.0. The Company wrote off the remaining net book value of assets sold, resulting in the recognition of a gain of $70.4 ($42.9 after-tax, or $.19 per share) on the transaction.
2006 Impairment of Loans Receivable
In the second quarter of 2006, the Company recognized a loss of $65.8 ($42.4 after-tax, or $.19 per share) for the impairment of loans receivable from a long-term supplier of sulfuric acid, used in the production of DNT for the Company’s Polyurethane Intermediates business. To facilitate the supplier’s ability to emerge from bankruptcy in June 2003 and continue to supply product to the Company, the Company and other third parties agreed to participate in the supplier’s financing. Subsequent to the initial financing, the Company and the supplier’s other principal lender executed standstill agreements which temporarily amended the terms of the loan agreements, primarily to allow the deferral of principal and interest payments. Based on events occurring within the second quarter of 2006, management concluded that the Company would not be able to collect any amounts due. These events included the Company’s announcement of its plan to restructure its Polyurethane Intermediates business and notification to the supplier of the Company’s intent not to enter into further standstill agreements. In November 2007, the Company canceled all of the outstanding debt and accrued interest due from the supplier under the loan agreements.
Additional Cash Flow Information
Cash paid for interest and taxes was as follows:
                         
    2008     2007     2006  
   
Interest (net of amounts capitalized)
  $ 159.5     $ 141.3     $ 107.6  
Taxes (net of refunds)
    237.2       248.7       278.5  
 


66   AIR PRODUCTS 2008 ANNUAL REPORT | Notes to the Consolidated Financial Statements

 


 

21. SUMMARY BY QUARTER (Unaudited)
These tables summarize the unaudited results of operations for each quarter of 2008 and 2007:
                                         
2008   First     Second     Third     Fourth     Total  
     
Sales
  $ 2,407.4     $ 2,542.7     $ 2,749.7     $ 2,714.7     $ 10,414.5  
Operating income(A)
    380.4       348.6       393.7       373.1       1,495.8  
Income from continuing operations(A)
    262.3       259.8       295.0       273.4       1,090.5  
Income (loss) from discontinued operations(B)
    1.4       54.5       (224.9 )       (11.8 )     (180.8 )  
Net income(A)(B)
    263.7       314.3       70.1       261.6       909.7  
Basic earnings per common share
                                       
Income from continuing operations
    1.22       1.22       1.40       1.30       5.14  
Income (loss) from discontinued operations
    .01       .26       (1.07 )     (.06 )     (.85 )
 
Net income
    1.23       1.48       .33       1.24       4.29  
Diluted earnings per common share
                                       
Income from continuing operations(A)
    1.18       1.18       1.35       1.26       4.97  
Income (loss) from discontinued operations(B)
    .01       .25       (1.03 )     (.05 )     (.82 )
 
Net income(A)(B)
    1.19       1.43       .32       1.21       4.15  
Dividends declared per common share
    .38       .44       .44       .44       1.70  
Market price per common share: high
    105.02       98.80       106.06       100.14          
low
    92.05       80.73       92.20       65.05          
 
(A)  2008 included charges for pension settlements of $30.3 ($18.9 after-tax, or $.09 per share) which were reflected in each of the quarters as follows: First $1.4, Second $26.3, Third $1.0, Fourth $1.6.
 
  Fourth quarter included a net loss of $14.7 ($10.7 after-tax, or $.05 per share) related to property damage at an NF3 production facility in Korea.
 
(B) Second quarter included a gain of $89.5 ($57.7 after-tax, or $.26 per share) for the sale of the Company’s interest in its VAE polymers joint ventures to Wacker Chemie AG.
 
  Third quarter included an impairment charge of $314.8 ($237.0 after-tax, or $1.09 per share) related to the U.S. Healthcare business and a gain of $30.5 ($18.5 after-tax, or $.08 per share) in connection with the sale of the Elkton and Piedmont facilities which completed the disposal of the Company’s Polymer Emulsions business.
 
  Fourth quarter included a charge of $14.4 ($9.2 after-tax, or $.04 per share) for the write-down of the U.S. Healthcare business to net realizable value.
                                         
2007   First     Second     Third     Fourth     Total  
     
Sales
  $ 2,198.3     $ 2,229.7     $ 2,348.9     $ 2,371.3     $ 9,148.2    
Operating income(A)
    321.6       313.6       360.0       380.4       1,375.6  
Income from continuing operations(A)(B)
    223.6       220.0       280.4       295.6       1,019.6  
Income (loss) from discontinued operations(C)
    6.7       7.6       4.5       (2.8 )     16.0  
Net income(A)(B)(C)
    230.3       227.6       284.9       292.8       1,035.6  
Basic earnings per common share
                                       
Income from continuing operations
    1.03       1.02       1.30       1.37       4.72  
Income (loss) from discontinued operations
    .03       .03       .02       (.01 )     .07  
 
Net income
    1.06       1.05       1.32       1.36       4.79  
Diluted earnings per common share
                                       
Income from continuing operations(A)(B)
    1.00       .99       1.26       1.32       4.57  
Income (loss) from discontinued operations(C)
    .03       .03       .02       (.01 )     .07  
 
Net income(A)(B)(C)
    1.03       1.02       1.28       1.31       4.64  
Dividends declared per common share
    .34       .38       .38       .38       1.48  
Market price per common share: high
    72.45       78.63       82.74       98.51          
low
    66.19       68.58       73.30       77.26          
 
(A)  Fourth quarter included a gain of $36.8 ($23.6 after-tax, or $.11 per share) for a customer contract settlement, a charge of $10.3 ($6.4 after-tax, or $.03 per share) from a pension settlement, a charge of $13.7 ($8.8 after-tax, or $.04 per share) for the global cost reduction plan, and a gain of $5.0 ($19.8 after-tax, or $.09 per share) from the donation and sale of a cost-basis investment.
 
(B) Third quarter included a tax benefit of $27.5, or $.12 per share, from audit settlements.
 
  Fourth quarter included a tax benefit of $11.3, or $.05 per share, from tax audit settlements and adjustments.
 
(C) Fourth quarter included a loss of $15.3 ($9.3 after-tax, or $.04 per share) for the write-down of the assets of the HPPC business to net realizable value.
67

 


 

22. BUSINESS SEGMENT AND GEOGRAPHIC INFORMATION
The Company’s segments are organized based on differences in product and/or type of customer. The Company has four business segments consisting of Merchant Gases, Tonnage Gases, Electronics and Performance Materials, and Equipment and Energy.
Previously, the Company reported results for a Healthcare segment and a Chemicals segment [which consisted of the Polymer Emulsions business and the Polyurethane Intermediates (PUI) business]. Beginning with the first quarter of 2008, the Polymer Emulsions business was accounted for as discontinued operations, and the PUI business was reported as part of the Tonnage Gases segment. Beginning with the fourth quarter of 2008, the U.S. Healthcare business was accounted for as discontinued operations, and the Europe Healthcare business was reported as part of the Merchant Gases segment. Prior period information has been restated. Refer to Note 5 for information on discontinued operations.
Merchant Gases
The Merchant Gases segment sells industrial gases such as oxygen, nitrogen and argon (primarily recovered by the cryogenic distillation of air), hydrogen and helium (purchased or refined from crude helium), and medical and specialty gases, along with certain services and equipment, throughout the world to customers in many industries, including those in metals, glass, chemical processing, food processing, healthcare, medical gases, steel, general manufacturing, and petroleum and natural gas industries. There are four principal types of products: liquid bulk, packaged gases, small on-sites, and healthcare products. Most merchant product is delivered via bulk supply, in liquid or gaseous form, by tanker or tube trailer. Smaller quantities of industrial, specialty, and medical gases are delivered in cylinders and dewars as “packaged gases,” or through small on-site gas generation plants (cryogenic or noncryogenic generators). Through its healthcare business, the Company offers respiratory therapies, home medical equipment, and infusion services. Electricity is the largest cost component in the production of atmospheric gases. The Company mitigates energy prices through pricing formulas and surcharges. Merchant Gases competes worldwide against global and regional industrial gas companies. Competition in industrial gases is based primarily on price, reliability of supply, and the development of industrial gas applications. Competition in the healthcare business involves regulatory compliance, price, quality, service, and reliability of supply.
Tonnage Gases
The Tonnage Gases segment supplies industrial gases, including hydrogen, carbon monoxide, syngas, nitrogen, and oxygen, via large on-site facilities or pipeline systems, principally to customers in the petroleum refining, chemical, and metallurgical industries. The Tonnage Gases segment also includes the Company’s PUI business. The PUI business markets toluene diamine to customers under long-term contracts. For large-volume, or “tonnage” industrial gas users, the Company either constructs a gas plant adjacent to or near the customer’s facility—hence the term “on-site”—or delivers product through a pipeline from a nearby location. The Company is the world’s largest provider of hydrogen, which is used by refiners to lower the sulfur content of gasoline and diesel fuels to reduce smog and ozone depletion. Electricity is the largest cost component in the production of atmospheric gases, and natural gas is the principal raw material for hydrogen, carbon monoxide, and syngas production. The Company mitigates energy and natural gas price changes through its long-term cost pass-through type contracts. Tonnage Gases competes against global industrial gas companies, as well as regional sellers. Competition is based primarily on price, reliability of supply, the development of applications that use industrial gases and, in some cases, provision of other services or products such as power and steam generation.
Electronics and Performance Materials
The Electronics and Performance Materials segment employs applications technology to provide solutions to a broad range of global industries through expertise in chemical synthesis, analytical technology, process engineering, and surface science. This segment provides specialty and tonnage gases, specialty chemicals, services, and equipment to the electronics industry for the manufacture of silicon and compound semiconductors, LCD and other displays, and photovoltaic devices. The segment also provides performance chemical solutions for the coatings, inks, adhesives, civil engineering, personal care, institutional and industrial cleaning, mining, oil field, polyurethane, and other industries. The Electronics and Performance Materials segment faces competition on a product-by-product basis against competitors ranging from niche suppliers with a single product to larger and more vertically integrated companies. Competition is principally conducted on the basis of product performance, reliability of product supply, global infrastructure, technical innovation, service, quality, and price.


68   AIR PRODUCTS 2008 ANNUAL REPORT | Notes to the Consolidated Financial Statements

 


 

Equipment and Energy
The Equipment and Energy segment designs and manufactures cryogenic and gas processing equipment for air separation, hydrocarbon recovery and purification, natural gas liquefaction (LNG), and helium distribution, and serves energy markets in a variety of ways. Equipment is sold worldwide to customers in a variety of industries, including chemical and petrochemical manufacturing, oil and gas recovery and processing, and steel and primary metals processing. Energy markets are served through the Company’s operation and partial ownership of cogeneration and flue gas treatment facilities. The Company is developing technologies to continue to serve energy markets in the future, including gasification and alternative energy technologies. Equipment and Energy competes with a great number of firms for all of its offerings except LNG heat exchangers, for which there are fewer competitors due to the limited market size and proprietary technologies. Competition is based primarily on technological performance, service, technical know-how, price, and performance guarantees.
Other
Other operating income includes other expense and income which cannot be directly associated with the business segments, including foreign exchange gains and losses, interest income, and costs previously allocated to businesses now reported as discontinued operations. Also included are LIFO inventory adjustments, as the business segments use FIFO and the LIFO pool is kept at corporate. Corporate research and development costs are fully allocated to the business segments.
Other assets include cash, restricted cash, deferred tax assets, pension assets, financial instruments, and corporate assets previously allocated to businesses now reported as discontinued operations.
Customers
The Company has a large number of customers, and no single customer accounts for a significant portion of annual sales.
Accounting Policies
The accounting policies of the segments are the same as those described in Note 1. The Company evaluates the performance of segments based upon reported segment operating income. Operating income of the business segments includes general corporate expenses.
Intersegment sales are not material and are recorded at selling prices that approximate market prices. Equipment manufactured for the Company’s industrial gas business is generally transferred at cost and not reflected as an intersegment sale.
Long-lived assets include investment in net assets of and advances to equity affiliates, net plant and equipment, goodwill, and net intangible assets.
Business Segments
Business segment information is shown below:
                         
    2008     2007     2006  
   
Revenue from External Customers
                       
Merchant Gases
  $ 4,192.7     $ 3,556.9     $ 3,002.8    
Tonnage Gases
    3,574.4       2,936.7       2,544.7  
Electronics and Performance Materials
    2,209.3       2,068.7       1,801.0  
Equipment and Energy
    438.1       585.9       536.5  
 
Segment and Consolidated Totals
  $ 10,414.5     $ 9,148.2     $ 7,885.0  
 
                         
    2008     2007     2006  
   
Operating Income
                       
Merchant Gases(A)
  $ 789.5     $ 656.4     $ 517.3    
Tonnage Gases(A)
    482.6       463.2       371.7  
Electronics and Performance Materials(A)
    245.9       229.2       190.0  
Equipment and Energy
    38.9       76.8       68.9  
 
Segment Total
    1,556.9       1,425.6       1,147.9  
Pension settlement
    (30.3 )     (10.3 )      
Global cost reduction plan(B)
          (13.7 )     (71.0 )
Other
    (30.8 )     (26.0 )     (35.0 )
 
Consolidated Total
  $ 1,495.8     $ 1,375.6     $ 1,041.9  
 
 
(A)  The impact of the hurricanes in 2006 from insurance recoveries recognized, net of property damage and other expenses, has been allocated to the business segments as follows: Tonnage Gases $31.0, Merchant Gases $23.5, and Electronics and Performance Materials $1.5.
 
(B) Information about how this charge related to the businesses at the segment level is discussed in Note 3.
                         
    2008     2007     2006  
   
Depreciation and Amortization
                       
Merchant Gases
  $ 370.2     $ 332.0     $ 320.5    
Tonnage Gases
    278.9       271.0       211.9  
Electronics and Performance Materials
    208.0       171.7       159.4  
Equipment and Energy
    11.8       14.1       12.9  
 
Segment Total
    868.9       788.8       704.7  
Other
    .1       1.0        
 
Consolidated Total
  $ 869.0     $ 789.8     $ 704.7  
 
                         
    2008     2007     2006  
   
Equity Affiliates’ Income
                       
Merchant Gases
  $ 131.8     $ 97.8     $ 82.4  
Other segments
    13.2       16.6       9.1  
 
Segment and Consolidated Totals
  $ 145.0     $ 114.4     $ 91.5  
 


69

 


 

                         
    2008     2007     2006  
   
Total Assets
                       
Merchant Gases
  $ 5,565.9     $ 5,081.7     $ 4,197.2   
Tonnage Gases
    3,397.8       3,387.7       3,085.3  
Electronics and Performance Materials
    2,388.8       2,481.2       2,293.0  
Equipment and Energy
    328.3       393.2       330.1  
 
Segment Total
    11,680.8       11,343.8       9,905.6  
Other
    775.2       402.5       339.8  
Discontinued operations
    115.3       913.2       935.3  
 
Consolidated Total
  $ 12,571.3     $ 12,659.5     $ 11,180.7  
 
                         
    2008     2007     2006  
   
Investment in and Advances to Equity Affiliates
                       
Merchant Gases
  $ 684.3     $ 642.3     $ 538.7  
Other segments
    138.3       135.8       129.7  
 
Segment and Consolidated Totals
  $ 822.6     $ 778.1     $ 668.4  
 
                         
    2008     2007     2006  
   
Identifiable Assets
                       
Merchant Gases
  $ 4,881.6     $ 4,439.4     $ 3,658.5  
Tonnage Gases
    3,335.4       3,328.4       3,028.6  
Electronics and Performance Materials
    2,341.0       2,435.3       2,245.7  
Equipment and Energy
    300.2       362.6       304.4  
 
Segment Total
    10,858.2       10,565.7       9,237.2  
Other
    775.2       402.5       339.8  
Discontinued operations
    115.3       845.3       875.4  
 
Consolidated Total
  $ 11,748.7     $ 11,813.5     $ 10,452.4  
 
                         
    2008     2007     2006  
   
Expenditures for Long-lived Assets
                       
Merchant Gases
  $ 593.0     $ 888.6     $ 579.5  
Tonnage Gases
    387.9       435.9       534.4  
Electronics and Performance Materials
    198.8       210.5       200.0  
Equipment and Energy
    2.3       9.9       39.6  
 
Segment Total
    1,182.0       1,544.9       1,353.5  
Other
    1.7       1.6       3.1  
 
Consolidated Total
  $ 1,183.7     $ 1,546.5     $ 1,356.6   
 
Geographic Information
Geographic information is presented below:
                         
    2008     2007     2006  
     
Revenues from External Customers
                       
United States
  $ 4,845.1     $ 4,487.6     $ 4,245.5  
Canada
    241.2       185.1       108.0  
Europe
    3,448.0       2,873.5       2,323.1  
Asia
    1,661.3       1,436.9       1,088.3  
Latin America
    218.9       165.1       120.1  
 
 
  $ 10,414.5     $ 9,148.2     $ 7,885.0  
 
                         
    2008     2007     2006  
     
Long-lived Assets
                       
United States
  $ 3,017.0     $ 3,007.4     $ 3,130.9  
Canada
    441.9       442.5       228.7  
Europe
    3,048.6       2,949.5       2,099.6  
Asia
    1,815.3       1,769.7       1,574.3  
Latin America
    255.0       224.1       210.2  
All other
    77.3       81.0       42.8  
 
 
  $ 8,655.1     $ 8,474.2     $ 7,286.5   
 
Geographic information is based on country of origin. Included in United States revenues are export sales to unconsolidated customers of $629.1 in 2008, $677.3 in 2007, and $709.4 in 2006. The Europe segment operates principally in Belgium, France, Germany, the Netherlands, Poland, the U.K., and Spain. The Asia segment operates principally in China, Japan, Korea, and Taiwan.


70   AIR PRODUCTS 2008 ANNUAL REPORT | Notes to the Consolidated Financial Statements

 


 

Five-Year Summary of Selected Financial Data
                                         
(millions of dollars, except per share)   2008     2007     2006     2005     2004  
     
Operating Results
                                       
Sales
  $ 10,415     $ 9,148     $ 7,885     $ 6,822     $ 6,163  
Cost of sales
    7,693       6,699       5,817       4,974       4,456  
Selling and administrative
    1,090       1,000       892       841       799  
Research and development
    131       129       140       121       108  
Global cost reduction plan
          14       71              
Operating income
    1,496       1,376       1,042       922       837  
Equity affiliates’ income
    145       114       92       91       79  
Interest expense
    162       162       118       109       120  
Income tax provision
    365       287       262       231       209  
Income from continuing operations
    1,091       1,020       734       659       575  
Net income
    910       1,036       723       712       604  
Basic earnings per common share
                                       
Income from continuing operations
    5.14       4.72       3.31       2.92       2.57  
Net income
    4.29       4.79       3.26       3.15       2.70  
Diluted earnings per common share
                                       
Income from continuing operations
    4.97       4.57       3.23       2.85       2.51  
Net income
    4.15       4.64       3.18       3.08       2.64  
 
Year-End Financial Position
                                       
Plant and equipment, at cost
  $ 14,989     $ 14,439     $ 12,910     $ 11,915     $ 11,253  
Total assets
    12,571       12,660       11,181       10,409       10,040  
Working capital
    636       436       289       471       711  
Total debt(A)
    3,967       3,668       2,846       2,490       2,385  
Shareholders’ equity
    5,031       5,496       4,924       4,546       4,420  
 
Financial Ratios
                                       
Return on average shareholders’ equity(B)
    20.1 %     19.5 %     15.1 %     14.2 %     14.0 %
Operating margin
    14.4 %     15.0 %     13.2 %     13.5 %     13.6 %
Selling and administrative as a percentage of sales
    10.5 %     10.9 %     11.3 %     12.3 %     13.0 %
Total debt to sum of total debt, shareholders’ equity and minority interest(A)
    43.4 %     39.8 %     36.3 %     34.8 %     34.6 %
 
Other Data
                                       
Depreciation and amortization
  $ 869     $ 790     $ 705     $ 656     $ 662  
Capital expenditures on a GAAP basis(C)
    1,159       1,553       1,358       928       704  
Capital expenditures on a non-GAAP basis(D)
    1,355       1,635       1,487       984       748  
Cash provided by operating activities
    1,680       1,500       1,348       1,304       1,098  
Dividends declared per common share
    1.70       1.48       1.34       1.25       1.04  
Market price range per common share
    106–65       99–66       70–53       66–52       56–44  
 
Weighted average common shares outstanding (in millions)
    212       216       222       226       224  
Weighted average common shares outstanding assuming dilution (in millions)
    219       223       228       231       229  
 
Book value per common share at year-end
  $ 24.03     $ 25.52     $ 22.67     $ 20.49     $ 19.57  
Shareholders at year-end
    8,900       9,300       9,900       10,300       10,700  
Employees at year-end(E)
    21,100       22,100       20,700       20,200       19,900  
 
 
(A)  Total debt includes long-term debt, current portion of long-term debt, and short-term borrowings as of the end of the year. Calculation based on continuing operations.
 
(B) Calculated using income and equity from continuing operations.
 
(C) Capital expenditures on a GAAP basis include additions to plant and equipment, investment in and advances to unconsolidated affiliates, acquisitions (including long-term debt assumed in acquisitions), and capital lease additions.
 
(D) The Company utilizes a non-GAAP measure in the computation of capital expenditures and includes spending associated with facilities accounted for as capital leases. Certain facilities which are built to service a specific customer are accounted for as capital leases in accordance with EITF No. 01-08, “Determining Whether an Arrangement Contains a Lease,” and such spending is reflected as a use of cash within cash provided by operating activities. The presentation of this non-GAAP measure is intended to enhance the usefulness of information by providing a measure which the Company’s management uses internally to evaluate and manage the Company’s capital expenditures.
 
(E)  Includes full- and part-time employees from continuing and discontinued operations.
71